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ABSTRACT 
Background: HIV is now manageable as a chronic disease for those who are 
adherent to medication and remain in care for life. However, remaining in care 
and achieving optimal health outcomes is challenging for many HIV-infected 
individuals. Examining the impact of socio-contextual factors may provide an 
opportunity to design interventions to improve retention in HIV care among 
vulnerable populations. 
Objectives: This study examines the relationship between retention in HIV care , 
social support, and stigma among two vulnerable populations of people living 
with HIV: racial ethnic/minorities and older Black women. 
Methods: I analyzed data collected from a multi-site study of six urban HIV 
clinics to quantitatively examine the relationship between social support, stigma, 
and age with retention in HIV care. I also conducted semi-structured qualitative 
interviews with 20 older Black women (age 50+) who were currently in care at 
Boston-area HIV clinics. The qualitative thematic analysis examined how the two 
viii 
primary domains, the role of stigma and the role of social support, were related to 
engagement and retention in care among the older Black women interviewed. 
Results: The multivariable results from the quantitative analysis showed that 
social support, stigma, and age were not significantly associated with retention in 
care. Among the older Black women I interviewed, those who did not receive 
social support or experienced ongoing stigma portrayed their social world as a 
source of potential distress that affected their ability to engage in care . However, 
women were able to engage in care if they could successfully limit their distress 
by disclosing their HIV status to someone and receiving social support. 
Conclusions: Despite the null results from the multivariable analysis, the 
qualitative findings highlight nuanced and important roles of stigma and social 
support among a particular vulnerable population. The negative consequences 
related to both stigma and low levels of social support, as revealed by the 
qualitative interviews, highlight their remaining importance among older HIV-
infected Black women. Future research and interventions can focus on 
empowering patients to self-manage their HIV care as they age and reducing the 
effects of stigma and low social support to improve patient engagement in HIV 
care. 
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CHAPTER 1: INTRODUCTION 
Statement of the problem 
Current U.S. clinical practice guidelines recommend that HIV-infected 
individuals have primary care appointments at regular intervals. 1 Lapses in 
regular HIV care contribute to poor clinical outcomes.2•3 Irregular attendance at 
clinical visits undermines the effectiveness of treatment because patients who 
miss visits are unable to consistently access antiretroviral therapy (ART).4 
Therefore, lifelong and sustained attendance to clinical care is critical for people 
living with HIV in order to avoid morbidity and mortality.4 
Despite advances in HIV treatment and care in recent decades, often the 
most vulnerable populations of people living with HIV have suboptimal retention 
in HIV care.5·6 Although behavioral, clinical, and community based interventions 
have had an effect on improving retention among vulnerable populations, 3•7-9 
these interventions may ineffective without considering the socio-contextual 
determinants of health. The World Health Organization (WHO) states that the 
socio-contextual determinants of health are the social structures and economic 
systems "in which people are born, grow, live, work, and age, as well as the 
systems put in place to deal with illness."10 Multiple socio-contextual factors may 
contribute to suboptimal retention in HIV care including but not limited to: 
stigma, 11 •12 access to social support, 13 geographic location,14 economic 
resources, 15 or unstable housing. 16 Socio-contextual determinants can also have 
profound effects on health, influence health behaviors, and impact how 
1 
individuals manage their illness and engage with the health care system. 15 
Understanding the variation in socio-contextual determinants of health among 
vulnerable populations is important for identifying specific groups who are more 
or less likely to be retained in care and to develop interventions to improve their 
retention in HIV care. While there are many socio-contextual factors that may 
influence retention in HIV care, in this dissertation I focus on two- social support 
and stigma. Thus, the focus of my research is to explore the relationship between 
retention in HIV care, social support, and stigma among two HIV-infected 
vulnerable groups: ethnic/minorities and older Black women. 
Overview 
Below I provide a brief summary of the content of the chapters in this 
dissertation. 
Throughout this dissertation I refer to both retention and engagement in 
care, because I use a clinically defined retention in care measure, as well as 
characterize reasons for missed visits from the patient-based perspective. 
Although retention and engagement in care are interrelated, both are distinct 
processes that exist along a continuum of care. Retention can be defined as 
patient attendance at primary HIV care visits over a specific time interval.6·17 In 
contrast, engagement in care can be defined as more than just attendance at 
visits and has multiple levels from not being in care to being fully involved in all 
aspects of HIV care. 17·18 For example, HIV-infected individuals who are not 
engaged may be unaware of their HIV status because they have not been tested 
2 
for HIV or have not received their HIV test results. Whereas patients engaged 
fully in care are involved in the multiple aspects of their care, such as receiving 
continued treatment for HIV, receiving prevention messages, and use of ancillary 
support services. 17 
This introductory chapter will provide an overview of: 1) the scope, 
prevalence, and residual effects of poor retention in HIV care; 2) methodological 
issues related to assessing retention in care; 3) why racial/ethnic minorities and 
older Black women are considered vulnerable HIV-infected populations; 4) the 
impact of social support and stigma on retention in HIV care; and 5) the 
limitations of prior research on retention in HIV care. I also offer a conceptual 
framework for understanding retention in HIV care among the two vulnerable 
populations that are the focus of this dissertation. 
Chapters 2 - 4 include the methods, analyses, and discussion of the 
quantitative and qualities studies. Combining both quantitative and qualitative 
methods can provide deeper insight into the association between social support, 
stigma, and retention in care among vulnerable population groups who fail to be 
retained consistently in HIV care. In Chapter 2 I used quantitative data from the 
Centers for Disease Control and Prevention (CDC)/ Health Resources and 
Services Administration (HRSA)-funded multi-site Intervention Trial to Retain 
HIV-Positive Patients in Medical Care study (RIC). The purpose of the 
quantitative analysis conducted in this dissertation is to expand our 
understanding of the impact of social support and stigma on retention in HIV care 
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by examining differences between younger and older groups enrolled in primary 
HIV care at six urban HIV clinics affiliated with academic medical centers and 
serving predominately high-risk populations. In Chapter 3 I collected and 
analyzed qualitative data from older Black women (age 50+) receiving HIV 
primary care in the Boston Metropolitan area. The purpose of the qualitative 
study was to understand subjective experiences with HIV care among older 
Black women, and specifically how their experiences with social support and 
stigma facilitate or inhibit retention in HIV care. The qualitative study will help to 
contextualize the quantitative results and provide further insight into what factors 
contribute to the ability to be retained in HIV care. Finally, in Chapter 4 I 
summarize the results from the two studies, integrate the findings, provide 
insights into how these findings could be applied to interventions designed to 
improve engagement and retention in care, and provide suggestions for future 
research . 
REVIEW OF THE RELEVANT LITERATURE 
The extent of problem: Retaining HIV-infected populations in care 
Retaining HIV-infected individuals in care, through avoiding missed visits, 
has become a recent national public health priority. Individuals who are retained 
in HIV care have reduced treatment delays,2·3 have decreased costs related to 
HIV care, 19 and achieve optimal health outcomes.2·3 However, remaining in care 
and achieving optimal health outcomes is challenging for many HIV-infected 
4 
individuals. Nationally, only 80% of the 1.2 million people living with HIV have 
been diagnosed20 and only 51% were retained in care. 9•21 Of the 51% who are 
retained in care, 89% are prescribed ART and of these, 77% achieve viral 
suppression.21 However, many patients are not retained in care and therefore 
cannot be prescribed antiretroviral medication. In fact, in contrast to the high 
rates of treatment success for those who are retained in care, only 28% of the 
1.2 million HIV-infected individuals are virally suppressed. 9·21 ,22 
Healthy People 2020 23 and the National HIV/AIDS Strategy,24 seminal 
documents related to the nation's health and priorities, outline HIV-specific goals 
including: 1) increasing access and linkage to care; 2) reducing HIV-related 
disparities; 3) improving clinical health outcomes; and 4) improving retention in 
care. Recent literature suggests that progress has been made in these areas, 
with 77% of HIV-infected individuals being linked to care following an HIV 
diagnosis9•21 ·25; however, translating linkage to sustainable retention across time 
remains elusive in many vulnerable HIV-infected populations. 
The profile of HIV-infected populations has shifted to a more vulnerable 
and diverse demographic and risk profile. The HIV epidemic has been 
increasingly marked by a disproportionate growth among older, nonwhite, 
heterosexuals, and injection drug users.20·26 The most vulnerable among these 
groups are often in need of more preventive, acute, and long-term health 
services to remain healthy.6 Thus, examining and understanding the factors 
associated with not being retained in care among vulnerable HIV-infected 
5 
individuals is of major interest to health care providers and the health care 
system.27 
Several studies have documented poorer health outcomes among HIV-
infected individuals who are not retained in care. Researchers have investigated 
the link between missed visits and higher mortality rates in HIV populations.28•29 
For instance, a Veterans Affairs' study found a dose-response relationship 
between retention in care (dose) and survival (response) among newly infected 
HIV patients.28 They found that HIV-infected individuals with suboptimal retention 
in care have worse health outcomes compared to those with optimal retention in 
care. 28 The dose-response relationship significantly affected both CD4 cell count 
and viral load because individuals who accessed HIV care infrequently did not 
have sustained access to ART. 28 Another study of 543 HIV-infected patients 
initiating outpatient care found that patients who missed visits within the first year 
of establishing HIV care had more than twice the rate of long-term mortality 
compared to patients who attended all visits. 29 They suggest that missed visits 
are not the direct cause of higher observed mortality, but instead identify patients 
who are more likely to exhibit health behaviors that may predict poor future 
health outcomes, including mortality.29 Researchers have also found that HIV-
infected patients who missed visits after establishing care posed a greater risk of 
ongoing HIV transmission. 30 One longitudinal study examined receipt of HIV care 
and the risk of HIV transmission among HIV-infected individuals from four U.S. 
cites. They found that those who received HIV primary care at least three times 
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in the previous six months had a reduced risk of HIV transmission compared to 
those with fewer visits.30 They suggest that the reduced risk of HIV transmission 
occurred because patients were retained in regular medical care and had an 
uptake of ART. 30 
Defining and measuring retention in care 
Because there is variation in how retention is reported in the literature, 
below I discuss several ways that retention is assessed and some 
methodological issues related to retention in care measurement. 
Although various definitions of retention in care exist, all definitions include 
visits related to HIV care. Retention can be defined as sustained attendance at 
regularly scheduled visits, attending visits at defined intervals, or reduction in 
missed visits.6 More specifically, retention can be calculated as the number of 
missed appointments, number of kept appointments, appointment adherence, 
appointment non-adherence, or visit constancy. 31 -34 Missed appointments are 
defined as visits that the patient does not attend and that were not canceled or 
rescheduled. Kept appointments are defined as completed visits that patients 
attended. Appointment adherence can be calculated as the proportion of visits 
that were kept of total appointments (missed visits+ kept visits). 34 Appointment 
non-adherence can be calculated as the proportion of visits that were not 
attended of total appointments. 34 Visit constancy can be calculated as the 
proportion of time intervals with at least one kept appointment over a specified 
observation time period (e.g. attended at least one appointment in each of the 
7 
four 3-month intervals within a 12 month observation period).34 
Selecting an appropriate retention measure depends upon the available 
data, how the data are generated, and the intended purpose and context for 
reporting retention34 ; thus, the advantages and disadvantages of the measure 
must be considered . As described by Mugavero et al., 34 the retention in care 
measures referred to above have several advantages and disadvantages. The 
ease of defining the number of kept or missed appointments has led to 
widespread use, especially among researchers and clinicians. However, the 
missed and kept visit appointment measures may mlsclassify the longitudinal 
retention patterns of patients who did not schedule follow-up visits because the 
patients do not have any scheduled visits to attend or miss.34 Likewise, visit 
constancy is easy to measure because one only has to account for completed or 
missed visits at specified intervals over a period of time. 34 In addition, it is easy to 
define which patients have been lost to follow-up because the measure tracks 
patients longitudinally. The primary disadvantage of using missed appointments, 
kept appointments, and visit constancy is the inability to account for the impact of 
disease severity on the frequency of scheduling of appointments.34 The impact of 
disease severity is important to consider because the number of scheduled visits 
can be highly variable among a population if sicker patients have more total 
scheduled visits, and thereby more opportunities to miss or attend visits. Defining 
retention as appointment adherence or non-adherence accounts for the 
cumulative number of scheduled visits (kept and no show) and the variation in 
8 
number of visits due to disease severity.34 The disadvantage of using 
appointment adherence as well as the visit constancy measure is the exclusion 
of canceled visits -- technically canceled visits do not count towards the number 
of scheduled visits since patients give prior notification to the clinic. However, 
they can be an indicator of patients who habitually cancel visits and who are not 
coming to care. Moreover, it may be more difficult to distinguish between those 
who cancel and reschedule their visits, visits that are canceled by the clinic due 
to a scheduling conflict, and those who cancel and do not reschedule their 
visits.34 The difficulty of including canceled visits in the appointment adherence or 
visits constancy measures may be related to the lack of information on whether 
specific visits were rescheduled and the variation in time between the cancelled 
and rescheduled visits. 
The above definitions have evaluated retention from a clinical/medical 
paradigm. However, exploring retention from both a clinical and patient 
perspective can be important in order to comprehensively understand why 
patients fail to stay consistently in care. In Chapter 2 I use a clinical retention 
measure, defined as two kept visits separated by greater than or equal to 90 
days within a 12-month observation period. In Chapter 3 I use qualitative 
methods to characterize reasons for missed visits from the patient-based 
perspective. 
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Major risk factors associated with poor retention in HIV care 
Identifying the characteristics that place HIV-infected individuals at the 
greatest risk for not being retained in care is critical for monitoring and improving 
health outcomes such as HIV suppression and improvement in quality of life_2a 
Sustaining optimal clinical outcomes requires patients to be retained in 
continuous care for life, attending visits at regular intervals.1 More frequent 
follow-up may be necessary for newly diagnosed patients, those with advanced 
disease progression, or those in need of ancillary support services.1·35 
Some studies have found differences in characteristics between HIV-
infected patients who are retained in care and those who are not. For example, 
socio-demographic characteristics that have been associated with poor retention 
in care include identifying as Black, younger age, heterosexual orientation , low 
educational attainment, poverty, and lack of health insurance. 31 ·32·36-39 The 
literature has also documented that a myriad of other well-known factors are also 
linked to poor retention in care such as substance abuse, lack of stable housing, 
unemployment, lack of access to support services, and incarceration.6.4° These 
factors along with other sources of vulnerability such as gender, age, and 
socioeconomic status contribute to disparities in HIV care. 41 The most vulnerable 
HIV-infected populations are at increased risk for illness and often have poor 
health outcomes because of a lack of access to resources that may facilitate 
retention in care.6 In addition, there are less tangible characteristics, such as 
attitudes and beliefs that influence retention in care. Attitudes and beliefs, such 
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as lack of acceptance of one's HIV diagnosis or not going to HIV appointments 
unless one feels sick, are critical for understanding an individual's opinion about 
their illness and whether they can achieve a positive health outcome if they 
successfully follow recommendations for their medical care.42 These factors have 
been linked with avoidance of medical care in persons infected with HIV and 
could be an important link between socio-demographic and clinical factors. 3.43-45 
Vulnerable populations living with HIV 
In general, vulnerable populations are those groups who are at greater 
risk for adverse health outcomes and at risk for diminished quality of life.46 
Research has shown that retention in HIV care is worse among groups bearing a 
disproportionate risk for HIV, such as racial/ethnic minorities and women.47 .48 
Each of the studies in this dissertation will explore aspects of the interaction 
between patient vulnerability, social support, stigma, and retention in care. 
Exploring these issues among vulnerable populations living with HIV is critical as 
there has been a decline in overall HIV-related morbidity and mortality in the U.S. 
over the past decade, yet HIV-related morbidity and mortality among vulnerable 
populations have remained virtually unchanged.49 For the purpose of this 
dissertation , I chose to explore the relationship between retention in HIV care, 
social support, and stigma among two vulnerable populations of people living 
with HIV: racial ethnic/minorities and older Black women. Below, I provide an 
overview of the vulnerable populations included in the two studies of this 
dissertation. 
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Racial/ethnic minorities. The CDC estimates that nearly 1.2 million 
individuals are living with HIV/AIDS in the United States. 5° However, HIV/AIDS 
continues to disproportionately affect racial/ethnic minority populations in the 
U.S., predominantly Blacks and Hispanics. 51 Both of these groups continue to 
represent the majority of 1) new HIV infections, 2) people living with HIV, 3) new 
AIDS cases, and 4) AIDS-related deaths. 51 ·52 The CDC estimated that Black 
American adults and adolescents had approximately eight times (1 ,685 per 
100,000 persons) a greater prevalence of HIV than Whites (223 per 100,000 
persons) and three times the rate (617 per 100,000 persons) of HIV than 
Hispanics/Latinos. 53 Blacks comprised nearly 14% of the U.S. population,54 but 
accounted for an estimated 44% of people living with HIV in 201 0.53·55 In 2011, 
the AIDS diagnosis rate per 100,000 persons was highest among Blacks (41.6) 
compared to any other group (12.2 among Hispanics and 4.2 among Whites). 55 
Hispanics represented nearly 16% of the total U.S. population54, but accounted 
for an estimated 19% of all people living with HIV53 and nearly 21% of new HIV 
infections in 2010. 55 The number of Hispanics/Latinos living with HIV increased 
by 8% between 2008 and 2010, compared to a 5% increase among Whites and a 
7% increase among Blacks. 55 In 2010, the rate of new HIV infections per 100,000 
persons among Hispanic/Latinos was the second highest among all racial/ethnic 
groups (27.5), which is more than three times that of Whites (8.7), but less than 
half that of Blacks (68.9).56 Hispanics also accounted for 21% of new AIDS 
diagnoses in 2011. 55 
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Although the two studies in this dissertation do not focus on men who 
have sex with men (MSM), it is important to note that among all racial/ethnic 
populations, MSM remain the group that is most affected by HIV. Even though 
MSM represented approximately 4% of all males in the U.S., MSM accounted for 
63% of all new infections in 2010.56 White MSM represented the largest number 
of new infections among MSM in 2010 (11 ,200), followed by Black MSM (1 0,600) 
and Hispanic/Latina MSM (6,700).56 Black MSM represented an estimated 72% 
of new infections among all Black men and 36% of new infections among all 
MSM in 2010.56 Black MSM also had the highest estimated number and 
percentage of AIDS diagnoses in 2011 (6,468, 39%).55 Hispanic/Latina MSM 
represented an estimated 79% of new infections among all Hispanic/Latina men 
and 24% of new infections among all MSM in 2010. 56 Among all MSM, 
Hispanic/Latina MSM accounted for 23% of AIDS diagnoses in 2011.55 
Women. HIV disparities are also evident by gender. In particular, Black 
American women have consistently experienced the highest HIV incidence rates 
among all women in the U.S.; the rate of HIV infection within this group was 15 
times the rate of White women and over three times that of Hispanic women. 55 
The multicenter Women's HIV Seroincidence Study (ISIS) confirms high rates of 
HIV infection among Black women in metropolitan areas. 57 In this study, 
conducted in 10 urban metropolitan areas in the eastern U.S., HIV infection rates 
among Black women were five times previous national estimates and 
comparable to estimated HIV adult prevalence in parts of sub-Saharan Africa. 57 
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The findings from the ISIS suggest that Black women living in urban metropolitan 
may be at more of an increased risk for HIV than previously thought. 58·57 The 
women were not engaged in more risky behaviors compared to other women, but 
a complex interaction between social and environmental factors placed them at 
greater risk for HIV.57 
Older populations. It is estimated that by 2015 nearly 50% of persons 
living with HIV will be older than age 50. 59 The increased prevalence of older 
persons, defined as age 50 years and older,60·61 living with HIV is attributable to 
an increase in life expectancy due to ART and to larger numbers of older adults 
being newly diagnosed. 52 The gains in life expectancy have led to an increase in 
older HIV-infected individuals. In the U.S. the estimated life expectancy after an 
HIV diagnosis increased from 10.5 years in 1996 to 22.5 years in 2005.63 In 
terms of new HIV diagnoses, HIV continues to be a disease primarily of younger 
persons55 ; however, the CDC estimates that new HIV diagnoses are also 
increasing in older persons.64 The most recent data from 2010 estimates that 
among older adults (age 50+), the largest percentage (47%) of HIV diagnoses 
occurred among adults age 50-54 compared to other older adults. 54 Additionally, 
the CDC estimates that compared to younger HIV-infected individuals, older 
Black and Hispanic/Latinos were diagnosed with HIV at higher rates than other 
populations.65 Rates of HIV diagnoses (per 100,000 persons) among older 
Blacks (49.2) and Hispanics/Latinos (19.5) were 12.6 and 5.0 times the rate 
among older Whites (3.9), respectively; while rates (per 100,000 persons) among 
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younger Blacks (1 02.5) and Hispanics/Latinos (39.0) were 7.7 and 2.9 times the 
rate among younger Whites, respectively. 65 
Factors that contribute to HIV care outcomes 
Understanding what factors contribute to poor retention in HIV care and 
designing interventions that address these factors, remains paramount to 
improve retention in HIV care. Many factors contribute to the disparities in clinical 
outcomes and retention in care among vulnerable HIV-infected populations, 
including social, historical and economic issues, as well as factors related to 
health care access. 22·66·67 There is considerable debate concerning the 
contribution of each of these factors to disparities in retention in HIV care, yet it is 
plausible that disparities result from a complex interaction among these factors, 
as no single factor can explain disparities. Specifically, in this dissertation, I 
discuss how two of these factors -social support and stigma- influence retention 
in HIV care. 
Social support. Social support has been studied in relation to a variety of 
health outcomes and illnesses. Social support, defined as resources, assistance, 
or help that people receive from a network of individuals and social groups.68,69 
As a multidimensional construct, social support includes both the sources of 
support in one's life and the type of support received.Y0 There are two sources of 
support, formal and informal. I refer to formal support as defined by Schopler and 
Mesibov as "the assistance that is social, psychological, physical, or financial and 
is provided either for free or in exchange for a fee through an organized group or 
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agency."71 In contrast, informal support is defined as assistance provided by "a 
network that may include the immediate and extended family, friends, and 
neighbors."71 The support received from formal and informal sources may 
facilitate provision of specific types of support- informational, emotional, and 
tangible support. Informational support includes providing useful information or 
guidance on how to cope with stressors; this type of support is relevant for 
problem solving. Emotional support consists of the expression and 
communication of affection to let an individual know that he/she is respected and 
valued. Tangible support consists of the provision of goods and services to assist 
others (e.g. financial support, provision of ancillary services, etc.). 69 ·7o 
In general, the presence of social support has been shown to be beneficial 
for overall health and well-being because strong support system helps individuals 
mobilize their psychological resources, optimally respond to stress, and master 
their emotional burdens.72 As applied to the health care field and individuals living 
with illness, the construct of social support has been useful to understand the 
emotional, social, health behaviors, biological links, and the health conditions of 
persons living with illness.73 Social support has been documented to influence 
differences in various health outcomes and behavioral changes among people 
living with HIV, cancer, diabetes, and cardiovascular disease.7°·74-77 
The relationship between social support and HIV care. The two studies 
presented in this dissertation focus on social support, given how social support 
can potentially impact individual patient behavior. Social support is relevant for 
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understanding why individuals with HIV respond to care and treatment 
recommendations differentially. Because social support has been found to be a 
strong enabling factor for engaging in HIV care,78 each of the three types of 
social support described above may be relevant for understanding specifically 
how vulnerable HIV-infected populations engage in care. A good support system 
may encourage HIV-infected individuals to take personal responsibility to remain 
healthy by using health care services regularly. 78 For example, one could seek 
informational support to learn how to manage their HIV care or one could seek 
emotional support to mitigate emotional distress that may be a barrier to care. In 
addition, it is also important to further understand which type(s) of support can be 
most effective for engaging HIV-infected populations in care.79 It is likely that 
specific types of social support may serve as enabling resources that may 
facilitate regular HIV care.78 For example, George et al. have shown that when 
family and friends supported a HIV patient's access to HIV care, they mostly 
provided transportation to appointments or emotional support to encourage 
appointment attendance.80 
Lifetime management of HIV requires strong social support to ensure 
optimal health. For instance, studies have found positive social support to be 
linked to medication adherence.13·81 One study of 179 HIV-infected clinical trial 
participants that investigated the relationship between seven specific social 
support indicators (general support, living situation support, perception of 
economic support, perception of emotional support, perception of physician 
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support, and perception of nurse support), psychological and stage of illness 
factors, and medication adherence behaviors found that having positive 
emotional support was predictive of being adherent to medication.82 The ability to 
cope with an HIV diagnosis has also been linked to having strong social 
support. 13·81 A meta-analytic review of stress and coping among women living 
with HIV found that women who used coping mechanisms such as avoidance 
and denial were less likely to seek support from health and social service 
providers.83 Other studies have highlighted the importance of social support to 
improve retention in HIV care. 13·84·85 For example, Busza and colleagues 
examined barriers to retention in care and have found that social support is 
critical to overcoming barriers to care. 85 Their findings reveal that community-
based social support initiatives such as women's participatory groups have been 
successful for improving retention in care and treatment outcomes in resource-
poor settings. 85 
The quality and structure of social support systems have also been found 
to be an important link to being retained in care. McCoy and colleagues studied 
the association between the quality of social support and delays to entry in care 
after an HIV diagnosis among 216 patients receiving HIV primary care and found 
that among patients with a history of alcoholism, those with lower levels of 
positive social interactions were less likely to enter care than those with high 
levels of positive social interactions.86 Wahl et al. used a cross-sectional design 
to understand how the specific structure of social support systems, stress, HIV 
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disclosure, and stigma impacted retention in HIV care for 398 Latinos and 
Blacks. 87 They found that the number of people to whom one's HIV status was 
disclosed was a significant predictor of retention, because disclosure facilitated 
access to HIV-specific support that was related to the management of their 
illness. In addition, their findings reveal that the types of support provided and the 
sources of support systems were significantly different when compared by 
race/ethnicity and gender/sexual orientation. The Latina and African-American 
women in their study primarily depended on family members for HIV-specific and 
emotional support; while MSM were primarily dependent on friendships. They 
also found that all participants were highly dependent on their providers for HIV-
specific informational support, but MSM relied more heavily on their HIV 
providers compared to HIV-positive women. They suggest that many of the MSM 
who did not remain in care may have experienced stigma from their families to 
the degree that they were either afraid or ashamed to obtain HIV care. 87 
Stigma. Stigma is also relevant to health outcomes and illnesses because 
stigma has the potential to impede social interactions, 88 affect health behaviors, 
and interfere with an individual's ability to cope with disease.89 Goffman defined 
stigma as a label that is attached by society to "an attribute that is deeply 
discrediting" and reduces the stigmatized "from a whole and usual person to a 
tainted, discounted person."88 As a result of stigma, stigmatized individuals are 
labeled as different from non-stigmatized groups and in essence separated from 
mainstream society.88 According to Goffman, this degree of separation or 
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discrimination is a critical contributing factor to social inequality.88 Stigma has 
been linked with social inequality because stigmatized groups are often 
devalued, treated unfairly, and viewed as inferior compared to non-stigmatized 
groups.90 
HIV-related stigma may be considered a type of health-related stigma. A 
health-related stigma is defined by Weiss et al as "a social process, experienced 
or anticipated , characterized by exclusion , rejection, blame or devaluation that 
results from experience, perception or reasonable anticipation of an adverse 
social judgment about a person or group" that is identified with particular health 
problems. 91 Stigma is relevant for understanding retention in care among HIV-
infected populations because stigma can negatively impact individual perceptions 
about the importance of care and negatively impact one's willingness to access 
support that may be useful for navigating care.77·92 Although effective 
management of HIV requires prompt action by the HIV-infected individual to 
access care in order to benefit from treatment and thus achieve optimal health 
outcomes; HIV-related stigma remains a major barrier to accessing care .93 In 
fact, the negative effects of HIV-related stigma, such as the perceived 
discrimination and separation that accompanies HIV-related stigma,92·94•95 can 
interfere with adjusting to the disease96 and remains a major barrier to obtaining 
care.93 
Studies of stigma and HIV care. While research examining the role of 
stigma among people living with HIV continues to evolve, studies examining 
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retention in HIV care and its association with stigma have yielded conflicting 
results. Studies have highlighted the importance of focusing on stigma in efforts 
to improve retention in HIV care. A mixed methods study examining the impact of 
HIV-related stigma among patients in an urban HIV clinic found that patients who 
perceived stigma experienced significant difficulty remaining in HIV care. 11 ·12 
Patients experienced difficulty staying in care because stigma affected their 
ability to connect with family, friends, and primary care providers, who often 
provided support for navigating care. 11 ·12 Another study examining retention in 
HIV care among Latino and African-American women and MSMs receiving HIV 
care found that a high level of perceived stigma was significantly associated with 
poor retention for Latino MSMs.87 Many of the MSM who did not remain in care 
may have experienced stigma from their families to the degree that they 
concealed their HIV status and were afraid or ashamed to obtain HIV care. 87 
These studies indicate that stigma is an important barrier to overcome for 
retaining patients in care and may have even more of an impact in some groups 
as compared to others. In contrast, a study by Naar-King and colleagues of 104 
newly diagnosed people living with HIV found that stigma was not associated 
with retention in their overall results. 97 However, a sub-analysis of the same 
study found that people who reported reduced or no stigma at 6-month follow-up 
were significantly more likely to be retained compared to those who continued to 
report stigma at follow-up. 97 
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The link between social support, stigma, and retention in HIV care. It is 
important to consider the roles that both social support and stigma play in HIV 
care. Rather than considering stigma and social support separately, it is likely 
that stigma and issues related to social support interact to affect retention in H IV 
care. The environment in which social support resources are formed and in which 
stigma occurs may provide links for understanding the relationship between the 
individual health and behavior. 98 Studies have found that social support and 
experiences with stigma are critical to whether and how HIV-infected individuals 
decide to disclose their HIV status. 99 Disclosure can provide an opportunity to 
obtain social support to cope with HIV, and conversely, disclosure can expose 
individuals with HIV to potential stigma, shame, and discrimination. 100 Thus, 
individual perception of stigma might be a contributing factor why vulnerable 
groups often face more difficulty using social support to be retained in HIV 
care.78·101 An HIV-infected individual who has not disclosed his or her HIV status 
may not be able to benefit from social support that encourage consistent care-
seeking behavior. 102 Shehan et al. have suggested that individual beliefs about 
stigma may override the benefits of social support. 103 For example, vulnerable 
populations are often socially marginalized and reside in communities where HIV 
is stigmatized.93 Due to fear of stigma, this social marginalization can affect the 
use of support that facilitates engaging with the health care system. 93 
Conceptual framework 
For this dissertation, I combined two conceptual models: the Engagement 
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in Care Modef1 8 and the Network Episode Modef1°4 to explain the socio-
contextual factors associated with retention in HIV care. Developed by HRSA, 
the Engagement in Care ModeJ1 8 describes engagement in HIV care as a 
continuum (Figure 1.1 ). This model includes six stages on the continuum ranging 
from not in engaged in care through full engagement in HIV care. The model 
defines the first stage (not engaged) as HIV-infected individuals who unaware of 
their HIV status because they either have not been tested for HIV or have not 
received their HIV test results. The second stage consists of HIV-infected 
individuals who are aware of their HIV status, but either are not referred to HIV . 
care or do not keep a referral visit for HIV care. The third stage consists of HIV-
infected individuals who receive other medical care, but not HIV-specific care. In 
the fourth stage, HIV-infected individuals have attended their initial HIV care visit, 
but they do not continue to receive HIV care. Individuals in the fifth stage have 
attended their initial HIV care visit, but thereafter do not consistently utilize HIV 
care. In the final stage, patients engaged fully in care have been tested for HIV, 
acknowledged their HIV status, adhered to scheduled appointments, and have 
adhered received to treatment. HIV-infected individuals may often cycle in and 
out of the six stages of engagement over their lifetime. For example patients may 
become engaged fully in care, but may disengage in care at a later time or the 
contrary, where patients may not be engaged care, but later become engaged in 
care. 
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Figure 1.1 HRSA Engagement in Care Model 
Continuum 
Engagement in Care 
A major strength of the HRSA Engagement in Care Model is the 
emphasis upon the continuum of engagement in care. However, the model does 
not detail the actual process or mechanisms that patients must undertake to 
benefit from HIV care, nor does it detail the demographic factors or social 
conditions that surround persons living with HIV and their impact on where a 
patient may fall in the continuum at any one time. Therefore, it is important to go 
beyond a model that simply describes engagement. 
Several conceptual frameworks, supported with empirical evidence, 
suggest that socio-contextual factors influence a variety of health outcomes. In 
particular, the Network Episode Model (NEM) provides guidance for my research 
by describing socio-contextual factors that influence health outcomes. The NEM 
(Figure 1.2)104, conceptualized by Pescosolido et al., posits that health care 
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decisions are made within a social support system and the social support system 
is the mechanism through which individuals: 1) recognize and respond to illness, 
2) decide when and where to seek medical care, and 3) decide to adhere to 
medical treatment and care. The NEM furthers the idea that social support is an 
integral component of medical care because social connections are important for 
understanding the context and lives of individuals. The model specifies social 
support occurs within the community and medical treatment settings. The NEM 
model also emphasizes that social support that occurs within the community 
consists of personal ties with family, friends, clergy, etc. Social support that 
occurs within the medical treatment setting consists of social ties with physicians, 
nurses, case managers, etc. Further, the structure and content of these 
interactions within the community and medical treatment settings determines how 
and why health care decisions are made. Additionally, the social support that 
occurs within the medical treatment setting is a key factor that influences the 
patient-provider relationship . 
25 
Figure 1.2 The Network Episode Model 
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Although developed as a theoretical underpinning for testing health care 
utilization and medication compliance of persons with serious mental illness, the 
NEM has been applied in other health contexts. 105· 106 Applying the framework of 
the NEM to this dissertation study, I focus on how the social support system 
impacts the retention of vulnerable populations living with HIV. 
For this dissertation, I have conceptualized a model (Figure 1.3) that is an 
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extension of the Engagement in Care and the Network Episode Models to 
describe retention in primary care of HIV-infected individuals. This integrated 
model will guide the analysis and interpretation of data from this dissertation. I 
propose that HIV-infected individuals will respond to illness based on their 
location within the engagement in HIV care continuum, as described by the 
Engagement in Care Model. Furthermore, the decision to stay in care and 
successfully engage in care is dependent upon the social connections within the 
social support system, as described in the NEM. Beliefs and attitudes towards 
HIV care and experiences with stigma will influence the ability to obtain social 
support that facilitates sustained use of HIV care. 
In summary, the integrated theoretical framework may generate a better 
understanding of specific factors that facilitate or inhibit retention in care. 
Previous literature examining retention in HIV care has provoked questions about 
the how the most vulnerable populations enter and exit care and how this cycle 
of entrances and exits impacts health behaviors and outcomes. The framework 
explains how the social support system may impact retention in HIV care. In 
addition, the framework links the HIV care continuum to a larger support system 
that is set within the individual level , community level , and medical system. By 
formulating questions about retention in context of both the HIV care continuum 
and the social support system, I hope to gain deeper insight into how 
experiences with stigma and social support influence how individuals respond to 
their illness. 
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Figure 1.3 Conceptual framework illustrating social and contextual factors and HIV retention in care 
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The CDC/HRSA Intervention Trial to Retain HIV-Positive Patients in Medical 
Care (RIC) Study 
The use of data from the two-phase CDC/HRSA RIC study is a major 
advantage of this dissertation study. 107 Specifically, the data for Chapter 2 of this 
dissertation originated from the CDC/HRSA RIC. The RIC study provides 
longitudinal data on patient characteristics and patient attendance to HIV primary 
care visits from six geographically diverse clinics . Additionally, the research 
design of the RIC is another advantage. Prior studies utilized observationa!1°8 or 
correlation7 methodologies in elucidating answers that required longitudinal or 
randomized designs. However, the RIC is one of several nationally randomized 
controlled studies3·30•109 testing intervention strategies to improve primary care 
retention for persons living with HIV. Thus far there have been three published 
articles from the RIC study,33•107•110 while several others were in progress as of 
2013. 
The RIC was conducted as a two-phase intervention study. The primary 
aim of Phase One of the RIC study was to examine the effect of a clinic-wide 
social marketing intervention on patient attendance for primary medical care. 107 
The intervention utilized brief messages about the importance of staying in care, 
as well as brochures, posters and reminder cards to address the importance of 
attending regular HIV primary care appointments. Phase One included a pretest 
and posttest evaluation of the clinic-wide social marketing intervention. Each 
clinic's attendance rate during a 12-month period before the start of the clinic-
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wide intervention was compared with the attendance rate during the first 12 
months of the intervention and with attendance during two subsequent 12-month 
intervention periods.107 The clinic-wide intervention produced an overall 3% 
increase in the proportion of kept visits and a 7% improvement in patients 
keeping two visits after the implementation of the intervention. Improvements in 
visit attendance were significantly larger for new and reengaging patients, young 
patients, and patients with detectable viralloads. 107 
The second published paper from the RIC study used 12 months of data 
to examine the correlation among six commonly used retention measures and to 
predict viral load suppression. 33 This analysis did not utilize data from the Phase 
One or Two RIC interventions, rather the analysis used medical record laboratory 
values, visit attendance, and demographic data that preceded the Phase One 
intervention . The six retention measures were calculated for patient level 
scheduled HIV primary care visits, the measures were: 1) a total count of missed 
visits; 2) dichotomous measure of missed visits, where "yes" was greater than or 
equal to one missed visit and "no" equaled no missed visits; 3) visit adherence, 
calculated as the proportion of kept visits divided by the number of kept plus 
missed visits; 4) 6-month visit gap, calculated as greater than or equal to 189 
days elapsed between sequential kept visits; 5) 4-month visit constancy, 
calculated as the number of 4-month intervals with at least one kept visit; and 6) 
the HRSA HIV/AIDS Bureau retention measure, calculated as 2 kept visits 
separated by greater than or equal to 90 days over a 12-month period . All six 
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retention in care measures were significantly associated with viral load 
suppression. Measures that were based on kept visits were highly correlated and 
similarly measures based on no-show visits were also highly correlated. 33 
The third published study used 12 months of data to examine if follow-up 
HIV primary care visits scheduled at 4 or 6 month intervals were associated with 
virologic failure compared to follow-up visits scheduled at 3-month intervals. 110 
This analysis also did not utilize data from the Phase One or Two RIC 
interventions, rather the analysis used medical record laboratory values, visit 
attendance, and demographic data that preceded the Phase One intervention. 
Compared to those with follow-up visits scheduled at 3 months intervals, 
individuals whose follow-up visits were scheduled in 4 or 6 months intervals after 
their index clinic visit were not at an increased risk for virologic failure at 12 
months.110 However, having follow-up visits that were missed or cancelled was 
predictive of virologic failure at 12 months after index clinic visit. 110 
The primary aim of Phase Two of the RIC study was to examine the extent 
to which a client-centered intervention improved patient attendance for HIV 
primary care over and above the effect of the clinic-wide intervention. Phase Two 
was a three-arm randomized controlled trial conducted at each of the 
participating six clinics. Two trained interventionists delivered skill-building 
modules to address barriers to care such as navigation, problem solving, 
communication, and organizational skills. Specifically, 300 patients (200 
established and 100 new) were enrolled in the Phase Two trial at each clinic. 
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Patients were randomized to (1) the comprehensive intervention arm in which 
patients received enhanced contact, HIV education, retention risk assessment 
screener, and a client-centered intervention from two trained interventionists, (2) 
limited intervention arm in which patients received enhanced contact and HIV 
education, or (3) the control arm in which patients received routine HIV clinical 
care (standard of care) only. As of the end of participant recruitment, a total of 
1834 participants were enrolled. 
Preliminary results from the Phase Two analysis indicate that both the 
comprehensive and limited intervention arms were associated with improved 
retention in care , with no difference between the two arms. Retention was 
measured as 1) visit constancy -- the percentage of HIV primary care visits 
attended in each of four-month intervals over a 12-month observation period and 
2) visit adherence -- the percentage of kept visits out of total scheduled visits 
(kept+ no show visits). The retention measures were calculated as a rate-ratio 
(relative improvement) compared to the control arm. For the comprehensive arm 
the rate-ratio for visit constancy was 1.22 and 1.08 for visit adherence. For the 
limited arm the rate-ratio for visit constancy was 1.21 and 1.06 for visit 
adherence. 
Summary of Context and Dissertation Study Aims 
The proposed dissertation study aims to expand on the retention in care 
literature by examining the effect of social support and stigma on retention in HIV 
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care for vulnerable groups living with HIV. The specific aims for the dissertation 
study are to: 
Aim 1 (Chapter 2) . Assess the relationship between two socio-contextual factors 
-social support and stigma- and retention in HIV care. To accomplish this aim, I 
analyzed secondary data collected from the RIC after the Phase One intervention 
began and at the baseline of the Phase Two intervention to examine whether 
social support, stigma, and age are associated with retention in HIV care. 
Aim 2 (Chapter 3). Examine how older Black women's retention in HIV care is 
influenced by social support and stigma. To further understand how older Black 
women perceive the effects of stigma and social support on HIV care, I 
undertook a qualitative study to explore how experiences with stigma and social 
support facilitate or inhibit retention in HIV care. To our knowledge, other studies 
have not focused on examining the link between social support, stigma, and 
retention in this population. Focusing on these issues in older Black women in 
particular is important because the long-term HIV-related experience in this 
growing population has been overlooked. 
In Chapter 4, I use the findings from the qualitative study (Chapter 3) to inform 
the quantitative study (Chapter 2) . I draw upon both studies to suggest 
implications for translating findings for retaining individuals in HIV care over their 
lifespan. 
Although there is a growing body of evidence on the impact of social 
support and stigma among vulnerable HIV-infected populations, there remain 
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gaps in the literature linking retention in care to these factors. This dissertation 
study contributes to the field of health services research by addressing gaps in 
our understanding of how social support and stigma are related to retention and 
health outcomes. The findings from this dissertation study may suggest potential 
key points for interventions to influence the course of retention in care. Further, 
the applications of the findings could potentially generate ideas for cross-
disciplinary studies, and development of interventions targeting improvement in 
retention among vulnerable populations living with HIV. 
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CHAPTER 2: ARE SOCIAL SUPPORT, STIGMA, AND AGE PREDICTORS OF 
RETENTION IN HIV CARE AMONG VULNERABLE HIV-INFECTED PATIENTS 
IN URBAN HIV PRIMARY CARE CLINICS? 
Background 
Retention in HIV care has become a national priority among medical 
providers and public health agencies. Poor retention in care remains a significant 
problem among HIV-infected individuals and contributes to poor health outcomes 
and decreased survival.9·21 •29·111 Regular attendance at routine HIV medical care 
can facilitate patients' adherence to antiretroviral therapy (ART), which 
suppresses viral load and mitigates the risk for opportunistic complications.28.112 
Retention in care provides the opportunity to help prompt behavior changes that 
may lead to reduced HIV transmission and prolonged survival.30 Prolonged 
survival has contributed to a demographic shift toward older HIV-infected 
individuals. In fact, projections estimate that fifty percent of HIV-infected 
individuals will be age 50 or older by 2015. 59 Those who survive with HIV are no 
longer dying an early death; however, to maximize the survival benefit they must 
stay in care. 
Socio-contextual factors may be related to how HIV-infected individuals 
respond to treatment recommendations and be related to whether they can stay 
in HIV care.11 -13·72 ·97 As described in Chapter 1, social support and stigma have 
been reported as two important socio-contextual factors that impact retention. 
The environment in which social support resources are formed and in which 
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stigma occurs may provide links for understanding the relationship between the 
individual health and behavior.98 The environment in which social support 
resources are formed and in which stigma occurs may provide links for 
understanding why individuals are or are not retained in care. But few studies 
have examined the relationship between social support, stigma, age, and 
retention in HIV care jointly. This study examined how social support, stigma, and 
age are associated with retention in HIV care among vulnerable patients at urban 
HIV primary care clinics. 
Methods 
The objective of this study was to characterize how social support, stigma, 
and age are associated with retention in HIV care. It is hypothesized that: 
(1) Patients who report lower levels of social support are less likely to be 
retained in care, as measured by 2 kept visits at least 90 days apart over a 
12-month period . 
(2) Patients who report higher levels of stigma are less likely to be 
retained in care , as measured by 2 kept visits at least 90 days apart over a 
12-month period. 
(3) Younger patients are less likely to be retained in care, as measured by 
2 kept visits at least 90 days apart over a 12-month period. 
Study Design 
This study was a retrospective, cross-sectional analysis of data collected 
from the Centers for Disease Control and Prevention (CDC)/ Health Resources 
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and Services Administration (HRSA)-funded Intervention Trial to Retain HIV-
Positive Patients in Medical Care (RIC). The RIC study was a two-phase 
intervention study conducted between January 2007 and March 2013. As 
described in Chapter 1, six large urban HIV primary care clinics participated in 
the RIC study. Phase One of the RIC study implemented a clinic-wide social 
marketing intervention for all patients that addressed the importance of staying in 
care. To examine the effect of the social marketing intervention, the rate of 
attendance at each clinic was compared before and after the intervention to 
determine if retention in care improved across time. Phase Two of the RIC study 
was a three-arm randomized controlled trial for a selected patient cohort 
designed to examine if a tailored patient-centered intervention improved retention 
in care. 
For the current study, a secondary analysis was conducted on baseline 
data from a subset of patients in the Phase One clinic-wide intervention who 
enrolled in Phase Two of the RIC study. These data were collected during the 
recruitment period, between June 2010 and February 2011. This study was 
approved by the CDC Institutional Review Board (IRB) and the IRBs of each of 
the six study sites, including the Boston University Medical Campus IRB. 
Sample 
Individuals eligible for enrollment in Phase Two were HIV-positive, at least 
18 years old, spoke English or Spanish, received outpatient care at one of the six 
HIV primary care clinics, and had no plans to relocate within 12 months post-
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enrollment. In addition, they had to meet the RIC Phase Two inclusion criteria 
which was based upon clinic attendance: 1) established patients with at least one 
no-show for an HIV primary care appointment during the 12 months prior to study 
enrollment; 2) established patients who were not seen at least once for HIV 
primary care in each of the two consecutive 6-month periods prior to study 
enrollment; or 3) all new patients to the clinic (inclusive of newly diagnosed, 
returned after a lapse in HIV care of at least one year, and those who transferred 
care and had no history of visits within the clinic of record). The sample was 
recruited between the period of June 2010 and February 2011. 
Each study site generated a list of all eligible patients who met the 
inclusion criteria. A study coordinator at each site used the list to recruit eligible 
patients when they came to scheduled primary care appointments. Once patients 
agreed to enroll and provided informed consent, the study coordinator collected 
survey data via an audio computer-assisted self-interview (ACASI). Across the 
six RIC study sites, 1,834 participants were enrolled in Phase Two and 
completed the ACASI survey. The ACASI survey included information about 
date of birth, demographic characteristics, mental health distress, social support, 
stigma, substance abuse, barriers to care, attitudes towards medical care, HIV 
risk behavior, medication adherence, unmet needs, health behaviors, sexual risk 
factors, job and housing status, patient-physician interaction, income, and 
education [see Appendix A]. In addition to ACASI data, data were collected from 
the electronic medical record (EMR) for one year prior to enrollment. The EMR 
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data for this analysis was limited to the year prior to enrollment so that the 
retention outcome would not be influenced by the Phase Two intervention. EMR 
data included: CD4 cell count, viral load, date of HIV diagnosis, insurance, and 
attendance at HIV primary care visits . 
This analysis was designed to understand retention in care in the year 
prior to RIC Phase Two enrollment. Only established patients (those with prior 
visits in the previous year who exhibited issues with retention) met the inclusion 
criteria for the final analytic sample. Therefore, of the total of 1,834 RIC Phase 
Two participants, new patients were excluded from this analysis because they 
did not have a visit history in the year prior to the survey (n=527). An additional 
267 respondents were excluded because they were missing one or more 
responses on the ACASI. Three respondents were excluded because they did 
not have linked IDs to their EMR data and nine respondents were excluded 
because they had missing or unknown visit information during the study period 
(July 1, 2009 to June 30, 201 0). Thus, the final analytic sample included 1,028 
participants who had visit data one year prior to survey completion/study 
enrollment and provided complete information for all questions in the ACASI. 
Appendix B provides comparisons of those missing responses to those with 
complete responses. 
The following flow chart (Figure 2.1) illustrates how the analytic sample for 
this study was identified from the overall population of participants in the RIC 
study. 
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Dependent variable 
The dependent variable for this analysis was retention in care. Since there 
are many ways to measure retention and there is no "gold standard" measure for 
retention, 33 the HRSA HIV/AIDS Bureau measure was utilized. The HRSA 
HIV/AIDS Bureau measure of retention has been primarily used to monitor the 
quality of care that HIV primary care clinics provide. 113 The HRSA HIV/AIDS 
Bureau measure of retention in care is defined as two kept visits at least 90 days 
apart within a 12-month period .113 Thus, individuals who kept two visits at least 
90 days apart within a 12-month period were classified as retained; whereas 
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those who did not meet this criteria were classified as not retained. Appendix C 
shows how the dependent variable was measured in the source dataset and 
provides details about the coding for this analysis. 
Main independent variables 
The main independent variables in this study were social support, stigma, 
and age. Appendix D shows how the independent variables were measured in 
the source dataset and provides details about the coding for this analysis. 
Social support was operationalized using the 4-item self-reported modified 
Medical Outcomes Study Social Support Scale (MOS-SSS). 114 The modified 
MOS-SSS assesses four support domains: tangible ("Do you have someone to 
help with daily chores if you are sick?"), emotional-informational ("Do you have 
someone to turn to for suggestions about how to deal with a personal problem?"), 
affectionate (Do you have someone to love and make you feel wanted?"), and 
positive social interaction (Do you have someone to do something enjoyable 
with?"). MOS-SSS respondents are asked , "how often is each of the following 
kinds of support available to you if you need it?" The response options are on a 
5-point Likert scale ranging from none of the time to all of the time. According to 
the literature, each of the Likert responses is summed for a total score where 
1 =none and 5=all of the time, with higher scores indicating a higher level of 
support. 114 The possible total score ranged from 4 to 20. Refer to Appendix E for 
the univariate statistics and distribution of the summary score. I considered the 
responses of "4= most of the time" and "5=all of the time" as indicators of high 
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levels of support. I dummy coded social support into high and low categories for 
the current analysis, because of ease of interpretation of the odds ratio relative to 
the outcome of retention . I derived the cut-point for high and low levels of support 
based on the total minimum summary score for high levels of support. For 
example, if one answered all four items with "most of the time" then their total 
score was 16, and scores of 16 or greater were considered high levels of social 
support, while scores below 16 were considered equal low levels of social 
support. The overall index alpha for the modified MOS-SSS overall index alpha is 
0.83. 114 In addition, the modified 4-item MOS-SSS maintains high Cronbach's 
alpha levels of internal consistency with the original 18-item (0.96) and the 
modified 12-item (0.97) MOS-SSS.114 
Stigma was operationalized using the using the 1 0-item modified HIV 
Stigma scale. 115 The modified HIV Stigma scale assesses four primary domains 
of stigma: personalized stigma as measured by consequences of people knowing 
the respondent's HIV status; disclosure concerns as measured by telling others 
about one's HIV status or hiding HIV status from others; negative self-image as 
compared to others, including feelings of shame or guilt; and public attitudes as 
measured by the public perception of HIV.115 According to the literature, the 
Likert response options range from 1 =strongly agree to 4=strongly disagree, with 
low scores indicating a high level of stigma.115 The total possible score ranged 
from 10 to 40. Refer to Appendix F for the univariate statistics and distribution of 
the summary score. I dummy coded stigma into high and low categories for the 
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current analysis, because of ease of interpretation of the odds ratio relative to the 
outcome of retention. I considered the responses of "1 =strongly agree the time" 
and "2=somewhat agree" as an indicator of a high level of stigma. I derived the 
cut-point for high and low levels of stigma based on the total maximum summary 
score for high levels of stigma. For example, if one answered all 10 items with 
"somewhat agree" then their total score was 20. Scores less than or equal to 20 
indicate high levels of stigma and scores greater than 20 indicate low levels of 
stigma. The Cronbach's alpha values for the four subscales range from 0. 72 to 
0.84 and demonstrate significant correlations with the original subscales. 116 
Age. Participants self-reported month of birth and year of birth. The 
specific date of birth was not collected in order to protect the confidentiality of the 
participants. Age was calculated as of the beginning of the Phase Two 
intervention (June 201 0). I conducted a sensitivity analysis of age to determine 
how to operationalize it as an independent variable in this analysis (see Appendix 
G) . 
The most appropriate choice for this study was to operationalize age as a 
three-level variable. The categories chosen for the three-level variable were 
based on the distribution of age for the sample. The mean age was 45.9 and the 
standard deviation was 10.2 years. The approximate interquartile range was 
used to classify age. The 25th percentile was 39 years, median age was 47.0, 
and the 75th percentile was 53 years. Age then was classified into three 
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categories that approximated this interquartile range: less than 40, 40-54, and 55 
and older. 
Co variates 
Other covariates used in the analysis included race/ethnicity, country of 
birth, education, marital status, housing status, insurance, employment, income, 
primary language spoken , life chaos, mental health distress, alcohol use, 
caregiver status, incarceration, attitudes towards care, structural and financial 
barriers to care, sexual risk behavior, and years living with HIV. In addition, 
information on use of drugs such as cocaine, heroin , and other drugs (crystal 
meth, amphetamines, and prescription drugs) were included. HIV.clinical factors 
(ART adherence, HIV vi ral load, and CD4 cell count) were also included. 
Appendix D shows how the covariates were measured in the source dataset and 
the coding for this analysis. 
Analytic Plan 
The objective of this study was to characterize how social support, stigma, 
and age are associated with retention in HIV care. The integrated conceptual 
framework presented in Chapter 1 illustrates the relationships between these 
factors. In addition, other factors that may also be linked to social support, 
stigma, and age are illustrated in the conceptual framework. These factors 
include demographic, risk, and clinical factors. Based on this framework, the 
effects of low levels of social support, high levels of stigma, and younger age 
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may be associated with poor retention in care adjusted for other influencing 
factors. 
To understand how social support, stigma, and age are associated with 
retention in care I used a four step analytical approach: (1) generate descriptive 
statistics that summarize the data, (2) conduct bivariate analyses to guide model 
construction for the multivariable analyses, (3) conduct correlation analysis to 
determine if candidate variables for the multivariable analysis are collinear, and 
(4) conduct multivariable analysis to address the hypotheses and to draw the 
conclusions. 
First, descriptive statistics were generated for all the variables. The 
income variable was excluded from analysis since the extreme range of 
responses ($0 to $5 million dollars annually, data not shown) led to questions 
about the validity of the income data. It is possible that some participants may 
have found this question to be overly sensitive or perhaps did not understand the 
question, and thus many of them did not respond accurately. 
Second, all of the variables in the conceptual model were tested for 
association with retention in care except for income. Bivariate analyses related 
each of the main variables of interest and the covariates for the groups who were 
retained and not retained in care. Bivariate analyses were conducted using chi-
square analysis and t-tests for categorical and continuous variables respectively. 
For bivariate analyses of two categorical variables, p-values were calculated 
using chi-square or Fisher's exact test (for low cell counts). For continuous 
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variables the mean, standard deviation, and p-value were calculated. Variables 
that were associated with the dependent variable, retention in care, at the p<0.1 0 
level or lower in the bivariate analyses were considered for inclusion in the 
multivariable analysis. To ensure that no important variables were omitted for 
inclusion in the multivariable analysis , variables were identified for inclusion 
based on a combination factors: the main variables of interest social support, 
stigma, and age; significance in the bivariate analyses; and importance in the 
retention in care literature and relevance to the conceptual model. I identified that 
the following variables were related with retention in care in the literature: 
race/ethnicity, gender, education, insurance, incarceration , housing, cocaine use, 
other drug use, and barriers to care. 
Next, all variables selected as candidates for the multivariable analyses 
were assessed for collinearity. Each pair of variables were examined with 
Pearson correlation coefficient analysis. If variables were found to be moderately 
(0.20<r>0.40) or highly correlated (>0.40) with the main variables of interest it 
was considered for exclusion from the model. Stigma and social support were 
inversely correlated with each other (r= -0.30, p<0.0001 ). However, because 
these were two of the main variables of interest I considered both as variables 
for inclusion in the multivariable models. Mental health was not included in the 
final models because it was moderately associated with social support and 
stigma (see Appendix H). 
In the final step, four sequential multivariable models were developed by 
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adding the main variables of interest and covariates in a stages (or groupings) 
based on the conceptual framework described in Chapter 1. The four models 
were developed in stages to assess the magnitude and direction of effect of the 
data. The estimates produced from the models allowed for detection of 
differences in social support, stigma, and age as a function of other significant 
covariates. In each model, I controlled for other influencing covariates and 
identified associations across all the model variables with retention in care. Since 
the parent RIC study was designed to detect differences based upon study site, 
the analyses were modeled as fixed-effects to adjust for unobserved differences 
by site. Each model was adjusted for site as a fixed-effect. The site specific 
effects were not reported in this analysis. The general model is as follows: 
Y= bo + b1 (social support)+ b2 (stigma)+ b3 (age) + ... + bi (covariate) +error. 
Where Y = dichotomous outcome (yes = retained in care, no = not retained in 
care). 
In model one, the effect of the main hypothesized independent variables 
of interest- social support, stigma, and age- were estimated. In model two, I 
controlled for key sociodemographic characteristics: race/ethnicity, gender, 
education, and insurance. In model three, I added other covariate variables: 
incarceration, housing, cocaine use, other drug use, and barriers to care. In the 
final model, CD4 cell count, viral load, ART status, an9 years living with HIV were 
added. I tested three separate final models to account for the correlation between 
social support and stigma. I first tested a model that removed social support but 
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included stigma, age and the significant covariates. I then tested another model 
that removed stigma but included social support, age, and the significant 
covariates. And finally, I tested a model that included both social support and 
stigma in the same model. I found the parameter estimates, significance of the 
parameter estimates, and odds ratios were approximately the same for all 
models (results not shown). However, because I was interested in the joint 
relationship between social support, stigma, and age I chose the model that 
included both stigma and social support. The final model was tested for 
interactions where I allowed for any combination of variables with social support, 
stigma, and age. However, I did not find any significant interactions. The 
multivariable model with the Akaike's Information Criterion (AIC) closest to zero 
was considered to fit the data best. 117 The findings reported in the Results 
section are taken from the final adjusted model (Model 4), unless otherwise 
specified. 
SAS software, version 9.1 was used for all analyses. The SAS procedure 
generalized linear mixed model (GLIMMIX) was used for all multivariable model 
estimates. 118 GLIMMIX was the most appropriate procedure for the multivariable 
model estimates based on the following conditions: (1) the data are correlated, 
(2) the outcome does not meet normality distributions, and (3) clustering of 
individuals by each study site. 119 The results from the correlation analysis 
(Appendix H) show that the data used in this analysis were marginally correlated. 
In addition, the outcome, retention in care, was skewed towards more individuals 
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retained rather than not retained -meaning that the outcome was not normally 
distributed. The analytic sample is drawn from six urban HIV primary care clinics 
that participated in the RIC intervention- meaning that these six sites were not 
drawn from a random sampling distribution of all possible HIV primary care 
clinics. Thus, inferences for this analysis are to be made only regarding the six 
sites. 
Results 
Characteristics of the overall study sample 
Characteristics of the study sample are shown in Table 2.1. Over 60% of 
the sample was male and more than half were between the ages of 40 and 
54.The sample was predominantly Black (69%). Three-fourths were not 
employed. Thirty seven percent reported that they had never completed high 
school or received aGED. The majority reported being born in the U.S. (81%) 
and speaking English as their primary language (87%). Seventy-seven percent 
had health insurance, with the largest proportion (44%) being insured by 
Medicaid. Fifty eight percent reported high levels of social support and 33% 
reported experiencing a high level of stigma. The mean time since HIV diagnosis 
was 12 years. 
Forty seven percent reported that their HIV risk factor was heterosexual 
contact and 20% reported injection drug use (IOU) as a risk factor. In terms of 
clinical factors, 67% had an undetectable viral load and 62% had a CD4 cell 
count greater than 350 copies/mi. 
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Twenty one percent reported high levels of alcohol use. When asked 
about different types of drug use in the past 90 days, 4% reported using heroin, 
13% reported using cocaine, and 5% reported using other drugs (prescription 
drugs, crystal meth , and amphetamines). 
Forty six percent reported a high level of mental health distress. Few 
participants reported ever being incarcerated (7%). Twelve percent reported 
being a caregiver for adults and 20% reported being a caregiver for children in 
their household. 
About 13% reported high levels of life chaos. Participants overwhelmingly 
reported positive attitudes about coming to care (95%). However, participants 
reported barriers to coming to care. When asked about six different types of 
barriers to coming to care: 8% reported difficulty scheduling appointments due to 
lack of access to a phone, 7% reported problems getting someone to answer 
calls to schedule an appointment, 11% reported problems booking appointments 
at convenient times, 3% reported difficulty finding providers who speak the same 
language, 19% reported having trouble paying for HIV medical care, and 17% 
encountered a lack of access to transportation to medical appointments. 
Notably, 11% of participants were not retained in care over the 12-month 
observation period . 
Characteristics of the 11% not retained in care 
Below I report the proportions for each characteristic within the 11% of 
the individuals who were not retained in care (Table 2.1 ). A third of these 
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individuals who were not retained were younger than age 40 (34%) while slightly 
more than half were between 40-54 in age (52%). Participants not retained were 
predominantly Black (66%), male (68%), born in the U.S. (83%), and spoke 
English as their primary language (90%). The largest proportion of individuals 
who were not retained reported an education of some college or greater (40%). 
The majority of those not retained reported being unemployed (73%). Forty 
percent reported being uninsured. Less than half (46%) reported low levels of 
social support or high levels of stigma (34%). The mean time since diagnosis 
was 11 years. 
Thirty nine percent reported that their HIV risk factor was heterosexual 
contact and 25% reported IOU as a risk factor. The In terms of HIV clinical 
factors, 51% had a CD4 observation above 350 cells/mL and 59% had a 
detectable viral load. 
Of those not retained , 25% the participants reported alcohol use. Current 
(20%) or past (38%) cocaine use was commonly reported among those not 
retained. More than half of the participants reported high mental health distress 
(62%), never using heroin (76%), and never using other drugs (62%). 
Less than a quarter reported a history of incarceration (15%), being a 
caregiver for adults (14%), and a caregiver for children (16%). Among those not 
retained, the majority either reported living in their own home/apartment (60%) or 
living in someone else's home/apartment (28%). 
Among those not retained in care, about 16% reported high levels of life 
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chaos. Participants who were not retained reported an overwhelmingly positive 
attitude towards care (95%). However, when asked about six different types of 
barriers to coming to care: 14% reported difficulty scheduling appointments due 
to lack of access to a phone, 7% reported problems getting someone to answer 
calls to schedule an appointment, 17% reported problems booking appointments 
at convenient times, 4% reported difficulty finding providers who speak the same 
language, 33% reported having trouble paying for HIV medical care , and 26% 
encountered a lack of access to transportation to medical appointments. 
The results of the bivariate and multivariable analyses are reported below. 
Bivariate results 
Below I compare those patients who were retained in care to those who 
were not retained (Table 2.1 ). Neither social support nor stigma were associated 
with retention in care significantly. However, age was associated with retention in 
care- compared to those who were not retained in care, a greater percentage of 
participants who were reta ined were either age 40-54 (55% compared to 52%) 
age 55 or older (21% compared to 15%, p=0.06). 
When examining the other covariates and their association with retention , 
there were some factors that were significant in bivariate association. A slightly 
higher proportion of those retained were Black (69%) compared to those not 
retained (66%, p=0.04) ; however, among all racial/ethnic groups Whites were the 
only group less likely to be retained than not retained (1 0% vs. 19%). More 
individuals who were retained reported having Medicaid (45%) as opposed to 
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being uninsured, which was more common among those not retained (40%, 
p=0.0002). Those who were retained were less than half as likely to report a 
history of incarceration (6% compared to 15% among those not retained, 
p=0.0002). More of those retained reported living in their own home/apartment 
(70% compared to 60% among those not retained, p=0.06). Fewer of those 
retained reported high levels of mental health distress (44%) compared to those 
who were not retained (62%, p=0.0003). In terms of drug use, those retained in 
care were less likely to report cocaine use in the past 90 days (p=0 .05) or other 
drug use (crystal meth, amphetamines, or prescription drugs [p=0.0004]) in the 
past 90 days. When asked about barriers to care, those who were retained were 
less likely to report encountering barriers related to paying for HIV medical care 
(p<0.0001 ), difficulty scheduling appointments due to lack of access to a phone 
(p=0.03), problems booking an appointment at a convenient time (p=0.02), or 
problems with transportation (p=0.006) compared to those were not retained in 
care, respectively. A higher proportion of those retained reported currently taking 
ART (87% vs. 69% among those not retained, p<0.0001 ). In terms of clinical 
characteristics, more individuals who were retained had CD4 cell counts above 
350 (64%) compared to those not retained (51%, p=0.02). Participants who were 
retained also were more likely to have an undetectable viral load (70%) 
compared to those not retained (41 %, p<0.0001 ). 
Multivariable results 
In multivariable analysis, none of the hypotheses were proven. None of 
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the three independent variables - social support, stigma, or age - were 
significantly associated with retention in care in any of the models (Table 2.2). 
However, some covariates were significantly related to not being retained in care. 
Individuals who were uninsured were less likely to be retained (OR: 0.48, Cl: 
0.27, 0.87). Use of other drugs in the past 90 days (crystal meth, amphetamines, 
or prescription drugs) was associated with not being retained in care (OR: 0.43, 
Cl: 0.20, 0.91 ); however this association did not remain significant across all 
models. Those who were not retained in care were significantly less likely to have 
an undetectable viral load (OR: 0.38, Cl : 0.23, 0.61) or to be currently taking ART 
(OR: 0.49, Cl: 0.29, 0.83). 
Discussion 
Overall, there was no association between social support, stigma, age and 
retention in care in the multivariable models. There are several possible 
explanations for the negative results. One explanation could be attributed to the 
parent study (RIC) design. Only patients who previously missed visits and 
attended an enrollment visit to complete the survey were included the sample for 
the RIC. This criteria does not represent a complete clinic sample, which should 
include both patients who had no prior challenges with retention and patients 
who had challenges with retention . Since this study sample was skewed towards 
patients who already had issues being retained there may not have been enough 
variation among the sample to detect a difference in retention . 
Although social support, stigma, and age had no effect on a patient's 
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retention in this sample, the findings are in contrast to some other 
studies.120,12·97·121 ·122 Once multiple covariates were included in the multivariable 
models, age was no longer significantly associated with retention. Other factors, 
such as substance use or being uninsured, can deter retention in care. This may 
indicate that these variables are better explanatory variables for retention . 
Participants in this study did not provide specific information about the sources 
and characteristics of social support related to HIV care, such as whether anyone 
encouraged them to attend clinic visits or if anyone offered to help them attend 
visits. Previous studies have shown that the sources, nature, and characteristics 
of a patient's social support system are most relevant to not only the quality, but 
also the consistency of health care received. 80·123·124 For example, barriers to 
care such as transportation or problems scheduling an appointment at a 
convenient time could have been mitigated if one was able to obtain tangible 
support. However, in this study the social support measure was not specifically 
linked to participants' views of social support and its relationship to retention in 
HIV care or HIV in general; therefore, it was difficult to detect whether 
participants viewed themselves as receiving social support related to overcoming 
barriers to remaining in HIV care. A large proportion of the participants reported 
high levels of social support and did not experience stigma. This suggests that it 
is possible there was not enough variation among the sample to detect 
differences in social support and stigma. In addition, other unmeasured factors-
such as self-efficacy125 or beliefs about the importance of HIV care77 -may 
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have influenced the results. These unmeasured factors may be located along the 
causal pathway between the three independent variables and retention in care, 
and thus, may have a mediating effect on retention. 
Similar to previous studies, participants who used other drugs (crystal 
meth, amphetamines, and prescription drugs) within the past 90 days, were 
uninsured, were not currently on ART, and were not virologically suppressed 
were significantly more likely to experience poorer retention in HIV 
care.3•6•67·126•127 While use of other drugs in the past 90 days remained 
significantly associated with poor retention in the adjusted multivariable results 
(model 3), when ART and viral load were included as clinical covariates (model 
4) the association between drug use and retention was no longer significant. In 
addition, insurance status was significant across models 2-4. These findings 
were expected, as it is widely known that having insurance increases access to 
care 6·78•128 - and that patients who have access to care and remain in care have 
increased access to ART, improved medication adherence, and are more likely 
to be virologically suppressed.6 
Limitations 
This study has some limitations. This analysis used cross-sectional survey 
data, as a result questions of causality or temporality could not be answered. 
Since the survey was based on self-report, the responses were subject to recall 
bias. The findings were not generalizable to patients who were not connected 
with care. Although only patients who exhibited prior issues with retention met 
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the inclusion criteria, the sample was exclusively composed of HIV-infected 
patients who were already in HIV care and were recruited from a clinical setting. 
In addition, although patients from six geographically diverse clinics were 
included in this analysis, the sample lacked variation in the primary outcome, 
retention in HIV care. The relationship between distressed mental health and 
retention could not be fully assessed in this analysis. Studies have observed the 
link between distressed mental health129·130 and retention in HIV care. However, 
because mental health was correlated with the main independent variables in the 
analysis, this relationship could not be fully understood among this sample. 
Additionally, several important factors related to social support and the 
health status of the sample were not assessed. Important dimensions of social 
support such as the quality of support, the structure of support, or the 
characteristics of support were not assessed. 131 In addition, dimensions of HIV-
specific social support were not assessed, because the instrument did not ask 
about social support specifically related to HIV care. 
Nevertheless, despite these limitations, the major strength of this study is 
that the age distribution of this sample may allow the findings to be generalizable 
to an older HIV-infected population. National projections estimate that that half of 
all persons living with HIV will be age 50 or older by 2015. 59 Similarly, based on 
the age distribution and the median age of the sample (age 47) in 2010, half of 
the sample will be age 50 by 2015. However, I found mixed results about the age 
distribution of this sample compared to prior literature that found either stigma or 
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social support was significantly associated with retention in care. I found that age 
distribution of the sample used for this analysis was older when compared to a 
study examining the association of support, stress, stigma, and HIV disclosure 
with retention in HIV care among 398 African-Americans and Latinos in HIV care 
at five clinics in Los Angeles, CA. 87 Participants who were age 50 or older 
comprised only 24% of the total population of the study,87 while 40% of the 
participants in the current analysis were age 50 or older. In contrast, I found that 
the age distribution of the sample used for this analysis was similar to a study 
that tested if social support and the patient-provider relationship was associated 
to adherence to routine HIV medical care among 210 patients in HIV care at two 
clinics in south Florida. 121 The mean age of the study was 47.1 years, 121 while 
the mean age for the current analysis was 45.9. 
Conclusion 
Achieving optimal retention in care remains a significant challenge for all 
people living with HIV. Although the hypothesized independent variables of social 
support, stigma, and age were not associated with retention in care in this 
analysis, literature has shown that stigma and low levels of social support can 
negatively affect the lives of those living with HIV. The negative consequences 
related to both stigma and low levels of social support highlight that they remain 
important factors to consider among vulnerable HIV-infected populations 
receiving HIV care. As HIV-infected populations are increasingly growing older, 
understanding more about the differences between younger and older HIV-
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infected populations will be critical for designing interventions and improving 
long-term HIV care. More research, in particular qualitative research on older 
populations, is likely to reveal the nuances of how social support and stigma are 
related to staying engaged in HIV care. In the next chapter, I focus on this 
question among older Black women living with HIV. 
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Table 2.1 Overall characteristics and factors associated with retention in 
care among patients who were retained and not retained in care over a 12 
month period 
2 ke t visits > 90 da s a art over a 12 month eriod 
Retained Not retained Total 
(n=912, 88.7%) n=116, 11.3% n=1028) 
Characteristics 
A e 
<40 223 (24.5) 39 (33.6) 0.06 262 (25.5) 
40-54 499 (54.7) 60 (51 .7) 559 (54.4) 
<::55 190 {20.8} 17 {14.7} 207 {20.4} 
Race/Ethnicity 
White, Non-Hispanic 95 (10.4) 22 (19.0) 117(11.4) 
Hispanic 158 (17.3) 16 (14.0) 0.04 174 (16.9) Other, Non-Hispanic 26 (2.9) 2 (1.72) 28 (2.7) 
Black, Non-Hiseanic 633 {69.4} 76 {65.5} 709 {69.0} 
Gender 
Female 360 (39.5) 37 (31 .9) 0.11 397 (38.6) Male 552 {60.5} 79 (68.1) 631 {61.4) 
Education 
Some College or 
greater 289 (31.7) 46 (39.6) 0.11 335 (32.6) HS graduate or GED 281 (30.8) 37 (31 .9) 318 (30.9) 
Some HS or less 342 (37.5} 33 {28.5) 375 (36.5) 
Insurance 
Uninsured/None 195 (21.4) 46 (39.7) 241 (23.4) 
Private 111 (12.2) 11 (9.5) 122 (11 .9) 
Medicare 198 (21.7) 17 (14.7) 0.0002 215 (20.9) 
Medicaid 408 (44.7) 42 (36.2) 450 (43.8) 
Social Support 
Low social support 378 (41 .5) 53 (45.7) 0.38 431 (41 .9) High social sueeort 534 {58.5} 63 {54.3} 587 {58.1} 
Stigma 
Low stigma levels 608 (66.7) 77 (66.4) 0.95 685 (66.6) High stigma levels 304 {33.3} 39 {33.6} 343 {33.4} 
Place of Birth 
Outside of U.S. 178 (19.5) 20(17.2) 0.56 198 (19.3) U.S. 734 {80.5} 96 {82.8} 830 {80.7} 
Language spoken the 
most 
Other 120 (13.2) 12(10.3) 0.39 132 (12.8) English 792 (86.8) 104 (89.7) 896 (87.2) 
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2 kept visits > 90 days apart over a 12 month period 
Retained Not retained Total 
(n=912, 88.7%) n=116, 11.3%) n=1028) 
History of Incarceration 
Yes 51 (5.6) 17 (14.7) 0.0002 68 (6.6) 
No 861 {94.4} 99 {85.3} 960 {93.4} 
Caregiver for Adults 
Yes 110(12.1) 16(13.8) 0.59 126 (12.3) No 802 {87.9} 100 (86.2) 902 {87.7) 
Caregiver for children 
Yes 188 (20.6) 19 (16.4) 0.28 207 (20.1) No 724 {79.4} 97 {83.6} 821 {79.9} 
Employment 
Employed 229 (25.1) 31 (26.7) 0.71 260 (25.3) Unemployed 683 {74.9} 85 {73.3} 768 {74.7} 
Housing status 
Someone else's 
home/apartment 181 (19.9) 32 (27.6) 
0.06 
213 (20.7) 
Other 89 (9.8) 15 (12.9) 104 (1 0.1) 
Own home/apartment 642 {70.4} 69 {59.5} 711 {69.2} 
Alcohol use 
High level of use 185 (20.3) 29 (25.0) 0.24 214 (20.8) 
Low level of use 727 (79.7) 87 {75.0} 814 (79.2) 
Mental Health Distress 
High distress 405 (44.4) 72 (62.1) 0.0003 447 (46.4) Low distress 507 {55.6} 44 {37.9} 551 {53.6) 
Substance abuse 
Cocaine 
Yes, in the past 90 
days 109 (12.0) 23 (19.8) 132 (12.8) 
Past history of use, but 0.05 
not in past 90 days 354 (38.8) 44 (37.9) 398 (38.7) 
Never used 449 (49.2) 49 (42.2) 498 (48.4) 
Heroin 
Yes, in the past 90 
days 30 (3.3) 8 (6.9) 38 (3.7) 
Past history of use, but 0.14 
not in past 90 days 180 (19.7) 20 (17.2) 200 (19.5) 
Never used 702 (77.0) 88 (75.9) 790 (76.9) 
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2 kept visits > 90 days apart over a 12 month period 
Retained Not retained Total 
n=912, 88.7% n=116, 11.3% n=1028 
Other drug use 
Yes, in the past 90 days 41 (4.5) 14(12.1) 55 (5.4) 
Past history of use, but 0.0004 
not in past 90 days 180 (19.7) 30 (25.9) 210 (20.4) 
Never used 691 {75.8} 72 {62.1} 763 {74.2) 
Attitudes about coming 
to care 
Negative 41 (4.5) 6 (5.2) 0.74 47 (4.6) Positive 871 {95.5} 110 {94.8} 981 {95.4} 
Life chaos 
High levels of life 
chaos 118(12.9) 19 (16.4) 0.30 137 (13.3) Low levels of life 
chaos 794 {87.1} 97 {83.6} 891 {86.7} 
Barriers to care 
Worried about paying 
for HIV medical care 
Yes 156 (17.1) 38 (32.8) 
<0.0001 194 (18.9) No 756 (82.9) 78 (67.2) 834 (81 .1) 
Problems scheduling 
appointments due to 
lack of access to a 
phone 
Yes 70 (7.7) 16(13.8) 0.03 86 (8.4) No 842 (92.3) 100 (86.2) 942 (91 .6) 
Problems getting 
someone to answer 
calls to schedule an 
appointment 
Yes 62 (6.8) 8 (6.9) 0.97 70 (6.8) No 850 (93.2) 108 (93.1) 958 (93.2) 
Problems getting 
appointment at 
convenient time 
Yes 93 (10.2) 20(17.2) 0.02 113 (11.0) No 819 (89.8) 96 (82.8) 915 (89.0) 
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2 kept visits > 90 days apart over a 12 month period 
Retained Not retained Total 
n=912, 88.7% (n=116, 11.3%) n=1028) 
Problems finding 
providers who speak 
the same language 
Yes 27 (3.0) 4 (3.5) 0.77 31 (3.0) 
No 885 (97.0) 112 (96.5) 997 (97.0) 
Problems with 
transportation to 
appointment 0.006 
Yes 144 (15.8) 30 (25.9) 174 (16.9) 
No 768 {84.2) 86 {74.1} 854 {83.1) 
Currently Taking ART 
No 118 (12.9) 36 (31 .0) 
<0.0001 154 (15.0) Yes 794 {87.1} 80 {69.0} 874 {85.0} 
Risk category 
MSM 231 (25.3) 31 (26.7) 262 (25.5) 
MSM +IOU 20 (2.2) 4 (3.5) 24 (2.3) 
IOU 175 (19.2) 29 (25.0) 0.30 204 (19.8) 
Unknown/Other 44 (4.8) 7 (6.0) 51 (5.0) 
Heterosexual 442 {48.5} 45 {38.8} 487 {47.4} 
CD4 (cellslmL)-
(within +120 day_sl 
0-200 147 (16.2) 26 (22.4) 173 (16.8) 
201-350 182 (20.0) 31 (26.7) 0.02 213 (20.7) 
>350 583 (63.9} 59 {50.9} 642 (62.5} 
VL (copieslml)-
(within + 120 day_sl 
Detectable ( :<!200) 271 (29.7) 68 (58.6) 
<0.0001 339 (33.0) Undetectable ( <200) 641 {70.3} 48 {41.4} 689 (67.0} 
Years living with HIV 
(range 0-30) 
Mean± SO 11.9±7.5 11 .0+7.4 0.23 11.8±7.5 
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Table 2.2 Multivariable fixed effects models of retention in care over a 12 
month periodt 
Model1 Model2 Model3 Model4 
(AIC =728.28) (AIC=708.69) (AIC =711.90) (AIC =681.48) 
Adjusted Odds Ratio (95% Cl) 
Main independent 
variables 
Social Support 
Low social support 0.92 0.87 0.89 0.97 
(0.61' 1.39) (0.57, 1.34) (0.57, 1.37) (0.62, 1.53) 
High social support ref ref ref ref 
Stigma 
Low stigma levels 1.13 1.17 1.30 1.37 
(0.73, 1.74) (0. 7 4, 1.83) (0.81 ' 2.06) (0.84, 2.25) 
High stigma levels ref ref ref ref 
Age 
<40 0.72 0.84 0.78 0.96 
(0.47, 1.14) (0.53, 1.34) (0.47, 1.28) (0.56, 1.65) 
~55 1.28 1.12 0.96 0.87 
(0.72, 2.26) (0.63, 2.01) (0.53, 1.74) (0.48, 1.61) 
40-54 ref ref ref ref 
Covariates 
Race/Ethnicity 
White, Non-Hispanic 0.68 0.80 0.69 (0.38, 1.21) (0.43, 1.46) (0.36, 1.31) 
Hispanic 1.29 1.31 1.10 (0.70, 2.38) (0. 70, 2.45) (0.58, 2.09) 
Other, Non-Hispanic 1.76 1.75 1.80 (0.39, 7.89) (0.39, 7 .89) (0.38, 8.54) 
Black, Non-Hispanic ref ref ref ref 
Gender 
Female 1.04 0.94 1.07 
(0.67, 1.64) (0.59, 1.49) (0.66, 1.73) 
Male ref ref ref ref 
Education 
Some College or 0.78 0.77 0.72 
greater (0.47, 1.32) (0.45, 1.31) (0.41 ' 1.26) 
HS graduate or GED 0.93 0.93 0.96 
(0.55, 1.58) (0.55, 1.60) (0.55, 1.65) 
Some HS or less ref ref ref ref 
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Model1 Model2 Model3 Model4 
AIC =728.28 AIC=708.69 AIC =711.90 (AIC =681.48) 
Insurance 
0.47** 0.49 * 0.48* Uninsured/None (0.29,0.81) (0.28, 0.87) (0.27, 0.87) 
1.35 1.37 1.23 Private (0.63,2 .88) (0.62, 3.02) (0.53, 2.82) 
1.56 1.59 1.45 Medicare (0.83, 2.93) (0.84, 3.04) (0.74, 2.82) 
Medicaid ref ref ref ref 
Incarceration 
Yes 0.54 0.56 
(0.27, 1.05) (0.28, 1.13) 
No ref ref 
Housing status 
Someone else's 0.91 0.91 
home/apartment (0.55, 1.51) (0.54, 1.53) 
Other 0.91 0.86 
(0.47, 1.76) (0.44, 1.70) 
Own ref ref 
Substance abuse 
Cocaine use 
Yes, in the past 90 0.69 0.69 
days (0.36, 1.33) (0.35, 1.34) 
Past history of use, 0.97 0.94 
but not in past 90 (0.58, 1.64) (0.54, 1.61) 
days 
Never used ref ref 
Other drug use 
Yes, in the past 90 0.43* 0.47 
days (0.20, 0.91) ( 0.22, 1.04) 
Past history of use, 0.86 0.85 
but not in past 90 (0.51 , 1.47) (0.49, 1.47) 
days 
Never used ref ref 
Barriers to care 
Worried about paying 
for HIV medical care 
Yes 0.66 0.68 
(0.40, 1.11) (0.39, 1.16) 
No ref ref 
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Model 1 Model 2 Model 3 Model 4 
(AIC =71 0.95) (AIC=718.29) (AIC =720.39) (AIC =685.01) 
Problems scheduling appointments due 
to lack of access to a phone 
Yes 
No 
Problems getting appointment at 
convenient time 
Yes 
No 
Problems with transportation to 
appointment 
Yes 
No 
Currently Taking ART 
No 
Yes 
CD4 (cellslmL)- (1 year prior to 
baseline ±120 days) 
0-200 
201-350 
>350 
VL (copies/ml)- (1 year prior to 
baseline ±120 days) 
Detectable ( <::200) 
Undetectable ( <200 ) 
Years living with HIV 
* p<0.05; **p<0.01; ***p<0.0001 
tAll models are adjusted for fixed-effect study site 
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0.87 
(0.44, 1.74) 
ref 
0.88 
(0.48, 1.63) 
ref 
0.93 
(0.53, 1.62) 
ref 
1.11 
(0.54, 2.27) 
ref 
0.92 
(0.48, 1. 76) 
ref 
0.84 
(0.48, 1.50) 
ref 
0.49 
(0.29, 0.83)** 
ref 
0.73 
(0.41, 1.29) 
0.68 
(0.40, 1.14) 
ref 
0.38 
(0.23, 0.61 )*** 
ref 
1.00 
(0.97, 1.04) 
CHAPTER 3: "MOVING FORWARD FOR ME": HOW OLDER BLACK WOMEN 
PERCEIVE THE EFFECTS OF STIGMA AND SOCIAL SUPPORT ON 
REGULAR ATTENDANCE TO HIV CARE 
Background 
Much has changed in HIV care over the past two decades. The 
effectiveness of antiretroviral therapy (ART), as well as the focus on engaging 
patients in HIV care has led to a shift from the need for acute care to chronic care 
management of people living with HIV.132•133 Public health efforts have focused 
on reducing the number of people newly infected with HIV, improving health 
outcomes, reducing HIV-related disparities, and increasing regular attendance to 
HIV care.24 However, as described in Chapter 1, those who are not engaged in 
regular HIV care face significant barriers to achieving optimal health outcomes. 
The problem of sub-optimal engagement in HIV care cuts across gender, 
age, ethnic, and socioeconomic groups. Studies have reported that vulnerable 
groups, such as Blacks and women are less likely to regularly attend HIV 
care.6·18•134 Despite the fact that consistent engagement in HIV care improves 
outcomes among people living with HIV,4 engagement in HIV care among 
another vulnerable group -- older populations -- has been less studied compared 
to younger populations, 135 and few studies have focused on this issue from the 
perspective of older Black women. 132 Thus, it is essential to identify factors that 
can affect successful engagement in care among older HIV-infected Black 
women. 
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As discussed in Chapter 1, social support and stigma are two factors that 
may affect how people engage in HIV care. Social support, defined as resources, 
assistance, or help that people receive from a network of individuals and social 
groups,68,69 can facilitate coping69·72 and shows direct effects on health and 
health service use.136·137 Among HIV-infected individuals, social support has 
been associated with better medication adherence 138 and appointment 
attendance. 77 Stigma is a label that is attached by society to "an attribute that is 
deeply discrediting" and reduces the stigmatized "from a whole and usual person 
to a tainted, discounted person".88 HIV-related stigma may be considered a type 
of health-related stigma. A health-related stigma is a "a social process, 
experienced or anticipated, characterized by exclusion , rejection , blame or 
devaluation that results from experience, perception or reasonable anticipation of 
an adverse social judgment about a person or group" that is identified with 
particular health problems.91 HIV-related stigma has been found to be a barrier to 
accessing HIV prevention and care services135·139 and can be a barrier to 
appointment attendance.84·130 In addition, HIV-related stigma is associated with 
various negative consequences including rejection , stereotyping, fear of 
contracting HIV, breach of confidentiality, and protective silence to avoid negative 
reactions from others. 140,141 
As a consequence of the negative effects of HIV-related stigma, many 
individuals may become socially marginalized , isolated, withdraw from social 
settings and disengage from medical care.142 Blacks, in particular, may face 
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unique challenges to remaining in care because of the confluence of stigma and 
lack of social support. 6 This confluence of stigma and social support may affect 
Blacks differently than other groups. Vulnerable populations, such as Blacks, 
often reside in socially marginalized communities where HIV is stigmatized. This 
stigma may occur because vulnerable populations may be less likely to use 
social support that can act as a buffer or protective mechanism against the 
negative effects of stigma.93,143 
To further understand how older Black women perceive the effects of 
stigma and social support on regular attendance to HIV care, I conducted a 
qualitative study of older Black women (age 50+) to explore how they believed 
their experiences with stigma and social support facilitated or inhibited their 
engagement in HIV care. Qualitative methods are well suited for this research 
given the goal of understanding older Black women's perception of HIV care and 
to further theorize why they may exit and enter care. This study will illuminate 
perceptions of the factors that contribute to the ability to engage in HIV care 
among these older vulnerable women. Given the dearth of research in this area, 
this study was exploratory and designed to qualitatively understand how 
participants viewed experiences with social support and stigma relative to their 
HIV care. 
Methods 
I conducted an exploratory qualitative interview study with a sample of 
older Black women (age 50+) to examine their perceptions of how social support 
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and experiences of stigma have affected their ability to engage in HIV care. All 
women interviewed were receiving HIV care services at primary care clinics in 
the Metropolitan Boston area. The interviews were conducted from February to 
September 2011. This study was approved by the Boston University Medical 
Campus Institutional Review Board. 
Sampling and Recruitment. 
I employed a purposeful sampling method, 144 selecting participants of 
primary interest based on the research aims: older Black women who were 
currently in HIV care. Inclusion criteria for participation included being female, 
aged 50 or older, self-identified as Black or African American, able to understand 
and speak in English, currently engaged in HIV care, and able to consent to a 
qualitative interview. 
To ensure a range of participants for inclusion, I recruited participants 
through several methods including: primary care provider referral within a HIV 
primary care clinic at a large urban safety net hospital, recruitment flyers posted 
in the clinic (see Appendix 1), and snowball-sampling. Snowball sampling relies 
on current participants identifying others in their network who may be potential 
participants. 144 For patients recruited through provider referral at the HIV primary 
care clinic, a study coordinator facilitated the process by generating a weekly list 
of eligible participants. Permission for the study coordinator to approach eligible 
participants was granted by their primary care physicians. At initial point of 
contact the study coordinator verified self-identified race and age before referring 
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interested participants to me. I then met with the potential participants and 
explained the purpose of the study and what they could expect as a participant. 
Participants recruited through flyers posted in the HIV primary care clinic were to 
call my direct number to inquire about eligibility and the purpose of the study. An 
interview was scheduled if they agreed to participate in the study. Finally, I also 
used snowball sampling to identify additional participants who were receiving 
care outside of the clinic. The snowball sampling method worked in the following 
manner: clinic participants were asked (at the conclusion of their interviews) if 
they would be willing to share my contact information with other potential 
participants. The snowball referral participants made direct contact with me if 
they were interested in scheduling an interview. 
Forty-one women were approached for enrollment; 21 declined to 
participate. Of the 20 final participants, 15 women were referred from primary 
care providers at the HIV primary care clinic. Five of the 20 women who 
participated in the study were referred by consented participants through the 
snowball sampling mechanism and thus indicated being in HIV care at another 
location. No women were recruited through the posted flyers. 
Data collection - Interview guide development 
Interviews were conducted using a semi-structured interview guide, which 
included central questions of interest, but also allowed for flexibility to explore 
emerging ideas (see Appendix J) . Questions were developed based on relevant 
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concepts from the literature and from the conceptual framework suggesting that 
social support and stigma can influence patient engagement behaviors across 
time as described in Chapter 1. 
The interview guide was pilot-tested individually with three older HIV-
infected Black women prior to finalizing the guide. The three women were 
recruited from the Consumer Advisory Board (CAB) of an HIV primary care clinic 
within a large urban safety net hospital. The CAB is comprised of 13 patients who 
receive care at the hospital and serve as liaisons between the patient population 
and hospital administration. CAB members share their knowledge and opinions 
to advise, inform, and assist with the design and implementation of service 
programs and other matters that affect the HIV primary care clinic. Following 
pilot-testing, I updated the interview guide to clarify questions, reorganize the 
structure, and add new questions that were generated from the pilot interviews. 
I used the updated semi-structured interview guide for all participant 
interviews. The semi-structured interviews began with a general discussion about 
participants' background and lives (e.g. questions regarding age, employment, 
education, etc.) which led into discussion about their HIV diagnosis. Some 
experiences with stigma were addressed with the following questions, "Have you 
ever felt discrimination because you are HIV positive?", or "Have you 
experienced stigma because you are HIV positive?" I asked participants to list 
people within their support network and followed-up by asking "Who did you 
specifically tell you had HIV?" Participants described how these individuals 
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provided social support in response to the question "How have any the 
individuals that we talked about earlier helped you with your HIV care?" I also 
asked questions related to their past and current experiences engaging in HIV 
care beginning with their initial diagnosis and ending with their current status and 
use of HIV care. I asked the women about their past and current experiences 
engaging in care with the following questions, "When you initially found out about 
your HIV/AIDS status how often did you come to the doctor?", or "Can you tell 
me about some things that help you to stay in care?", or "Can you tell me about 
some things that might interfere with you staying in care?" 
Data collection - Interviews 
Participants who agreed to be interviewed met with me on a scheduled 
date in a private room within the HIV primary care clinic. To protect participant 
confidentiality the IRB granted a waiver of documentation of consent and 
permission to obtain verbal consent only. I reviewed the consent form with the 
participant, describing: the purpose of the study; the risks associated with the 
interview; steps taken to minimize risks; their rights as a study participant; and 
informed participants that they did not have to answer any question which they 
did not feel comfortable answering. 
Each interview was audio-recorded. To preserve anonymity no identifying 
information was linked to the recordings. I took notes during each interview in the 
event that the audio recorder malfunctioned . To establish credibility during each 
interview I periodically checked with participants to verify that she understood 
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their responses correctly asking, "Do you mean [interviewer's interpretation] .. . ?" 
At the conclusion of each interview, participants were offered a $25 gift card for 
their participation. The interviews lasted as long as participants were willing to 
talk. The median interview time was 51 minutes and ranged from 26 minutes to 2 
hours 45 minutes. After each interview I wrote reflective notes, referred to as 
memos, to summarize concepts about each interview. 
Data Analysis 
Interviews were transcribed verbatim and identifying information was not 
linked to the transcripts. To help preserve anonymity I created pseudonyms for 
each participant. 
Data were analyzed using qualitative analytic techniques informed by 
grounded theory. This included systematic analysis of each interview transcript 
with constant comparison and evaluation of commonalities among themes across 
interviews.145 All coding and subsequent analysis was conducted using 
qualitative software (HyperResearch 3.0.2 Computer Software. ResearchWare, 
Inc., 2011). 
The first three transcripts were jointly examined by Drs. Bokhour, 
Drainoni, and me in order to develop common set of content codes, formulate 
coding rules, and to develop the codebook. Codes are short phrases assigned to 
segments of text that summarize the meaning and context of the text. 144 Complex 
codes were further divided into subcategories referred to as sub-codes. I coded 
additional transcripts using the codebook and met with Drs. Bokhour and 
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Drainoni to discuss and assess the reliability of the coding rules. Discrepancies 
were resolved and coding rules modified through discussion. Through this 
process the final codes were developed directly from key phrases identified in the 
transcripts. The final codebook included 39 main codes and 44 sub-codes. An 
example of a main code is support. Examples of sub-codes related to support 
are: support from family, support from friends, support from medical community, 
tangible support, informational support, and emotional support. Another example 
of a main code is stigma. Examples of sub-codes related to stigma are: negative 
treatment by others, negative stereotypes, and discrimination. 
The transcripts were further analyzed with a process of identifying 
connections between codes and grouping codes into broader themes, also 
known as axial coding. 144·145 Codes related to the broader concepts of support, 
stigma, and engagement in care were grouped together into larger themes. 
Throughout the analysis memos were useful to identify conceptual links between 
codes and themes. The themes were reviewed for unique perspectives, 
similarities between participants, and disconfirming cases. Complex themes were 
further divided into a subcategories referred to as sub-themes. The memos were 
also helpful to clarify my thoughts about the data and provided a mechanism to 
generate and organize conceptual ideas for analysis. 
Results 
Participant characteristics. Twenty African-American/Black women were 
interviewed over a nine-month period in 2011. One participant declined to have 
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her interview recorded after she consented to participate, thus there are no direct 
quotes from her interview. Descriptive characteristics of the study sample are 
included in Table 3.1. The participants' ages ranged from 50-63 with a mean age 
of 56.6, and 16.2 mean years living with HIV. Thirteen women were diagnosed in 
the pre-ART era (1985-1996) . Eight reported having less than a high school 
education, while the same number had at least some college. Fifteen women 
reported being disabled , currently unemployed, or unable to work. Sixteen 
women were born in the U.S. and four women described themselves as 
immigrants during their interviews; one from east Africa, two from the Caribbean, 
and one from Cape Verde. All women reported being currently engaged in care. 
Table 3.1 Participant characteristics 
Characteristics n=20 
Mean age in years, (range) 56.6, (50-63) 
Mean years living with HIV, (range) 16.2 (2-26) 
Era of Diagnosis (n) 
Pre-ART ( 1985-1996) 13 
Post-ART ( 1997 -2009) 7 
Education (n) 
Less than high school 8 
HiQh school 4 
Some College or greater 8 
Immigrant status (n) 
Yes 4 
No/Unknown 16 
Work Status (n) 
At least part-time employed 2 
Retired 2 
Disabled/Unemployed/Unable to 15 
work 
Unknown 1 
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Summary of findings 
Two primary domains were relevant to how older Black women engage in 
care: the role of stigma and the role of social connections. Once women were 
diagnosed as HIV-positive they were faced with a life-altering event which had 
personal and social ramifications. These women described their experiences 
related to stigma and seeking support as playing an important role in how they 
evaluated the risks and benefits of engaging in care. Many women detailed how 
social support facilitated their ability to engage in care, while stigma interfered 
with their ability to engage in care throughout the course of their illness. Women 
frequently struggled to engage in care because of a fear that attending HIV care 
appointments would put them at risk for of being exposed as HIV positive to 
strangers, friends, or family members. Stigmatizing experiences often created the 
fear of being rejected or being "outed" as HIV positive and thus created difficulty 
for women to access HIV care or to access adequate social support for engaging 
in HIV care. 
The role of stigma when engaging in care 
All of the women who were interviewed reported experiencing some form 
of stigma. Often, stigmatizing experiences discouraged or even prevented 
women from seeking care. Many expressed commonly reported forms of stigma 
such as: mistreatment by others out of fear of contracting HIV from daily 
interactions related to sharing utensils, using the same bathroom, or a simple 
touch. Stigmatizing events related to engaging in care were recounted in many 
77 
forms ranging from participants feeling the name "infectious disease clinic" as a 
stigma to medical provider behavior and attitudes towards patients. A main factor 
that contributed to a feeling of stigma was the fear of being exposed as HIV 
positive if they sought HIV care. Below I discuss two themes related to stigma: 
being in care can "out me" and stigma by medical professionals and clinicians. 
Being in care can "out me" Some women expressed that receiving care 
was a stigmatizing event because of the name or the location of clinics. One 
participant specifically described how she felt stigmatized because she perceived 
that HIV care organizations separated and segregated HIV positive patients from 
other patients. She felt that people living with HIV were easily identifiable if they 
sought treatment at HIV primary care clinics . She specifically commented that 
including the term "infectious disease clinic" offended and discouraged her from 
seeking care at certain clinics because of fear of being "outed" as HIV positive. 
I just don't like that, how they isolate. And I know it's not just the people 
with HIV and AIDS, it's other infectious diseases, but I don't like that. I 
don't like how [hospital], isolates the infectious disease clinic away from 
every-f******-body else, like we're not human. I find that very, very 
offensive ... I don't like how they separate. That really hurts my feelings. I 
already struggle on a daily basis, having to hide the fact that I'm HIV 
positive, just because even though we're in the 21st century. (Phyllis, age 
51) 
Similarly, other participants felt stigmatized in their interactions with health clinics 
and service organizations. One woman believed that clinics and service 
organizations contributed to the pervasiveness of HIV-related stigma by including 
"HIV or AIDS" within the organization's name. 
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Like, back then, everything was HIV services. AIDS this, AIDS that. 1 feel 
like, back then, if the label was just "primary care doctor," or different 
places that didn't have that label, I don't think the stigma would have been 
as strong. (Lanetta, age 50) 
Stigma by medical professionals and clinicians. Many women experienced 
stigmatizing encounters with medical professionals and clinicians, which 
impacted their ability to trust clinicians and engage in care. In the following 
interview a participant became emotional as she described a stigmatizing 
encounter with three EMTs. She described how the EMTs did not want to touch 
her after she told them about her HIV status and medications. 
I was real messed up in that mean wagon. I did not want to be in that 
ambulance, trust me. Yeah. If I was able to get out and not have to go, I 
wasn't going to go to the hospital. My youngest daughter went with me. 
She didn't notice this, only I did . Got to [Hospital name] he put the nose 
thing on me and everything, but they wouldn't touch me. They wouldn't 
touch me (crying). (Bernadette, age 57) 
Bernadette continued to explain how two of the EMTs were afraid to touch her; 
however a male EMT was the only one willing to touch her and treat her with 
dignity. Bernadette went on to describe that she first talked about this experience 
with her women's support group and felt like she "wanted to scream." This 
experience was quite difficult and she became overwhelmed with emotion as she 
recounted her experience. As a result of this experience she felt that she had to 
"be very careful who I disclose to, so I won't be rejected." This experience and 
the feelings associated with it resulted in reluctance to reveal her HIV status to 
others, and ultimately interfered with her ability to trust medical providers and 
engage in continuous care. 
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Other women focused their narratives on their impression of medical 
providers. Women perspectives focused on medical providers who created the 
impression that they did not care about patients living with HIV. Simone (age 
53), who was diagnosed between 1985 and 1996, described feeling that 
providers used to behave like they were "scared" to treat HIV patients and 
discouraged people from seeking care. She specifically mentioned that doctors 
did not care "if you even made appointments" and that they assumed "if they saw 
a scar on you, you were a junkie." These incidents led her to feel stigmatized. 
Simone also mentioned that she used to feel that it was not necessary to attend 
appointments because her doctors did not care. More importantly, she stated that 
her view about providers and view of HIV care has changed across time. This 
change of opinion demonstrates a shift in her perspective and highlights that she 
believed HIV care was necessary for being healthy. She believed that doctors 
became more caring because they no longer stigmatize their patients and are 
less judgmental about patient's lifestyles. She noted that changes in both 
provider behavior and attitude helped her to engage in care. 
Yeah, the doctors have come further along from that as to back then to 
now. You've got a lot more compassionate doctors that know more. But 
back then, they were making people feel like they shouldn't go and get 
care. (Simone, age 53) 
Another woman diagnosed between 1985 and 1996 further reiterates Simone's 
point of how doctors did not compassionately care for patients. 
Well , like I said , the first doctor I had, I did not like him at all. Now I see 
why, because he didn't give a damn ... I think I saw him for the first six 
months, and he could care less. (Felicia, age 57) 
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Likewise, across time she also changed her perspective about the importance of 
care. She credits her current providers as the reason why she changed her 
perspective. Having providers who are her "backbone" and who help her "to do 
what I need to do" was critical for remaining in care and being healthy. 
These reflections clearly show how specific interactions with health care 
professionals affected the women's willingness to engage in care. Women were 
more reluctant to seek care when they perceived that providers were not 
compassionate or concerned for their overall well-being. However, many women 
found that providers they encountered later in the course of their illness were 
more compassionate. The perceived change in provider behavior was 
instrumental in changing the women's' views on the importance of attending 
visits. 
The role of social connections 
Women discussed their social connections throughout the interviews. 
They revealed that how they evaluated the risks and benefits of engaging in care 
was closely linked to their social connections. They were able to find their own 
personal reasons to engage in care when they felt supported and socially 
connected. As a result, women thought carefully about establishing and 
maintaining social connections. Their perceptions of, either the benefit of 
disclosing to gain support, or the negative consequences of disclosing were 
validated by the social environment in which the women lived . Women perceived 
that they could potentially gain support for engaging in care if they disclosed their 
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HIV status. However, the act of disclosing to gain support was not an easy 
decision . Many women felt the anxiety of disclosure. Women perceived that if 
they disclosed their HIV status they could potentially experience a negative 
response from their social environment. 
Below I discuss four themes related to the role social connections played 
in decisions about engaging in care: disclosing to gain support, how women 
obtained support, role of the social world, the role of religious and spiritual 
connections. 
Disclosing to gain support. Disclosure of one's HIV status was a critical 
step for some women to determine whether, when, and how to seek support for 
navigating HIV care. In addition, disclosure was often related to stigma and 
ultimately impacted the women's ability to stay in care. Disclosing one's HIV 
status was often a difficult decision for some women, because they were 
uncomfortable and feared they would be stigmatized or judged. Many 
participants detailed that they were reluctant to disclose or seek support because 
people would relate HIV to carelessness or socially improper behaviors such as 
promiscuity or drug use. Some women who did not disclose felt a need to hide 
their disease due to this perception of potential stigma. These efforts to hide their 
HIV impacted their ability to stay in care. Moreover, the fear of the stigma 
associated with HIV led the women to believe that they would not have adequate 
support they might need to navigate HIV care. In contrast, many women noted 
that they were able to engage in care when family members and friends were 
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"supportive" and "encouraging." 
For women to access support they had to accept that disclosing their HIV 
status was how they would obtain assistance. As a result of disclosing many 
participants experienced strengthened relationships and were able to begin to 
believe that they would not have to endure their journey with HIV alone. Several 
narratives depicted positive experiences when disclosing , such as emotional 
encouragement and strengthened familial relationships. For example, Cathy 
talked about feeling more assured to live, learn more about HIV, and have 
adequate support to move forward with life after she disclosed to her family. 
When I found out I had HIV, I brought all my family together at the 
hospital , and I told them all, "I have something to tell you ." And I said, "I 
have HIV." They said, "Okay. You're not going to die." I said, "Well I don't 
know too much about this." They said , "You'll be alright. We're here for 
you, so you'll be alright." It wasn 't hard. It wasn't hard to tell them at all. 
(Cathy, age 59) 
Earlier, I described how Bernadette felt she had to be careful to whom she 
disclosed, for fear of being stigmatized or rejected. However, she described a 
change in this belief, " ... as time went on, it sunk in. You're HIV-positive, now you 
have another hurdle to go over to telling your family." She expressed that 
disclosing to her children was beneficial for engaging in care, as she felt 
receiving support from her children was the main reason that she was able to 
engage in and navigate care-- "Mind you, my kids played a role in my life to keep 
me in health care. Because if it wasn't for my four children , I would not even go 
[to health care visits]. " She specifically mentioned that her daughter played an 
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important supportive role as she transitioned from sporadic care into regular HIV 
care. 
Because [her oldest daughter] went through with it with me as I 
transitioned into being HIV-positive. [She] went with me. Every program, 
every institute that you say that's HIV-involved, my daughter was sitting 
there beside me. Like I said , I did not get here by myself. (Bernadette, 
age 57) 
Even though many women were able to disclose to their family and friends 
and obtain support, some women feared that revealing their HIV status would 
ultimately lead to isolation. Some participants recounted experiences of not being 
supported after they disclosed to their families. Earlene described feeling "down" 
after she disclosed to her family. 
In my country they look down on you , things like that [HIV]. They look 
down at you. You're done. You're no more. So you know I don't want to 
talk about it. My family, most of them, curse me, look at me a way. So I 
was like feeling down about it. .. Well , some of my family was really angry 
with me, you know, about it. (Earlene, age 56) 
Even though her family was not supportive in regards to her HIV care Earlene 
continued her story to explain that psychotherapy and HIV support group 
meetings helped her to cope with the rejection and remain in care. By continuing 
to attend therapy and group meetings she learned to: 
... understand it [HIV] and try to live with it. And just take people off my 
mind, put a blockage about people, about what they're saying , and just 
deal with it. You know, understand that it's not you alone, it's [HIV] not 
something going to kill if you take your medication. Eat right, do the right 
thing. And that's what I do. (Earlene, age 56) 
How women obtained support. The transition from fear of disclosing and 
feeling devastated about living with HIV to accepting responsibility for their HIV 
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care was often facilitated by supportive relationships. Women described different 
dimensions of support, including the sources and the types of support that were 
conducive to helping them engage. Here I refer to two types of support - formal 
and informal support. I refer to informal support as defined by Schopler and 
Mesibov as "the assistance that is social, psychological, physical, or financial and 
is provided either for free or in exchange for a fee through an organized group or 
agency."71 While informal support is defined as assistance provided by "a 
network that my include the immediate and extended family, friends, and 
neighbors."71 
Both formal and informal types of support helped the women remain 
engaged in care. Family and friends were most often the informal support 
sources for coping with HIV and with accessing care. Health care providers (e.g. 
doctors, nurses), support groups, case managers, social workers, and HIV/AIDS 
service organizations (ASO) were identified as formal support sources for 
engaging in care. ASOs provide a range of support services, but typically provide 
either direct service provision or referral to community-based agencies that 
provide financial, medical, legal, substance abuse treatment, and psychological 
assistance. 146·147 With support from informal and formal sources, women were 
able to take steps to fully live their lives and to remain in HIV care. 
One woman described how family played a key role in influencing her 
attitude towards attending care. Fiona (age 59) described that it was easy to 
disclose to her family. However, she was reluctant to attend HIV care. The 
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support gained from family members facilitated a change in her attitude about the 
importance of care. 
I just didn't' want to go [to appointments]. But, I mean, I just didn't want to 
go, but my kids and my sisters would bring me. "Oh, you don't want to go? 
Come on, we'll take you." Like I said, I have support. They wanted me to 
do what I was supposed to do, and plus I finally woke up and said, "Yeah, 
I have to do something. You don't even have to take me. I'll go. I'll go, I 
promise." 
Another woman summarized her feelings about receiving support from 
both formal and informal sources and how it helped her to make healthy choices, 
including going to care: 
So I take my challenges. And I try to make healthy choices. I also made a 
vow to myself-- I make no decisions by myself. My kids are involved, my 
treatment team, and my sponsors. So anything I do, even when it comes 
to, like, doing the Willow training, I discuss with all those folks. Get their 
honest opinion. The biggest thing is, like, don't get overwhelmed. So as 
long as I keep those folks involved in every aspect of my life, I live pretty 
good, okay. (Lanetta, age 50) 
The opinions of informal (children) and formal (treatment team and sponsors) 
sources of support were essential to move forward with life for this participant. 
The support from both informal and formal sources was instrumental to help her 
avoid feeling overwhelmed with too many responsibilities. She also highlighted 
how both informal and formal support were instrumental in her decision to be 
trained as a HIV peer educator through WILLOW (Women Involved in Life 
Learning from Other Women). The WILLOW intervention was designed as a 
small group, skill-training that emphasizes gender pride and supportive social 
networks to reduce HIV transmission risk behaviors, and to improve self-efficacy 
and skills regarding safe sex. 148 Lanetta felt that being involved with WILLOW 
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was important to be connected to HIV care and to be supportive of other women 
living with HIV. 
Several women described friends acting as surrogate family members. 
These friends provided encouragement and support to engage in care. Some of 
the women could relate much better with friends because some of their friends 
were also HIV positive or substance users. One woman described how a friend 
who also had HIV encouraged her to engage in HIV care and receive substance 
abuse treatment. 
A friend of mine called me and said, "You know, I went into this program 
that not only can you get help around your alcohol and drug use, you can 
help around HIV too, because they focus on both." So that's what brought 
me here, and I've been here ever since. (Isabelle, age 55) 
Another source of support was through support groups and ASOs. 
Support groups and ASOs provided a safe place for women to talk, ask 
questions, and gain more knowledge about HIV care. One woman described 
ASOs as a place to access support groups because they were able to provide 
information and resources for coping with HIV. She felt that ASOs provided a 
means for women to progressively get their lives back on track: 
And then I met someone from the AIDS Action Committee. And he really 
sat down and told me explained everything to me, and said you know you 
know that feeling that you don't want anyone to know what's really going 
on. I guess it was being ashamed while being let down ... And there was no 
trust. So this AIDS Action really helped me through and do my housing 
thing again with the drinking counseling . So that's how I started moving 
forward for me going--getting back on track. (Jackie, age 53) 
Relationships with medical providers also were instrumental for supporting 
and encouraging women to engage in care. Women reported that interactions 
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with providers who listened to their needs and concerns made them feel like they 
were not being discounted because of their HIV status. Subsequently they were 
more eager to engage in care. In contrast to the narratives about the impact of 
providers who stigmatized the women, the following two quotes revealed how 
positive interactions with providers influenced engagement in care. 
Me and my doctor are so close, we talk about my family, she talks about 
my health. She always asks me how my kids are doing. It's just a nice 
friendly-- And if I have any, any questions, I'll ask her, and she explains 
everything to me so I can understand it. I have a good doctor. (Cathy, age 
59) 
I've been very, very fortunate to have very thorough doctors. They're very 
thorough. They treat me like a human being, not like I am just a piece of 
something that is rotten or whatever. They don't judge me. They actually 
take me as a patient no matter what. They're very thorough. (Mona, age 
63) 
Similarly, other members of the medical team provided encouragement for 
living with and learning about HIV. In particular, case managers and social 
workers assisted women in finding resources to link them to care and often 
helped women find their own personal reasons to take responsibility for their own 
care. 
I said, so where do we go from here? He [case manager] said, "Okay, 
your first thing to remember, you have two children in the lobby waiting for 
you . So think about them, and worry about this part of your life later 
because you're not going to die. You can survive. If you survived what 
you're telling me you went through already, I don't see you going 
anywhere anytime soon. I see we'll see each other again." (Bernadette, 
age 57) 
And while I was in the program [addiction recovery], it was close to where 
Cambridge Cares about AIDS is at, so I was able to go from the program 
over to Cambridge Cares, because the social worker there or the case 
manager there said, "Why don't you go over there? And then you can 
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learn some more things." And that was the beginning of me really being 
educated and learning a lot more. (Mona, age 63) 
These positive experiences with providers and other members of the 
medical team were important for the women to gain control of their disease and 
to become responsible for their current and future HIV care decisions. 
Role of the social world. For the women I interviewed, maintaining an 
active role in their social environment was an important motivator for sustained 
care . Familial ties were often described as key social motivators for engaging in 
care . Strong kinship connections were important for these women to sustain their 
HIV care. While kinship ties often facilitated supportive relationships and 
encouragement for the women to engage in care, these ties were an influential 
reason for women to continue in HIV care. Women described how their role as 
grandmothers and mothers was influential for engaging in care. As women 
became more actively engaged with these familial relationships, they also 
became more active and engaged in care because relationships with their 
children and grandchildren were important motivators to engage in care. Marian, 
(age 61) commented , "Things that keep me staying in care is mostly my kids . My 
sons, my daughters and family." Jackie (age 53) noted that engaging in care 
gave her a chance to have a "do over" and make things right with her son. Jackie 
also explained that her motivation for living was due to her grandson. 
That's what I live for now, my grandson. I see him on weekends. I just 
spend as much quality time as I can with him. And basically things that I 
missed out on my son. What I didn't do with my son what I should have 
been doing, I try to do it with him [her grandson], just to make up for what I 
didn't give him [her son]. 
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Anticipating life events helped many of the women to realize that HIV care was 
critical to actually live to experience these events. Women expressed that staying 
engaged in care would allow them to live to see important life events such as 
marriage, graduations, and birth of grandchildren. 
Well, what helps me is watching my grandkids grow up. My daughter is 
getting ready to get married. Being around to see her get married. My son, 
he's getting ready to get into dancing. Different things. My family is what 
has got me staying in the care and doing what I've got to do. (Cathy, age 
59) 
In contrast, women who were socially isolated had more difficulty 
maintaining strong social connections for engaging in care. These acts of social 
distancing were common throughout the early phases of their HIV experience. 
Several women described how they isolated themselves from friends and family 
and how this affected their ability to seek care. Isabelle (age 55), who was 
diagnosed between 1985 and 1996, recounted feeling alone because she felt 
that HIV was viewed as a "gay disease" and not a disease that afflicted women . 
"I can recall not knowing very many women that were infected. It was 
considered back then a gay disease, because that's what-- I didn't know of 
any, so I really felt isolated, alone. I didn't tell anybody for a very long time, 
a long time ... I was in total denial, " 
She further described how feeling isolated impacted her ability to live with her 
diagnosis and enter care: "My way of dealing with it was not to deal with it, if that 
makes any sense. That was my only hope for me at the time." Later in her 
narrative, Isabelle described that she was diagnosed for 15 years before she 
sought support to deal with her HIV care. In addition, once she disclosed her HIV 
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status (20 years after her diagnosis) to her daughter she felt that her daughter 
was the inspiration for staying in HIV care- "And then, when I'm not doing things 
right, she's [her daughter] on top of me." 
Often, the women had complicated social issues in their lives which 
impacted their care. Several of the women were unable devote attention to their 
HIV care because of their struggles with other problems besides HIV, such as 
depression or other mental health disorders, substance use, or traumatic events. 
One woman highlighted how she used drugs and alcohol, purposely stayed out 
of care, and socially isolated herself after her son died. 
There was times that I kept myself out of care. And that time was when I 
lost my son five years ago. My older son was found dead in [town name]. 
That devastated me. And I felt like I was going to die then ... And I took 
myself out of here. I stopped coming. I stopped taking my meds and 
everything .. . But I did a lot of cocaine and I drank a lot after my son had 
passed. (Marian, age 61) 
She also noted that when she took herself out of medical care "I don't care about 
me "; however, she implied that she now recognizes that it is important to care 
about herself by mentioning that "I'm back [in care] now." 
Role of religious and spiritual connections. For some women, having a 
strong spiritual or religious grounding was beneficial for making decisions about 
engaging in care and to understand their position and purpose within their social 
world. Women described how spiritual and religious ties impacted their attitudes 
about care and living with HIV. The relationship with a higher power or being was 
a basis for "strength" for a second chance to live. Bernadette, talked about how 
God gave her second chance to live. She described that in order maximize her 
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second chance she had attend HIV appointments. 
That is my future. As long as I've got Jesus, I don't need nobody else. I 
have to keep that up front. I have to. Because that's what gave me this 
second chance to live. And to do what I do. And to stay healthy, and to 
take my time and my appointments. And I truly, truly believe God is here 
for a reason for me. (Bernadette, age 57) 
The two women below described how their spiritual values helped them move 
forward living life with HIV . 
. . . I thank the Lord for putting me in a position where I'm well and to the 
point where I'm surviving. (Jackie, age 53) 
I pray a lot. We can't do nothing without him [God] , none of us. And I really 
feel I'm here because of him, because I'm here for a reason. Because I've 
seen and heard of some many people that have had it, and I've known 
that's had it after me, and they're gone. And I sit there and I say, "Well I've 
had mine since 1990. How come I'm still here?" But it's for a reason. He 
has a plan for me, so I'm good. I'm good with it. (Anita, age 61) 
The prior quotes reflect the benefits of spirituality rather than a specific religion . 
Only one woman described that her church was part of her social world. Her 
quote reflects the more formalized aspect of God as part of feeling supported and 
encouraged as a woman living with HIV. 
And the church I go to was really open. Not every church is. And we were 
one of the first churches that would-- It was one of the things that attracted 
me to the church is the fact that they were so connected and really 
supportive around HIV. Once a year we would have-- I don't know if you 
ever heard of a like a week, prayer week around HIV. So, I mean, he's 
[her pastor] been my biggest inspiration and support. (Isabelle, age 55) 
She described the church as an institution that encouraged a range of social 
events, such as a prayer week dedicated to HIV. She also highlighted that many 
churches are not willing to discuss HIV, but she felt supported by her church , and 
in particular her pastor, because he was willing to be open about HIV. 
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Discussion 
Staying engaged in care is critical to the successful management of HIV. 
Past experiences with stigma often inhibited the ability to engage in care among 
the older Black women I interviewed. Their social connections who supported 
them, in contrast, often facilitated engagement in care. However, a fear of stigma 
related to disclosure often resulted in a reluctance to disclose and subsequent 
lack of such social connections. Women perceived that they could lose social 
connections if they disclosed. The fear of being "outed" as HIV positive, 
marginalized , or even isolated inhibited positive social support. However, once 
women began to cope with potential stigma many were able to disclose their 
status and obtain support that facilitated engagement in care. 
Disclosure was closely related to stigma among the women in this study. 
Often, the process of disclosing one's HIV status evolved over many years and 
the women described feeling tension between the positive and negative aspects 
of disclosing. The discomfort and fear of disclosing prevented the women from 
accessing social support from family and friends. Despite the benefits they could 
potentially receive from their social support networks, experiences with stigma 
undercut the ability of the women to seek support for engaging in HIV care. 
Most of the participants described a period of time in which they lived in 
isolation away from family and friends. When they felt that family members or 
friends judged or shunned them, women withdrew socially. Even though they 
may have been isolated , by not disclosing women felt protected and safe. In 
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contrast, if they disclosed they feared being exposed to discrimination, 
separation, and rejection. These concerns discouraged women from seeking 
care because of further judgment from society and family members. 
Interestingly, seeking care was viewed as stigmatizing when women felt 
that clinic names or ancillary services were labeled with overt HIV-related 
terminology. For the women in this study, naming clinics or services in this 
manner violated the confidentiality of women's HIV status and again reinforced 
their beliefs about being stigmatized . This finding is consistent with the 
association between high levels of perceived stigma and decreased likelihood of 
disclosure among HIV-infected Black women as reported in the literature. 149,15o 
However, once the women felt that disclosing provided an overwhelming 
advantage for gaining support for navigating HIV care, they were eventually able 
to disclose. 
The number of persons the women disclosed to varied , but many realized 
disclosing to someone was a decisive step in navigating their HIV illness. The 
better connected the women were to their families and friends the more they 
appeared to feel supported and willing to engage in care. The women revealed 
that they relied upon their informal relationships , such as family and friends, 
during times when they initially established or reestablished HIV care. Family 
members and friends were critical in providing encouragement and support for 
engaging in care. By disclosing to at least one trusted family member or friend 
the women guaranteed some level of support in navigating care and mediating 
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barriers to care. 
Ties to family and friends also appeared to supply individuals with 
information and resources for engaging in care. Bourdieu coined the term ' social 
capital': "the aggregate of the actual or potential resources which are linked to 
possession of a durable network .. . to membership in a group."151 In this study, 
when women were no longer fearful of disclosing they were able to gain such 
social capital, facilitated by their social ties, including financial, emotional 
(encouragement, accepting the HIV diagnosis), and tangible support (taking 
women to appointment, reminders to take medicine, linking them to ASOs). 
Obviously, making the choice to disclose was a serious matter that required the 
women to weigh both the benefits of accessing social capital and the risk of 
being stigmatized by individuals within their social world. The informal 
relationships would be prominent in shaping the women's attitudes towards care 
if they were able to gain support from these relationships. In fact, several women 
articulated that shifts in their attitudes from apathetic to becoming strongly 
invested in their HIV care was facilitated by persistent encouragement from 
family members and friends. 
Considering that religion and spirituality are important cultural and social 
institutions within the Black community, 152•153 it is not surprising that several of 
the women in this study reported that their spirituality was valuable for engaging 
in care. Women primarily shared their experiences with the informal reliance of 
God as part of their social world ; however, only one woman expressed that both 
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the informal and formal (church as an institution) aspect of spirituality also was 
important. This individual narrative about the formal church may not be 
representative of how other women view formal churches. However, her narrative 
gave insight to how a church could be a source of support for engaging in care. 
She described that her church provided resources and support for people living 
with HIV. This may be particularly important because churches historically have 
been a source of support in the Black community. A growing number of churches 
in the Black community have made efforts to address HIV. 154 However, not 
everyone who could benefit from church support may have access or formally 
worship at church. The findings corroborate previous findings of the general 
benefit of religiosity and spirituality in promoting psychological well-being among 
older adults. 155•156 While this study did not focus specifically on psychological 
well-being, the findings suggest a spiritual connection facilitated both a positive 
disposition for living with HIV and a positive attitude towards HIV care among the 
women in this study. 
Throughout the course of their illness women used formal sources of 
support such as support groups and ASOs. These formal support sources 
provided resources such as counseling , housing assistance, and a safe 
environment to disclose while serving as a means for engaging in care. Women 
were likely to be engaged in care because many of these services were 
accessible through case managers and organizations that work closely with HIV 
primary care clinics. 
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Medical professionals and clinicians also played a particularly influential 
role that affected participant attitudes about the importance of care. Providers not 
only educate patients about their disease, assess disease progression, and 
deliver medical care, but can be an instrumental source of support.77 Some 
women who were diagnosed with HIV earlier in the epidemic felt they could not 
trust providers because they perceived their providers' behaviors and attitudes as 
stigmatizing. Many of these same women felt that regular HIV care was not 
important because they perceived that providers did not care if they attended 
appointments. Providers may have not realized that both subtle and blatant cues 
contributed to disengagement from care. Women described receiving both verbal 
and non-verbal cues that inhibited or encouraged future care-seeking behaviors. 
Verbal cues, such as intonation or specific language, and non-verbal cues, such 
as unwillingness to touch a patient, contributed to reluctance to seek future care. 
As time progressed many women perceived positive changes in provider 
behavior and attitudes. When women in this study perceived that their provider 
was a positive source of social support they appeared to feel more empowered to 
engage in care. These results are consistent with findings by Boden los and 
colleagues that indicated that patient attitudes toward HIV providers and 
satisfaction with social support were associated with adherence to 
appointments.77 
These findings extend and support prior research that links social support 
and stigma to health outcomes.68•87·149·157·158 In addition the findings from this 
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study may prompt health care providers to better understand factors that 
motivate older Black women to engage in care and their needs from their HIV 
primary care providers. These findings also may inform interventions designed to 
improve patient engagement in care, in particular interventions that target the 
growing proportion of minority women who are growing older with HIV.159 
Limitations 
The findings from this study need to be considered in the context of 
various limitations. Since the interviews were conducted within a HIV primary 
care clinic participants receiving care at that clinic may have been reluctant to 
fully report negative encounters with their providers, even though they were told 
that interviews were confidential and no providers from the clinic were aware of 
their participation. Inclusion of some participants who received care outside of 
the clinic may have mitigated this limitation. 
The strength of this qualitative inquiry allowed for a naturalistic approach 
in obtaining rich data directly from a group of women who have a range of 
experiences engaging in HIV care; however, since participants recalled their past 
behaviors no definitive conclusions could be made to determine how this affects 
the behavior of patients prospectively. Women were currently engaged in care 
and thus self-selection may have limited the findings and themes that emerged 
from the interviews. The experiences of women who were not currently in care 
were not included in this analysis; however, the majority of the women had past 
experiences of not engaging in care. Thus, participants gave insight into what 
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kept them out of care and subsequently what helped them to return to care. 
Since participants self-identified as Black, I discovered that while a 
majority of the women were African-American, a small portion of participants 
represented Blacks from other segments of the African diaspora. There were not 
sufficient numbers to distinguish the experiences of these women from each 
other. The narratives may have been biased towards Black women of African-
American heritage and thus not generalizable to all women within the diaspora. 
Finally, all of the women also identified that they had children and grandchildren 
and based on their responses it was difficult to determine if their experiences 
were similar to women without children and grandchildren. 
Conclusion 
While clinicians play an important role in engaging HIV-infected 
individuals in ongoing care, these findings indicate that supportive relationships 
within the social world of these older HIV-infected Black women were also critical 
to their engagement in care. The ability to accept one's diagnosis and realize the 
benefits of seeking care was highly influenced by both informal and formal 
support sources. The interviews suggest that the barriers to engaging in care 
were minimized once women were able to disclose to someone and accept 
support. However, if they continued to experience stigma or did not perceive 
support from friends , family, or providers, their social world could be a potential 
source of distress and affected their health-seeking behavior. The findings also 
suggest that cumulative experiences with support, stigma, and long-term survival 
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with HIV influenced the women's preferences for regular HIV care. 
For these older Black women liVing with HIV, the process of negotiating 
how to engage in care is set within the social context. The social context 
provided the support necessary for engaging in care and was also a source of 
stigma that interfered with the ability to engage in care. The findings reveal that 
shifts in the influence of social support and stigma may have important 
implications for engagement in care for women living with HIV for extended 
period of time. The shifts of these factors and a lack of focus on the worlds in 
which women live and manage their HIV are in contrast to the clinical emphasis 
of a patient's medical presentation . Subsequently, providers may overlook the 
critical role of social support and stigma in patients' abilities to engage in care. 
Capitalizing on the power of social support may be essential to continue to 
engage older Black women with HIV in medical care . The social context may be 
characterized more comprehensively by understanding how the findings in this 
study compare to that of young Black HIV-positive women or whether the 
findings were unique to older Black women living with HIV. Providers can foster 
the relationship between formal and informal sources of support by 
understanding the changes in these women 's lives as they struggle with stigma 
and disclosure while engaging in HIV care. Because these findings focus on the 
patient's perception and individual behaviors related to engaging in HIV care, the 
findings can help providers and medical teams ta ilor efforts to engage older 
Black women in regular HIV care . . 
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CHAPTER 4: CONCLUSIONS - INTEGRATING THE FINDINGS AND 
RELEVANCE TO TRANSLATION AND PRACTICE 
Once HIV-infected individuals are diagnosed and linked to HIV care there 
remain significant challenges to staying iil care. Research examining how socio-
contextual factors, such as social support and stigma, influence retention and 
engagement in care has experienced burgeoning growth as HIV-infected 
persons are now living longer than they ever have.26 The literature related to 
stigma and social support and their relationship to retention in care has typically 
focused on the impact of these factors individually, and few studies have 
examined if these factors are jointly associated with retention and engagement in 
care. This dissertation potentially extends this line of research by providing an 
understanding of how social support and stigma can influence a patients' ability 
to remain in care. This dissertation also examines the links between social 
support and stigma. I specifically investigated whether social support, stigma, 
and age were associated with retention in HIV care among persons of color. I 
also investigated how stigma and social support played a role in patients' 
engagement in care among older Black women. 
Below I briefly summarize the main findings of the two studies, provide a 
reflection about the conceptual framework, synthesize the findings, and suggest 
alternative research strategies, and provide ideas for translating the findings to 
future research. 
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Summary of the main findings 
In Study 1, I examined a large cohort of survey data of HIV-infected of all 
ethnic groups to understand factors that may contribute to patients' being 
retained in care. In Study 1, I found no evidence that social support, stigma, and 
age were directly or indirectly associated with retention in HIV care. These 
findings are different to previous literature and may have be due in part to several 
factors. Study 1 had a large proportion of participants (89%) who were retained 
in care compared to those not retained in care (11 %). This lack of variation in the 
primary outcome, retention in care, could be related to the design of the parent 
study. A clinic-wide intervention was conducted to improve retention in care for 
all patients in the six clinics. The cohort for my analytic sample was recruited 
post-intervention and could have been impacted by spill-over effects from clinic-
wide the intervention. In addition, although the study included a large proportion 
of vulnerable minorities, I did not detect any significant differences in retention 
based on race/ethnicity. Finally, participants who were included in the final 
analytic sample were already established in care and completed the survey at 
one point in time, thus conclusions could not be made about the presence the 
levels of social support or stigma at the time as participants cycled in and out of 
care. 
In Study 2, I examined in depth how a particular vulnerable population, 
older Black women, believed their experiences with stigma and social support 
facilitated or inhibited their engagement in HIV care. The women that I 
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interviewed portrayed low social support and stigma as sources of distress that 
affected their ability to engage in care. Women were able to engage in care if 
they could limit these sources of distress by disclosing their HIV status and 
receiving social support. 
Study 2 provided evidence from the patient perspective that may give 
further insight into the null findings from Study 1. Although the results related to 
stigma and social support from the two studies may seem disparate, they 
suggest that quantitative measures may not be able to fully capture how social 
support and stigma shapes the context of patients' lives and how these two 
constructs affect their ability to engage in care. The findings from both studies 
indicate that while it is important to capture general support (as measured in 
Study 1 ), the specific type and sources of support (informal, formal , support 
related to HIV care, etc. as measured in Study 2) is a key aspect of 
understanding how social support affects medical decision-making among HIV-
infected patients. 
Reflection about the conceptual framework and characterizing retention in 
care 
While this dissertation provides further understanding of the relationships 
between social support, stigma and age and HIV care, I believe that examining 
the conceptual framework may provide more insight about the results. I discuss 
three key areas related to the conceptual framework as presented in this 
dissertation. First, I discuss the adequacy of the concept of retention in care as it 
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relates to the continuum of care. Second, I contrast the difference between the 
medical system and the social priorities of patients. Third , I suggest how the 
conceptual framework could be revised . 
First, the concept of retention in care may not adequately characterize the 
continuum of care, given the null findings of Study 1 and the in-depth findings of 
Study 2. A chronic illness such as HIV can be thought of as a trajectory across 
time. This trajectory begins with discovery of illness and transitions to 
management of the illness across time. The manner in which the two studies 
characterized the phenomenon of the continuum of care may have contributed to 
the opposite findings. Study 1 examined the phenomenon of the continuum of 
care at a specific interval of time; whereas participants in Study 2 retrospectively 
described this same phenomenon as they cycled in and out of care. Given the 
results of Study 1, the narrow definition of retention seems unable to capture the 
dynamic nature of the continuum of care when restricted to a point in time. 
Second, the narrow definition of retention at a specific interval of time also 
highlights a distinction between patient needs as defined by the medical system 
and the social priorities of patients. The medical system prioritizes optimal health 
as a key outcome of medical care; in comparison , participants in Study 2 
revealed that they prioritized their social world above achieving optimal health 
and remaining in care. Findings from both studies may indicate that in contrast to 
clinical or a priori provider assumptions, patients have a different perspective 
(e.g. experiences with stigma, disclosure, or navigating care) on what is relevant 
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to stay in care. The care that the participants received was set within their social 
world. If their social world was a source of distress then they were unable to 
engage in care successfully; however, when the social world became a source of 
support then they were able to engage. The process of engagement for these 
women was a process that changed across time. This process of engagement 
was not captured by the narrow definition of retention and the difference between 
the two could have contributed to the disparate findings of Study 1 and 2. The 
findings from this dissertation suggest attending visits is one component of the 
care experience for patients who engage in care. How patients perceive their 
illness and respond to long-term challenges for navigating care are also 
important components of their care experience. 
Finally, while I believe that my focus on the social world and the support 
received was an integral part of conceptual framework, the NEM component of 
conceptual model could be amended given the findings from the two studies. The 
two studies further an understanding of the role of the support system relative to 
retention and engagement in care. The NEM postulates that health care 
decisions are made within a social support system and the social support system 
is the mechanism through which individuals: 1) recognize and respond to illness, 
2) decide when and where to seek medical care, and 3) decide to adhere to 
medical treatment and care. However, I believe the NEM is specific to how 
individuals make health care decisions. If one was interested in understanding 
how a specific intervention or change in clinic process impacted care of 
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individuals the model could be revised . For example, the NEM could be 
exchanged for another framework that incorporates clinic structure or process, 
such as the Donabedian model. 160 
Reflection on why patients engage in care 
The information gleaned from Study 2 provided a detailed understanding 
of why patients engage in care. I found that the women described how and why 
they were able to engage, rather than simply describing attending visits. For the 
women I interviewed, engagement meant that they established supportive 
relationships with providers, family, friends, etc. These supportive relationships 
enabled women to engage in care because the person who provided support 
often provided resources, such as information or emotional support, which 
facilitated sustained care. For example, women viewed the relationship with 
providers as critical for sustaining care. This relationship often consisted of 
feeling connected to their providers and being receptive of their 
recommendations for care. I also found that informal relationships within the 
social world (e.g family , friends, etc.) were a key influence for the women's 
motivation to be responsible for their HIV care. The concept of patient willingness 
and ability to be responsible for managing their own health, has been termed as 
patient activation .161 The women who were able to successfully engage in care, 
were able to use the support gained from the social world in addition to 
knowledge, skills, and behaviors162-all components of patient activation-for 
managing their health . 
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Reflection on the relationship between social support, stigma, disclosure 
and engagement in care 
The findings from Study 2 study also provide a more comprehensive 
understanding of how social support and stigma interacted in distinctive yet 
important ways. As described in Chapter 1 , prior research has shown that stigma 
and social support are important to engagement in care. However, the findings 
from Study 2 show the specific connections between stigma and social support. 
The ways in which social support and stigma interacted influenced the women's 
ability to engage in care. When women were able to overcome the fear of stigma, 
disclose their status, and obtain support, they were better able to engage in care. 
In contrast, when women disclosed and became stigmatized , they did not obtain 
support. The women I interviewed, revealed that past experiences with stigma 
often interfered with their ability to engage in care. A fear of stigma related to 
disclosure of one's HIV status frequently resulted in a lack of access to social 
support that could facilitate engagement in care. The negative consequences of 
stigma, such fear of discrimination and isolation , often led women conceal their 
HIV status by not practicing health behaviors (e.g. taking medication or attending 
HIV care) that are beneficial for their health . While these findings give insight into 
how social support and stigma interact, they do not directly predict if patients will 
engage in care. 
A key finding from Study 2 was that disclosure of one's HIV status was 
necessary to obtain support. Disclosure was an important and interrelated aspect 
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of stigma. Disclosure of one's HIV status was inhibited by fear of stigma. The 
narratives suggest that even if the women did not disclose their HIV status, their 
experiences with HIV-related stigma could have been shaped by the potential 
effects of disclosure. For example, women revealed that if they disclosed they 
could experience potential stigma or they could receive potential support. Those 
who perceived potential stigma often hid their disease and did not engage in 
care. In contrast, those who perceived potential support were able to disclose 
and gain support for engaging in care. Two studies corroborate these findings 
that disclosure of one's HIV status was associated with retention in care87 and 
HIV-infected individuals who overcame the barrier of stigma were able to engage 
in care .97 I also found that the number of persons to whom women disclosed did 
not impact whether women engaged. In several of the narratives women 
described that only a single person knew of their HIV status. The support that 
they received from this individual often was beneficial for engaging in care. This 
finding is in contrast to one study that found disclosure to more people facilitated 
access to HIV-specific support that was related to management of HIV.87 
Reflection on age and engagement in care 
The findings from Study 2 also have direct implications for understanding 
the influence of age relative to engaging in care. The findings raise two important 
questions regarding age: 1) Do older HIV-infected individuals have better 
adherence to HIV care because they have lived with HIV for a long time and 
have adapted being responsible for their care? or 2) do older HIV-infected 
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individuals have better adherence to HIV care because of a mediating effect of 
other factors? The concurrence of aging with HIV, lived experience in the world, 
prominence of mortality as one ages, and surviving with a disease that was once 
a death sentence are all factors that may impact how one conceptualizes 
disease. The narratives indicate that both adapting to care and past experiences 
had an impact on engaging in care. Even though I selected one group (age 50+), 
the women described changes in engagement as they aged across time. This 
was true in particular for women who were diagnosed with HIV for an extended 
period of time. Additionally, other factors correlated with age, such as 
comorbidities or attitudes towards care, may be another factor related to staying 
in care. Age on its own may not directly act on sustained care, but may act 
through these factors. With increasing age HIV-infected populations are more 
likely to have comorbid conditions, such as hypertension or coronary artery 
disease. 122 This may indicate that patients have sustained care because they are 
concerned about managing other health conditions in addition to their HIV. I was 
not able to distinguish between the roles of age, the impact of comorbidities, and 
adapting to an illness across time, but I believe that this is an important yet 
complex issue that merits more attention in future research. 
Implications for potential interventions 
These findings may have implications for potential interventions to 
improve retention and engagement in care. Retaining and engaging patients in 
HV care are complex issues that require multi-faceted research and 
109 
interventions. Evidence from several national initiatives found retention and 
engagement in care was sustained when interventions were designed to reduce 
barriers to care by improving self-efficacy in conjunction with increased access to 
ancillary services.3·97·163 However, there remain challenges in translating the 
knowledge generated from this type of research into mainstream practice. HIV 
research has demonstrated success in a controlled research environment; 
however, it is unclear if the interventions are sustainable outside of the research 
setting. 164·165 Furthermore, disparities related to race, ethnicity, sexual 
orientation, age, and geographic location persist.53·55 Therefore, integrating 
research into health care practice and policy will require tailoring research to 
vulnerable HIV-infected populations and understanding the contextual and 
clinical environments in which the interventions are delivered. 165 
While Study 1 focused on retention from a clinical perspective, Study 2 
focused on various aspects of retention in care from the patient's perspective. 
The patient perspective is important for providers to understand the factors that 
influence decision-making and patient preferences for their clinical care when 
seeking HIV care. Analysis of women's narratives revealed the reasons why 
women entered, exited, or remained in HIV care. This finding highlights the need 
for providers and researchers to consider retention more than just a "snapshot" of 
a moment in time, rather retention should be viewed as a critical component of 
life long engagement in care. 
Understanding the experiences of vulnerable populations, particularly the 
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unique experiences of older HIV-infected populations in the U.S., will provide 
insight into how and why patients enter and exit HIV care. The findings from this 
from dissertation, support the initial assumption that vulnerable and older 
populations have distinct challenges for long-term retention in care. The findings 
from Study 2 confirmed that age is a relevant factor to consider in regards to 
retaining HIV-infected patients in care. Overall these findings suggest that 
different groups of patients may engage in care differently because 1) patients 
have adapted to their illness across time or 2) an interaction of factors (e.g. 
comorbidities, mental health, attitudes towards care, etc) may have a mediating 
effect on age and how patients perceive their illness. Future research should 
include adequate samples of both younger and older HIV-infected patients, such 
that meaningful conclusions about the effect of age can be inferred. 
Although, Study 1 did not indicate the relevance of social support to 
retention in care, this issue merits further study among HIV-infected individuals at 
various stages of engagement in HIV care (e.g. patients who re-establish care, 
patients with no prior challenges with retention , newly diagnosed, etc.). 
Specifically at the individual level, research needs to understand the factors that 
impact long-term engagement beyond clinical and demographic characteristics. 
And how to effectively maintain optimal retention. Both studies in this dissertation 
were limited to sampling individuals at one point in time; however, Study 2 asked 
about prior experiences in care. Interventions that longitudinally follow patients 
across time are necessary to impact factors that may influence entrances and 
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exits in care. 
Present studies examine the existence of sub-optimal retention in 
care, 6•28·107 but an important question that was raised from the findings is how to 
empower and motivate patients to remain in care. Much of the retention in care 
literature examines retention from a clinical perspective. As mentioned in Chapter 
1, the majority of studies focus solely on measuring attendance to visits. The 
variation of experiences among the qualitative findings in Study 2, indicates that 
in addition to patients being motivated to attend visits, how patients build long-
term and meaningful relationships with providers is also important for sustained 
engagement in care. The qualitative narratives reveal that women were able to 
build long-term relationships with providers when their providers were invested in 
their over well-being in addition to their HIV care. 
Several authors have found that better patient-provider relationships result 
in improved engagement in HIV care, HIV health outcomes, and medication 
adherence.2·166•167 Mallinson et al.2 found that clinicians have a significant role as 
either a facilitator or barrier in the process of engaging and retaining HIV-infected 
patients in care. Their findings indicate that patients who experienced gaps in 
care partially attributed gaps in care to a poor patient-provider relationship. 
Likewise, findings from study 2 indicate that providers play an important role for 
engaging patients in HIV care. Sustaining long-term relationships with patients 
requires providers to be able to provide patient-centered care that is-- "respectful 
of and responsive to individual patient preferences, needs, and values, and 
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ensuring patient values guide all clinical decisions". 168 A key focus of future 
interventions should be to identify and design interventions that test aspects of 
social support that have the most impact on patient self-efficacy and related 
health related outcomes. These interventions could be tested among different 
populations of providers such as physicians or case workers. Findings from 
Chapter 3, suggest that social support specifically related to HIV care plays a 
major role in facilitating engagement in care. Given the limited time of a clinical 
visit, expanded supportive relationships with family and friends, peer 
advocates, 169 and case managers109 may be a potential means of helping HIV-
infected individuals better navigate long-term HIV care. 
In addition to supportive relationships with providers, findings from Study 
2 indicate that the social context in which live could also be a source of barriers 
to engaging in care . Barriers related to HIV stigma and disclosure were key 
reasons for not being retained in care. Although in industrialized countries, such 
as the U.S., HIV has transitioned from a disease with high morbidity and mortality 
to a chronic disease, yet HIV-related stigma continues to persist. 12·87 In a 
comprehensive review of 22 interventions designed to reduce HIV-related 
stigma, Brown et al. found that even though the interventions varied in design, 
context, content, and scale many gaps remain in designing wide-reaching 
interventions that achieve long-term impact. 170 Many of the studies in the review 
assessed stigma at an individual-level (e.g. patient or health care provider) and 
report evidence of superficial changes in attitudes and knowledge, but few 
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provided evidence for sustained impact. Despite these limitations, the 
interventions that used multiple components, such as information and skills 
building, were more effective in reducing stigma. Interventions such as the ones 
identified in the review by Brown et al. 170 have the potential to influence 
individuals who develop programs and policies for improving retention in care; 
thus, future efforts should also focus on scaled-up and comprehensive 
interventions for reducing stigma as a barrier to retention in care. 
Future research 
These findings suggest specific studies that may be useful for future 
research. Studies that may help better understand differences in retention in care 
among vulnerable populations might include: 1) a longitudinal study to examine 
the dynamic between age and years since HIV diagnosis on retention in care; 2) 
an intervention study that focuses on disclosure and supportive relationships with 
family and friends to improve retention; 3) an observational study to better 
understand differences in how socio-contextual factors impact retention among 
other vulnerable populations, such as urban compared to rural HIV-infected 
patients or MSM populations; and 4) longitudinal studies to better understand 
how socio-contextual factors change across time and how these change as HIV-
infected patients age and navigate HIV care. Studies in this area should also 
consider alternative methods of measuring HIV-specific socio-contextual factors , 
like stigma and social support, at the patient, community, and institutional levels. 
These multi-level factors may interact in opposing or similar ways. Understanding 
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these multi-level factors could potentially provide deeper insight into the aspects 
of the context of how individuals respond to their illness. The findings also 
provide support for future studies to create and evaluate patient-based measures 
of retention and engagement in care. Study 1 used clinical-based measures but 
was unable to capture the nuances of how or why patients remain in care. Study 
2 revealed that the patient perspective is important to contextualize how social 
support and stigma interact and why patients remain in care. Finally, a broader 
and more comprehensive perspective of retention can be explored. This more 
comprehensive perspective of retention should include the impact of the social 
world and how patient cycle in and out of care across time. 
In conclusion, these findings contribute to a more specified understanding 
of retention in HIV care among vulnerable populations. Although findings indicate 
that patient vulnerability is related to retention and engagement in HIV care, 
examining how vulnerability directly or indirectly leads to sub-optimal retention 
and engagement should be considered in future research. In particular, additional 
work is needed to fully understand how social support and stigma is related to 
retention and engagement in care among the group most affected with H IV, 
MSM. Future studies must bridge the gap between the continuum in HIV care 
and socio-contextual factors that facilitate or hinder care -- particularly among 
vulnerable populations. Finally, studies must also consider that engagement is a 
process of entrances and exits across time. 
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APPENDIX A. ACASI QUESTIONNAIRE 
INTERVIEWER READ: 
Thank you for agreeing to talk with me today. This interview is going to cover 
many topics, including your health and your experiences with HIV medical care. 
This information will help us to improve care for people living with HIV. 
Everything that we are going to talk about is confidential. If there are any 
questions you don't feel comfortable answering, you don 't have to answer them. 
This interview will take about 30 minutes. As I go through the questions, please 
let me know if there is anything that is unclear. Are you ready to begin? 
Demographics 
1. What is your month and year of birth? 
Month: ____ (Select a month Jan through Dec from the 
dropdown menu) 
Year: ________ (Select a year from the dropdown menu) 
2. What is your gender? 
0 Male 
0 Female 
0 Transgender or transsexual (Male to Female) 
0 Transgender or transsexual (Female to Male) 
3. What race do you consider yourself to be? (Choose ALL groups that 
describe your race) 
0 White 
0 Black or African- American 
0 American Indian or Alaska Native 
0 Asian 
0 Native Hawaiian or other Pacific Islander 
4. What is your ethnicity? Choose one. 
0 Hispanic or Latino 
D Not Hispanic or Latino 
5. Where were you born? 
0 In the United States of America , Puerto Rico, or other U.S. dependent 
area (American Samoa, Guam, Northern Mariana Islands, or U.S. 
Virgin Islands) 
0 In another country 
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6. What language do you speak most of the time, with friends and family? 
D English 
D Spanish 
D French 
D Haitian Creole 
D Portuguese 
D Chinese 
D Vietnamese 
D Other 
7. How much school have you completed? 
0 sth grade or less 
0 Some high school 
0 High school graduate/GED 
0 Some college 
0 4-year college graduate 
0 Graduate school or professional degree 
8. Are you currently married or in a marriage-like or committed 
relationship? 
DYes 
0 No 
9. What is your sexual orientation? 
D Heterosexual/Straight 
D Homosexual/Gay 
D Homosexual/Lesbian 
D Bisexual 
10. In the past 2 years, with whom have you had sex? 
D Men only 
D Women only 
D Both men and women 
D Nobody 
11. Where do you live? (Choose one) 
D In my own home/apartment 
D In someone else's home/apartment 
D Supported/transitional housing 
D Shelter 
D Residential treatment program 
D The streets/in a car/in a park/on the beach 
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D In an abandoned building 
D Motel 
D Foster/group home 
D Boarding house/Single room occupancy (SRO) 
D Correctional facility 
D Moving from house to house; I have no permanent place to stay 
D Other 
12. Are you the primary caregiver for any of the following: 
A primary caregiver is someone who provides the most care or who assumes the 
most responsibility for another person. 
a. Are you the primary caregiver for any children? 
DYes 
D No 
b. Are you the primary caregiver for any adults, including any elderly 
person(s)? 
DYes 
D No 
13. At any time in the past 30 days, did you work at a paying job? 
D No, I did not work at a paying job 
DYes, I worked at a paying job 1 - 10 hours per week 
DYes, I worked at a paying job 11 -30 hours per week 
DYes, I worked at a paying job more than 30 hours per week 
14. What is the easiest way for you to tell me your (household) income? 
_Weekly 
_ Every other week or twice a month 
_Monthly 
_Yearly 
15. What is your combined household income from all sources? 
This is the amount of money you take home on a [insert time period indicated in 
the previous question] basis. $ ________________________ _ 
16. How many people depend on this income? 
D Myself only 
D Myself and 1 other person 
D Myself and 2 other persons 
D Myself and 3 or more persons 
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Health-related Quality of Life (SF-1) 
1. In general, would you say your health is: 
0 Excellent 
0 Very good 
0 Good 
0 Fair 
0 Poor 
Life Chaos 
INTERVIEWER READ: 
The following statements are about your life in general. Please tell me how much 
you agree or disagree with each statement. 
1. My life is organized 
0 Strongly agree 
0 Somewhat agree 
0 Somewhat disagree 
0 Strongly disagree 
2. My life is unstable 
0 Strongly agree 
0 Somewhat agree 
0 Somewhat disagree 
0 Strongly disagree 
3. My routine is the same from week to week 
0 Strongly agree 
0 Somewhat agree 
0 Somewhat disagree 
D Strongly disagree 
4. My daily activities from week to week are unpredictable 
0 Strongly agree 
0 Somewhat agree 
0 Somewhat disagree 
0 Strongly disagree 
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5. Keeping a schedule is difficult for me 
0 Strongly agree 
0 Somewhat agree 
0 Somewhat disagree 
0 Strongly disagree 
6. 1 do not like to make appointments too far in advance because I do not 
know what might come up 
0 Strongly agree 
0 Somewhat agree 
0 Somewhat disagree 
0 Strongly disagree 
HIV Stigma 
INTERVIEWER READ: 
The following statements are about some of your experiences, feelings, and 
opinions as to how people with HIV feel and how they are treated. Please tell me 
how much you agree or disagree with each statement. There are no right or 
wrong answers. 
1. Have you ever told anyone (for example, family members, friends, or 
sex partners) that you have HIV? 
0 Yes 
0 No 
*** SKIP INSTRUCTIONS: If the respondent answers "No", please 
skip to Q7. 
2. I have been hurt by how people reacted to learning I have HIV. 
0 Strongly agree 
0 Somewhat agree 
0 Somewhat disagree 
0 Strongly disagree 
3. I have stopped socializing with some people because of their reactions 
to my having HIV. 
0 Strongly agree 
0 Somewhat agree 
0 Somewhat disagree 
0 Strongly disagree 
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4. I have lost friends by telling them I have HIV. 
D Strongly agree 
D Somewhat agree 
D Somewhat disagree 
D Strongly disagree 
5. I am very careful who I tell that I have HIV. 
D Strongly agree 
D Somewhat agree 
D Somewhat disagree 
D Strongly disagree 
6. I worry that people who know I have HIV will tell others. 
D Strongly agree 
D Somewhat agree 
D Somewhat disagree 
D Strongly disagree 
7. I feel that I am not as good a person as others because I have HIV. 
0 Strongly agree 
D Somewhat agree 
D Somewhat disagree 
D Strongly disagree 
8. Having HIV makes me feel unclean. 
D Strongly agree 
D Somewhat agree 
D Somewhat disagree 
D Strongly disagree 
9. Having HIV makes me feel that I'm a bad person. 
D Strongly agree 
D Somewhat agree 
D Somewhat disagree 
D Strongly disagree 
10. Most people think that a person with HIV is disgusting. 
0 Strongly agree 
0 Somewhat agree 
0 Somewhat disagree 
0 Strongly disagree 
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11. Most people with HIV are rejected when others find out. 
D Strongly agree 
D Somewhat agree 
D Somewhat disagree 
D Strongly disagree 
Taking ARV Meds 
INTERVIEWER READ: Now I am going to ask you about HIV medications 
( antiretroviral medications). 
1. Are you currently taking any HIV medications? 
(These are medications such as [give a few common examples of HIV 
meds] and are NOT medications such as Bactrim or [another 
example]) 
DYes 
D No 
*** SKIP INSTRUCTIONS: If the respondent answers 11No", please skip to 
the next section of the survey. 
2. During the past 7 days, I took: 
0 ALL my pills 
D MOST of my pills 
0 About ONE-HALF of my pills 
0 VERY FEW of my pills 
D NONE of my pills 
3. When was the last time you missed any of your HIV medications? 
D Within the past week 
D 1-2 weeks ago 
D 2-4 weeks ago 
D 1-3 months ago 
D More than 3 months ago 
D I never skip medications 
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Social Support CMOS Scale) 
INTERVIEWER READ: 
People sometimes look to others for friendship, assistance, or other types of 
support. How often is each of the following kinds of support available to you if 
you need it? 
1. How often do you have someone to turn to for suggestions about how to 
deal with a personal problem? 
D None of the time 
D A little of the time 
D Some of the time 
D Most of the time 
D All of the time 
2. How often do you have someone to help with daily chores if you were 
sick? 
D None of the time 
D A little of the time 
D Some of the time 
D Most of the time 
D All of the time 
3. How often do you have someone to love you and make you feel wanted? 
D None of the time 
D A little of the time 
D Some of the time 
D Most of the time 
D All of the time 
4. How often do you have someone to do something enjoyable with? 
D None of the time 
D A little of the time 
D Some of the time 
D Most of the time 
D All of the time 
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Mental Health (851) 
INTERVIEWER READ: 
The following is a list of problems and concerns that people sometimes have. 
Please indicate how you have been feeling during the past week, including today. 
Please choose one answer only. 
1. In the past week, how much have you been bothered by nervousness or 
shakiness inside? 
D Not at all 
D A little bit 
D Moderately 
D Quite a bit 
D Extremely 
2. In the past week, how much have you been bothered by feeling easily 
annoyed or irritated? 
D Not at all 
D A little bit 
D Moderately 
D Quite a bit 
D Extremely 
3. In the past week, how much have you been bothered by thoughts of 
ending your life? 
D Not at all 
D A little bit 
D Moderately 
D Quite a bit 
D Extremely 
4. In the past week, how much have you been bothered by being suddenly 
scared for no reason? 
D Not at all 
D A little bit 
D Moderately 
D Quite a bit 
D Extremely 
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5. In the past week, how much have you been bothered by temper 
outbursts that you could not control? 
D Not at all 
0 A little bit 
D Moderately 
D Quite a bit 
D Extremely 
6. In the past week, how much have you been bothered by feeling lonely? 
D Not at all 
0 A little bit 
D Moderately 
D Quite a bit 
D Extremely 
7. In the past week, how much have you been bothered by feeling blue? 
D Not at all 
D A little bit 
D Moderately 
D Quite a bit 
D Extremely 
8. In the past week, how much have you been bothered by feeling no 
interest in things? 
D Not at all 
D A little bit 
D Moderately 
D Quite a bit 
D Extremely 
9. In the past week, how much have you been bothered by feeling fearful? 
D Not at all 
D A little bit 
D Moderately 
D Quite a bit 
D Extremely 
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10. In the past week, how much have you been bothered by feeling easily 
hurt? 
D Not at all 
D A little bit 
D Moderately 
D Quite a bit 
D Extremely 
11. In the past week, how much have you been bothered by feeling 
hopeless about the future? 
D Not at all 
D A little bit 
D Moderately 
D Quite a bit 
D Extremely 
12. In the past week, how much have you been bothered by feeling tense or 
keyed up? 
D Not at all 
D A little bit 
D Moderately 
D Quite a bit 
D Extremely 
13. In the past week, how much have you been bothered by having urges to 
beat, injure, or harm someone? 
D Not at all 
D A little bit 
D Moderately 
D Quite a bit 
D Extremely 
14. In the past week, how much have you been bothered by having urges to 
break or smash things? 
D Not at all 
D A little bit 
D Moderately 
D Quite a bit 
D Extremely 
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15. In the past week, how much have you been bothered by having spells of 
terror or panic? 
D Not at all 
D A little bit 
D Moderately 
D Quite a bit 
D Extremely 
16. In the past week, how much have you been bothered by getting into 
frequent arguments? 
D Not at all 
D A little bit 
D Moderately 
D Quite a bit 
D Extremely 
17. In the past week, how much have you been bothered by feeling so 
restless you could not sit still? 
D Not at all 
D A little bit 
D Moderately 
D Quite a bit 
D Extremely 
18. In the past week, how much have you been bothered by feeling 
worthless? 
D Not at all 
D A little bit 
D Moderately 
D Quite a bit 
0 Extremely 
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Alcohol Use 
INTERVIEWER READ: 
This portion of the questionnaire is about your use of alcoholic drinks during the 
PAST 90 DAYS. By a "drink", I mean a can of beer, a glass of wine, or a shot of 
hard liquor. 
1. In the past 90 days, how often did you have a drink containing alcohol? 
D Every day 
D 4 or more times a week 
D 2-3 times a week 
D 2-4 times a month 
D Monthly or less 
D Never 
***SKIP INSTRUCTIONS: If the respondent answers "Never", please skip to 
Q5. 
2. How many drinks containing alcohol do you have on a typical day when 
you drink? 
D 1 or2 
D 3 or4 
D 5 or6 
D 7 or8 
D 9 or more 
3. In the past 90 days, did you have 5 or more alcoholic drinks on one 
occasion? 
DYes 
0 No 
***SKIP INSTRUCTIONS: If the respondent answers uNo", please skip to the 
next section of the survey. 
4. How often do you have 5 or more alcoholic drinks on one occasion? 
D Daily or almost daily 
D Weekly 
D Monthly 
D Less than monthly 
D Never 
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***SKIP INSTRUCTIONS: After completing Q4, please skip to the next 
section of the survey. 
5. You indicated that you did not have a drink containing alcohol in the past 90 days. Did 
you become sober in the past 12 months? 
DYes 
0 No 
Drug Use 
INTERVIEWER READ: 
In this section, I am going to ask you some questions about drug use. The first 
question asks you to choose all answers that apply to you. Before proceeding 
with these questions, I would like to remind you that all your responses are 
confidential. 
1. Which of the following drugs, if any, have you ever used? (Check all that 
apply) 
Powder Cocaine (snort) 
Crack Cocaine (rock, gravel) 
Heroin (horse, smack, tar) 
Crystal Methamphetamine (Crystal Meth , Ice, Tina , Glass) 
Other Amphetamines (Speed) 
Prescription drugs or painkillers without a prescription (Oxycontin , 
Codeine, Demerol , Darvon, Xanex) 
None- you have never used any of these drugs 
*** SKIP INSTRUCTIONS: For any of the above drug items that are checked, 
please skip to the corresponding item(s) below (Q2-Q7) about use in the 
past 90 days. Please ask only about those drugs that the respondent 
indicated EVER using. If the respondent answers "None" or "Don't Want to 
Answer", please skip to QB. 
2. You said that you have used powder cocaine (snort.) Have you used 
powder cocaine in the past 90 days? 
DYes 
D No 
3. You said that you have used crack cocaine (rock, gravel.) Have you used 
crack cocaine in the past 90 days? 
DYes 
D No 
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4. You said that you have used heroin (horse, smack, tar). Have you used 
heroin in the past 90 days? 
DYes 
D No 
5. You said that you have used Crystal Methamphetamine (Crystal Meth, 
Tina). Have you used Crystal Methamphetamine in the past 90 days? 
DYes 
D No 
6. You said that you have used amphetamines (speed). Have you used 
amphetamines in the past 90 days? 
DYes 
D No 
7. You said that you have used prescription drugs or painkillers without a 
prescription (Oxycontin, Codeine, Demerol, Darvon). Have you used 
prescription drugs or painkillers without a prescription in the past 90 days? 
DYes 
D No 
8. Have you ever injected any non-prescription drugs (such as cocaine or 
heroin)? 
DYes 
D No 
*** SKIP INSTRUCTIONS: If the respondent answers "No" or "Don't Want to 
Answer", please skip to Q10. 
9. Have you injected any non-prescription drugs in the past 90 days? 
DYes 
D No 
10. In the past 12 months were you in any alcohol or drug treatment 
program, such as inpatient or outpatient treatment, or detox? 
DYes 
D No 
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11. In the past 12 months have you participated in any alcohol or drug self-
help program, such as Alcoholics Anonymous (AA), Narcotics Anonymous 
(NA), or 12-step? (Only include a program for you, not for someone else, 
such as AI-Anon). 
0 Yes 
0 No 
Unmet Needs 
INTERVIEWER READ: 
In this section I am going to read you a list of services. For each service, please 
tell me if you felt like you needed this service during the past 6 months. For 
those services that you tell me you needed, I will then ask you if you got that 
service. 
*** SKIP INSTRUCTIONS: For each service (1 - B) below, first ask the 
question in Column A ("Did you need . .. 'J. If the respondent answers 
"Yes", then ask the question in Column 8 ("Were you able to get . .. 'J. If 
the respondent answers "No" to a service in Column A, then skip to the 
next service below and repeat the question in Column A. 
A. Did you need B. Were you able to get 
[Interviewer: [Interviewer: insert 
insert service] service] during the past 6 
during the past 6 months? 
months? 
1. Counseling D Yes (Go to the D Yes 
box to the right) D Sometimes 
D No (Skip to the D No 
box below) 
2. Substance abuse D Yes (Go to the D Yes 
treatment box to the right) D Sometimes D No (Skip to the D No 
box below) 
3. Housing D Yes (Go to the D Yes 
box to the right) D Sometimes 
D No (Skip to the D No 
box below) 
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4. Emergency D Yes (Go to the DYes 
financial box to the right) D Sometimes 
assistance D No (Skip to the D No 
box below) 
5. Employment D Yes (Go to the DYes 
assistance box to the right) D Sometimes 
D No (Skip to the D No 
box below) 
6. Transportation D Yes (Go to the DYes 
box to the right) D Sometimes 
D No (Skip to the 0 No 
box below) 
7. Help with getting D Yes (Go to the D Yes 
food, groceries or box to the right) D Sometimes 
meals D No (Skip to the D No 
box below) 
8. Help with getting D Yes (Go to the 0 Yes 
benefits box to the right) 0 Sometimes 
0 No D No 
Incarceration 
INTERVIEWER READ: 
These next few questions are about incarceration. By incarceration, we mean 
being locked up in jail or prison. 
1. In the past six months, have you been in jail or prison? 
DYes 
0 No 
*** SKIP INSTRUCTIONS: If the respondent answers "No" or "Don't Want to 
Answer", please skip to Q3. 
2. How much total time have you spent in jail or prison in the past six 
months? 
D 1 day 
D Between 2 and 7 days 
D Between 8 and 30 days 
0 More than 30 days 
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3. Are you currently on probation or parole? 
DYes 
D No 
Structural and Financial Barriers 
INTERVIEWER READ: 
Now I am going to ask you some questions about things that may have made it 
difficult for you to get HIV medical care. Please tell me if any of the following 
problems made it difficult for you to get HIV medical care in the PAST 6 
MONTHS. 
1. In the past 6 months, were you worried about how you would pay for 
your HIV medical care (for example, you didn't have insurance, your 
insurance would not pay, you were worried about spending your own 
money for co-pays and for prescriptions)? 
DYes 
D No 
2. In the past 6 months, did you have problems making an appointment for 
HIV medical care because you did not have a telephone? 
DYes 
D No 
3. In the past 6 months, did you have problems getting someone to answer 
your calls to get a health care appointment? 
DYes 
D No 
4. In the past 6 months, did you have trouble getting an appointment at a 
time that was good for you? 
DYes 
D No 
5. In the past 6 months, did you have a problem finding providers who 
speak your language? 
DYes 
D No 
6. In the past 6 months, did you have problems getting transportation to the 
clinic for your appointment? 
DYes 
D No 
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History of HIV 
INTERVIEWER READ: 
Now I am going to ask you a few questions about when you first tested HIV-
positive and the medical care you get for your HIV. 
1. What is the date of your first positive HIV test? (month/year: _ _ 1 _ 
___ ) 
2. After you first tested HIV-positive in [insert date above], how long was it 
before you went to an HIV health care provider for the very first time? (By 
HIV health care provider, we mean a doctor, physician's assistant, or nurse 
practitioner who treats you for your HIV) 
D Less than 3 months 
D 3-6 months 
D More than 6 months but less than 12 months 
D Longer than 12 months 
3. Since you first tested HIV-positive, what was the longest period you 
went without seeing an HIV health care provider? 
D Less than 6 months 
D Between 6 and 12 months 
D More than 12 months 
Engagement with Provider 
Branching question (skip pattern): 
Have you seen an HIV medical provider at least once? (By HIV medical 
provider we mean a doctor, physician's assistant, or nurse practitioner who 
treats you for your HIV infection) 
D Yes (if yes, please continue with this section below) 
D No (if no, please skip to next section on Medical Communication 
Competence) 
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INTERVIEWER READ: 
The next few questions are about interactions between you and your main HIV 
health care provider during your most recent visit to this clinic. By "main HIV 
health care provider", we mean a doctor, physician's assistant, or nurse 
practitioner who treats your HIV infection. Please tell me how much you agree or 
disagree with each statement about your main HIV health care provider. 
1. During my most recent visit at this clinic, my main HIV health care 
provider listened carefully to me. 
D Strongly agree 
D Somewhat agree 
D Somewhat disagree 
D Strongly disagree 
2. During my most recent visit at this clinic, my main HIV health care 
provider explained things in a way that I could understand. 
D Strongly agree 
D Somewhat agree 
D Somewhat disagree 
D Strongly disagree 
3. During my most recent visit at this clinic, my main HIV health care 
provider showed respect for what I had to say. 
D Strongly agree 
D Somewhat agree 
D Somewhat disagree 
D Strongly disagree 
4. During my most recent visit at this clinic, my main HIV health care 
provider spent enough time with me. 
D Strongly agree 
D Somewhat agree 
D Somewhat disagree 
D Strongly disagree 
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Medical Communication Competence Scale 
Questions for participants who responded "Yes" to having seen an HIV medical 
provider at least once. 
INTERVIEWER READ: 
The next few questions are about communication between you and your main 
HIV medical provider. Remember, by "HIV medical provider", we mean a doctor, 
physician's assistant, or nurse practitioner who treats your HIV infection. Please 
tell me how much you agree or disagree with each statement. 
1. I feel comfortable talking with my medical provider about my HIV 
infection. 
D Strongly agree 
D Somewhat agree 
D Somewhat disagree 
D Strongly disagree 
2. I always let my HIV medical provider know when I don't understand 
something. 
D Strongly agree 
D Somewhat agree 
D Somewhat disagree 
D Strongly disagree 
3. I always ask my HIV medical provider all the questions that I have. 
D Strongly agree 
D Somewhat agree 
D Somewhat disagree 
D Strongly disagree 
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Questions for participants who responded uNo" to having seen an HIV medical 
provider at least once. 
INTERVIEWER READ: 
The next few questions are about communication between you and your main 
medical care provider. Please tell me how much you agree or disagree with each 
statement. 
1. I feel comfortable talking with my medical provider about my medical 
issues. 
D Strongly agree 
D Somewhat agree 
D Somewhat disagree 
D Strongly disagree 
2. I always let my medical provider know when I don't understand 
something. 
D Strongly agree 
D Somewhat agree 
D Somewhat disagree 
D Strongly disagree 
3. I always ask my medical provider all the questions that I have. 
D Strongly agree 
D Somewhat agree 
D Somewhat disagree 
D Strongly disagree 
Attitudes about coming to clinic 
I don't always need to let the clinic know when I have to miss my HIV medical 
appointment. 
D Strongly agree 
D Somewhat agree 
D Somewhat disagree 
D Strongly disagree 
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Skipping my HIV medical appointments every now and then will not harm my 
health. 
D Strongly agree 
D Somewhat agree 
D Somewhat disagree 
D Strongly disagree 
I do not always need to come in for my HIV medical appointments when I am 
feeling well. 
D Strongly agree 
D Somewhat agree 
D Somewhat disagree 
D Strongly disagree 
Problem-solving (adapted from Social Problem Solving Inventory) 
When a problem occurs in my life, I put off trying to solve it for as long as 
possible. 
D Not at all true of me 
D Slightly true of me 
D Moderately true of me 
D Very true of me 
D Extremely true of me 
When I am trying to solve a problem, I get so upset that I cannot think clearly. 
D Not at all true of me 
D Slightly true of me 
D Moderately true of me 
D Very true of me 
D Extremely true of me 
When I am trying to solve a problem, I think of as many options as possible. 
D Not at all true of me 
D Slightly true of me 
D Moderately true of me 
D Very true of me 
D Extremely true of me 
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When I am having trouble understanding a problem, I try to get as much 
information as possible to help me solve the problem. 
D Not at all true of me 
D Slightly true of me 
D Moderately true of me 
D Very true of me 
D Extremely true of me 
Whenever I have a problem, I believe that I can solve it. 
D Not at all true of me 
D Slightly true of me 
D Moderately true of me 
D Very true of me 
D Extremely true of me 
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APPENDIX B. Selection of the final analytic sample 
Of the 267 participants who were missing responses, 0.2% were missing a 
response for race/ethnicity, place of birth , or cocaine use (Table 2.4). Less than 
1% were missing responses for education, employment, or housing status. Three 
percent were missing a response for risk category; 0.9% were missing responses 
for alcohol use or mental health distress; 0.2% were missing responses for 
heroin use or other drug use. In terms of clinical indicators of HIV status, 1% 
were missing a response for viral load and 2% were missing a response for CD4. 
Eight percent were missing a response for self-reported years living with HIV and 
5% were missing a response for years living with HIV as reported in their medical 
records. 
There were no significant associations between response to the survey 
questions and social support or age. However, stigma was associated with 
response to the survey questions - a larger proportion of participants who were 
missing at least one response to the survey questions reported high stigma 
levels (43%) compared to those not missing any responses (33%, p=0.005). 
Compared to participants with complete responses, participants missing 
responses were more likely to be male (p<0.0001), Black (p=0.008) , and 
uninsured (p<0.0001 ). Those missing responses were more likely to be born 
outside of the U.S. (25%) compared to those with completed responses (19%, 
p=0.001 ). Individuals who were missing responses were less likely to report 
being a caregiver for adults (8% compared to 12% of those with complete 
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responses, p=0.04). High levels of alcohol use was common among those 
missing responses (26% compared to 21% of those not missing responses, 
p<0.0001). Low mental health distress was common among those who were 
missing responses (50%) compared to those with complete responses (54%, 
p<0.0001). 
More persons who were missing responses reported cocaine use in the 
past 90 days (16%) than those with complete responses (13%, p=0.002). A 
larger proportion of those missing responses never used heroin (84%) than those 
with complete responses (77%, p=0.002). Compared to those with complete 
responses, those who were missing responses were more likely to report 
encountering barriers related to problems scheduling appointments due to lack of 
access to a phone (p=0.002) and problems with calls scheduling medical 
appointments (p=O.O?). 
Individuals who were missing responses were more likely to report 
heterosexual contact as their risk category (49%) than those with completed 
responses (47%, p<0.0001 ). Compared to participants not missing responses, 
participants missing responses were less likely to have a CD4 cell count >350 
(57% vs. 63% among those with complete responses, p<0.0001 ). Those missing 
responses were less likely to report an undetectable viral load (61% compared to 
67% not missing responses, p<0.0001). Participants who were missing 
responses to any survey questions were more likely to be missing self-reported 
years living with HIV (p<0.0001) and also were more likely to be missing years 
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living with HIV as recorded in their medical records (p<0.0001).i 
Based on these results, the entire analytic sample was included for 
analysis, because there were no differences in the main independent variables of 
social support or age. 
i Because there were two variables for "years living with HIV", both variables are reported; 
however, in the final analytic sample the self-reported years living with HIV was used because the 
medical records variable contained mixed data sources- including self-report and lab reports. 
The medical records data did not have an indicator for the specific data source. Further analysis 
(not shown) was conducted to determine if it was possible to substitute the responses; however, 
the two variables did not accurately predict each other. 
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Table 8.1 Comparison of 267 participants who were missing at least one 
response to the 1 ,028 participants with complete responses 
Missing a'f least -- Complete 
responses for 
· one response 
alt questions p Total 
· n=267 · 
- (n=1295) 
... (20;6%) ·. n::::1028 ~ 
--
.· ·.--.{7$.4%) 
Characteristics 
A e 
<40 70 (26.2) 262 (25.5) 332 (25.6) 
40-54 141 (52.8) 559 (54.4) 0.90 700 (54.1) 
;:::ss 56 {21 .0} 207 {20.1} 263 {20.3} 
Gender 
Female 85 (31.8) 397 (38.6) 482 (37.2) 
Transgender 12 (4.5) 0 (0.0) <0.0001 12 (0.93) 
Male 170 {63.7} 631 {61.4} 801 {61 .9} 
Race/Ethnicity_ 
Missing 3 (1 .1) 0 (0.0) 3 (0.23) 
White, Non-Hispanic 23 (8.6) 117 (11.4) 140 (10.8) 
Hispanic 41 (15.4) 174 (16.9) 0.008 215 (16.6) 
Other, Non-Hispanic 7 (2.6) 28 (2.7) 35 (2.7) 
Black, Non-Hispanic 193 (72.3} 709 (69.0) 902 {69.7} 
Education 
Missing 1 (0.4) 0 (0.0) 1 (0.08) 
Some college or 73 (27.3) 335 (32.6) 408 (31 .5) greater 
HS graduate or GED 85 (31 .8) 318 (30.9) 0.10 403 (31.1) 
Some HS or less 108 {40.5} 375 {36.5} 483 {37.3} 
Insurance 
Missing 18(6.7) 0 (0.0) 18(1.4) 
Uninsured/None 71 (26.6) 241 (23.4) 312 (24.1) 
Private 41 (15.4) 122(11.9) 
<0.0001 163 (12.6) 
Medicare 38 (14.6) 215 (20.9) 254 (19.6) 
Medicaid 98 (36.7} 450 {43.8) 548 {42.3} 
Social Support 
Low social support 121 (45.3) 431 (41 .9) 0.32 552 (42.6) 
High social support 146 (54.7} 597 {58.1) 743 {57.4} 
Sti rna 
High stigma levels 114 (42.7) 343 (33.4) 0.005 457 (35.3) Low stigma levels 153 (57.3) 685 (66.6) 838 (64.7) 
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... . Complete ... : : 
:Missing at lee!sfone ·respon$es 
<response · · 
.·. for all · p Total 
· n:;:2&7 . 'questions (n=1.295} 
(20.6%) · n=1028 < 
{79.4%) 
Place of Birth 
Missing 3 (1.1) 0 (0.0) 3 (0.23) 
Outside of U.S. 66 (24.7) 198 (19.3) 0.001 264 (20.4) 
U.S. 198 (74.2} 839 {80.7} 1028 (79.4) 
Language spoken the 
most 
Other 37(13.9) 132 (12.8) 169(13. 1) 
0.66 
English 230 (86.1) 896 (87.2) 1126 (86.9) 
History of 
Incarceration 
Yes 24 (9.0) 68 (6.6) 
0.18 
92 (7.1) 
No 243 (91 .0) 960 (93.4) 1203 (92.9) 
Caregiver for Adults 
Yes 21 (7.9) 126 (12.3) 147(11.3) 
0.04 
No 246 (92.1) 902 (87.7) 1148 (88.7) 
Caregiver for children 
Yes 42 (15.7) 207 (20.1) 249 (19.2) 
0.10 
No 225 (84.3) 821 (79.9) 1046 (80.8) 
Employment 
Missing 1 (0.37) 0 (0.0) 1 (0.08) 
Employed 61 (22.9) 260 (25.3) 
0.15 
321 (24.8) 
Unemployed 205 (76.8) 768 (74.7) 973 (75.1) 
Housing status 
Missing 1 (0.37) 0 (0.0) 1 (0.08) 
Someone else's 63 (23.6) 213 (20.7) 276 (21 .3) home/apartment 
Other 27 (2.1) 104 (8.0) 0.23 131 (10.1) 
Own 176 (65.9) 711 (69.2) 887 (68.5) home/apartment 
Alcohol use 
Missing 12 (4.5) 0 (0.0) 12 (0.93) 
High level of use 69 (25.8) 214 (20.8) <0.0001 283 (21 .9) 
Low level of use 186 (69.7) 814 (79.2) 1000 (77.2) 
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. J\ftissing at . Complete, · 
leastone · response$ for Total 
· response · an ql.u~stiolls p 
·· n=267 ·. n=1028 (n=1295) 
. . {20.6%} ·. {79 .. 4%} . 
Mental Health Distress 
Missing 12 (4.5) 0 (0.0) 12 (0.93) 
High distress 121 (45.3) . 477 (46.4) <0.0001 598 (46.2) 
Low distress 134 (50.2) 551 (53.6) 685 (52.9) 
Substance abuse 
Cocaine use 
Missing 3 (1.1) 0 (0.0) 3 (0.23) 
Yes, in the past 90 42(15.7) 132 (12.8) 174 (13.4) days 
Past history of use, 0.002 
but not in past 90 82 (30.7) 398 (38.7) 480 (37.1) 
days 
Never used 140 (52.4) 498 (48.4) 638 (49.3) 
Heroin use 
Missing 2 (0.75) 0 (0.0) 2 (0.15) 
Yes, in the past 90 9 (3.4) 38 (3.7) 47 (3.6) days 
Past history of use, 0.002 
but not in past 90 32 (12.0) 200 (19.5) 232 (17.9) 
days 
Never used 224 (83.9) 790 (76.9) 1014 (78.3) 
Other drug use 
Missing 2 (0.75) 0 (0.0) 2 (0.15) 
Yes, in the past 90 15 (5.6) 55 (5.40 70 (5.4) days 
Past history of use, 0.09 
but not in past 90 48(18.0) 210 (20.4) 258 (19.9) 
days 
Never used 202 (75.7) 763 (74.2) 965 (74.5) 
Attitudes about 
coming to care 
Negative 13 (4.9) 47 (4.6) 
0.84 
60 (4.6) 
Positive 254 (95.1) 961 (95.4) 1235 (95.4) 
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· ··•. Missing at . 
. · Complet~ .. · 
least :on~· 
·. responses for ····· Total 
···.··· re~~onsfi .· aUquestie>r:ts : · p 
..... n:;:Z&7 · · n=102a ·· . (n=129$) 
(20~6%) ·. (79~4%)H , • • 
Life chaos 
High levels of life 37 (13.9) 137 (13.3) 174 (13.4) 
chaos 
Low levels of life 0.82 
chaos 230 (86.1) 891 (86.7) 1121 (86.6) 
Barriers to care 
Worried about paying 
for HIV medical care 
Yes 56 (21 .0) 194 (18.9) 0.44 250 (19.3) 
No 211 (79.0) 834 (81.1) 1045 (80.7) 
Problems scheduling 
appointments due to 
lack of access to a 
phone 
Yes 39 (14.6) 86 (8.4) 0.002 125 (9.7) 
No 228 (85.4) 942 (91.6) 1170 (90.4) 
Problems getting 
someone to answer 
calls to schedule an 
appointment 
Yes 27(10.1) 70 (6.8) 0.07 97 (7.5) 
No 240 (89.9) 958 (93.2) 1198 (92.5) 
Problems finding 
providers who speak 
the same language 
Yes 31 (11 .6) 113(11.0) 0.77 144(11.1) 
No 236 (88.4) 915 (89.0) 1151 (88.9) 
Problems getting 
appointment at 
convenient time 
Yes 8 (3.0) 31 (3.0) 0.99 39 (3.0) 
No 259 (97.0) 997 (97.0) 1256 (97.0) 
Problems with 
transportation to 
appointment 
Yes 54 (20.2) 174 (16.9) 0.21 228 (17.6) 
No 213 (79.8) 854 (83.1) 1067 (82.4) 
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· Missing ~t. ' ····•·· Complet~ ·· 
leastc:me respof'ls~~ffor Total 
response all question!; p 
. (n=1295) 
n=267 ... ·. n=~028 > 
•.{20 .. 6%} ••. ·•· .. •. {79.4%} .·· 
Risk category 
Missing 33(12.4) 0 (0.0) 33 (2.6) 
MSM 48 (18.0) 262 (25.5) 310 (23.9) 
MSM +IOU 5 (1.9) 24 (2.3) 
<0.0001 29 (2.2) 
IOU 38 (14.2) 204 (19.8) 242 (18.7) 
Unknown/Other 11(4.1) 51 (5.0) 62 (4.8) 
Heterosexual 132 (49.4) 487 (47.4) 619 (47.8) 
Currently Taking ART 
No 45 (16.9) 154 (15.0) 0.45 199 (15.4) 
Yes 222 (83.2) 874 (85.0) 1096 (84.6) 
CD4 (cellslmL)-
(within ±120 dal:.S2 
Missing 23 (8.6) 0 (0.0) 23 (1 .8) 
0-200 41 (15.4( 173 (16.8) 214 (16.5) 
201-350 50(18.7) 213 (20.7) <0.0001 263 (20.3) 
>350 153 {57.3} 642 {62.5} 795 {61.4} 
VL (copieslml)-
(within ±120 dal:.s2 
Missing 17 (6.4) 0 (0.0) 17 (1.3) 
Detectable (2::200) 88 (33.0) 339 (33.0) 
<0.0001 427 (33.0) 
Undetectable {<200} 162 {60.7} 689 {67.0} 851 {65.7} 
Years living with HIV 
(self-reported) 
Missing 107 (40.1) 0 (0.0) <0.0001 107 (8.3) 
Not missing 160 (59.9) 1028 (1 00.0) 1188 (91 . 7) 
Years living with HIV 
(medical records) 
Missing 59 (4.6) 0 (0.0) 0.0004 59 (4.6) 
Not missing 244 (91.4} 992 (96.5) 1236 ~95.4) 
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APPENDIX C. Dependent variables measurements, definitions, and sources 
Variable Definition Source Measurement Recoded for 
in original Analysis 
dataset 
Dichotomous 
measure 
HRSA HIV/AIDS Linked clinic Categorical 2 kept visits Retention Bureau attendance 1= kept in past year in care Measure113 records 2= canceled separated by 3= no show ::::90 days 
('yes'= 
retained) 
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APPENDIX D. Independent and covariate variables measurements, definitions, 
and sources 
Variable Definition Source Measurement in Recoded for 
original dataset Analysis 
Social Support* Availability of A CAS I 4 questions; Each Categorical 
support question Likert scale 1 Summary 
MOS (none of the time) to 5 score 
Social (all of the time) 
Support 16;:::high 
Scale114 levels of social 
support (1 = 
High social 
support) 
16< low levels 
of social 
support 
(0= Low 
social 
support). 
HIV Stigma* Measures the A CAS I 10 questions Categorical 
perception of 4 subscales: Summary 
stigma related HIV Personalized stigma, score all 
to feelings, Stigma disclosure, public subscales: 
experiences, Scale115·1 attitudes, negative self- 20$ high 
and opinions 16 image levels of 
about HIV and stigma 
how society Each question Likert (1=High 
treats people scale 1 (strongly agree) stigma); 
with HIV to 4 (strongly disagree) 20 >low 
levels of 
stigma (O=Low 
stigma). 
Age* Month and year Clinical Continuous Categorical 
of birth data 0= younger 
than 50 
1 = 50 or older 
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Variable Definition Source Measurement in Recoded for 
original dataset Analysis 
Race/Ethnicity Race/Ethnicity A CAS I Race: Categorical 
of respondent 1= White 1= White, 
2= Black Non-Hispanic 
3= American 2= Black, 
Indian/Alaskan Native Non-Hispanic 
4= Asian 3= 
5= Native Hispanic/Latin 
Hawaiian/Pacific Islander 0 
4= Other, 
Ethnicity: Non-Hispanic 
1 = Hispanic/Latino 
2= Not Hispanic/Latino 
Country of birth Birth place of ACASI 1= USA or USA No receding 
respondent territories 
2= Other country 
Site Study site ACASI 1= A All categories 
2= B the same 
3= c except 8 
4= D receded as 
5=E 'missing ' 
6=F 
8 =Refuse to Answer 
Education Highest level of A CAS I 1 = 81h grade or less Categorical 
education 2= Some high school 1= Less than 
attained 3= High schooi/GED high school 
4= Some college 2= High 
5= College graduate schooi/GED 
6= Graduate 3= College or 
school/professional greater 
degree 
Sexual oriental Current sexual ACASI 1 =Heterosexual/straight No receding 
orientation 2= Homosexual/gay 
3= Homosexual/lesbian 
4= Bisexual 
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Variable Definition Source Measurement in Recoded for 
original dataset Analysis 
Housing status Current housing A CAS I 1 = Own home/apartment Categorical 
status 2= Someone else's 1=0wn home/ 
home/apartment apartment 
3= Transitional housing 2= Other 
4= Shelter housing status 
5= Residential treatment 
program 
6= 
Streets/car/park/beach 
7= Motel 
8= Boarding house/single 
room occupancy 
9= Correctional facility 
1 0= No permanent 
housing 
11= Other 
Primary Caregiver for A) ACASI For each question No receding 
Caregiver children or B) 
adults 1= Yes 
2= No 
Paid ACASI 1 = No work at paying job Categorical 
Employment employment 2= Worked 1-10 hours 0= 
past 30 days weekly Unemployed 
3= Worked 11-30 hours 1= Employed 
weekly 
4= Worked more than 30 
hours 
Life Chaos Life chaos of A CAS I 6 questions Categorical 
respondent Each question Likert Summed 
Life scale of 1 to 4 (strongly responses for 
Chaos agree to strongly total score 
Scale 171 disagree) 1 = High chaos 
0= Low chaos 
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Variable Definition Source Measurement in Recoded for 
original dataset Analysis 
HIV Medication Current history ACASI 2 questions Categorical 
taking HIV a) Taking ART Taking ART 
medications ACTU- 1=yes no receding 
41 72,173 2=no 
b) During past 7 days I Past 7 days 
took ART (Likert 1= Adherent 
scale; all to none of 0= Non-
pills) adherent 
Mental Health Assesses A CAS I 18 questions; Each Categorical 
Distress respondents for question Likert scale, 1 to Score of 1 0 or 
psychological BSI 174,175 5 (Not at all to Extremely) more= high 
problems distress for 
men 
score of 13 or 
more= high 
distress for 
women 
1= High 
distress 
0= Low 
distress 
Alcohol use Use of alcohol A CAS I 5 questions; Each Categorical 
in past 90 days question Likert scale Summed 
AUDIT-C responses 
176 Score of 4 or 
more= risky 
drinking in 
men 
Score of 3 or 
more= risky 
drinking in 
women 
1 = High level 
of use (risky 
drinking) 
0= Low level 
of use (non-
risky drinking) 
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Variable Definition Source Measurement in Recoded for 
original dataset Analysis 
Drug Use Drug use in past A CAS I 7 questions No receding 
90 days 1 =yes, in the past 90 
days 
2= past use, but not in 
past 90 days 
3= never used 
Incarceration Incarcerated in A CAS I 1 question No receding 
past 6 months 1= yes 
2= no 
Structural Barriers that A CAS I 6 questions No receding 
barriers have impeded 1= yes 
receiving HIV 2= no 
care 
Attitudes about Respondent A CAS I 3 questions Categorical 
coming to clinic attitude about Likert scale 1 to 4 1= Positive 
coming to clinic (Strongly agree to attitudes 
strongly disagree) 0= Negative 
attitudes 
History of HIV Respondent ACASI Continuous No receding 
self-report about 
year of HIV 
diagnosis 
CD4 CD4 cell count Clinical Continuous Categorical 
level data 1= CD4 0-200 
copies/ml 
2= CD4: 201-
350 copies/ml 
3= CD4: >350 
copies/ml 
Viral load Viral load levels Clinical Continuous Categorical 
data 1: :5 200 
copies/ml 
0: > 200 
copies/ml 
*Bold variables are ma1n Independent vanables of Interest 
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APPENDIX E. Univariate statistics and distribution of the social support 
summary score 
Appendix E includes the univariate statistics and distribution of the social 
support summary score for the sample. Figure E.1 illustrates the distribution. The 
normality curve (blue line super-imposed on bar graph) indicates that the 
summary score is skewed to the right. The mean summary score was 13.5 and 
the standard deviation was 4.5. The 25th percentile was 1 0.0, median summary 
score was 14.0, and the 75th percentile was 17. 
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Figure E.1 Distribution of the social support summary score 
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APPENDIX F. Univariate statistics and distribution of the stigma summary 
score 
Appendix F includes the univariate statistics and the distribution of the 
stigma summary score for the sample. Figure F.1 illustrates the distribution. The 
normality curve indicates that the summary score had an approximate near 
normal distribution. The mean summary score was 24.6 and the standard 
deviation was 8.3. The 25th percentile was 19, median summary score was 25, 
and the 75th percentile was 31. 
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APPENDIX G. Sensitivity analysis of age 
For this analysis, a sensitivity analysis was conducted to specify the age 
variable. Age was examined in three ways as (1) a three level variable, (2) 
dichotomously, and (3) continuously. The benefits of using the three-level or 
dichotomous measure of age are that they allow for comparison between 
discrete categories for easier interpretation. However, creating a dichotomous 
measure results in a loss of some statistical power and a loss of information 
about the distribution of age. 177 The three-level measure also results in loss of 
some statistical power 177; however, this measure preserves some information 
about the distribution of age. The benefits of using a continuous variable is that 
the same effect can be observed for each year a person ages, there is no loss of 
information or power, and it may overall trends in relation to the outcome can be 
observed-- retention in care. However, the interpretation of this continuous age 
may not be as clear, because of the increase in one year of age relative to being 
retained in care. Table G.1 shows how the how the variables in this analysis 
were associated with the three-level age variable. Tables G.2 and G.3 shows 
how the variables in this analysis were associated with dichotomous age 40 and 
50 respectively. Finally, Table G.4 shows how the variables in this analysis were 
associated with the continuous age variable. 
The categories chosen for the three-level variable were based on the 
distribution of age for the sample. Figure G.1 illustrates the distribution of age for 
the sample. The normality curve indicates that the sample has a nearly normal 
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distribution. The mean age was 45.9 and the standard deviation was 10.2 years. 
The interquartile range was used to approximate the specific categories for age. 
The 25th percentile was 39 years, median age was 47.0, and the 75th percentile 
was 53 years. Therefore, age was classified into three categories that 
approximated the interquartile range: less than 40, 40-54, and 55 and older 
The categories chosen for the dichotomous age variable have been used 
in previous literature. Specifically, the CDC categorizes older HIV-infected 
individuals as greater than or equal to age 50. 133·178·179 Although CDC uses 50 
as the cut-point for the age of older HIV-infected individuals, age was examined 
more completely as done in the literature. Age was operationalized as categorical 
variable in two different ways: as dichotomous age greater than or equal to 40 
and less than 40 180-182, and as dichotomous age greater than or equal to age 50 
and less than 50.60·61 
The three-level age variable was chosen for the analysis because this 
categorization of age provides more information about the distribution about age 
than the dichotomous age variables. In addition, the three-level variable has 
more explanatory power than the dichotomous age variables and provides an 
easier interpretation than the continuous age variable. 
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Table G.1 Bivariate analysis of characteristics of study sample stratified by 
age <40, 40-54, 2:55 
A e 
<40 40-54 2:55 Total 
, (n=262, (n=559, (1:1=,207, ·. p (n=1028) 
.• 25.5%} 54.4%) · 20.4%} 
Characteristics 
Social Support 
Low social support 103 (39.3) 250 (44.7) 78 (37.7) 0.13 431 (41 .9) High social sueeort 159 (60.7} 309 (55.3) 129 (62 . 3~ 597 {58.1) 
Sti ma 
High stigma levels 92 (35.1) 184 (32.9) 67 (32.4) 0.77 343 (33.4) Low stigma levels 170 (64.9} 375 {67.1) 140 (67.6} 685 {66.6} 
Gender 
Female 110 (42.0) 216 (38.6) 71 (34.3) 0.24 397 (38.6) Male 152 {58.0} 343 {61.4~ 136 {65.7~ 631 {61.4~ 
Race!Ethnicity_ 
White, Non-Hispanic 36(13.7) 69 (12.3) 12 (5.8) 117(11.4) 
Hispanic 43 (16.4) 98(17.5) 33 (15.9) 0.14 174 (16.9) Other, Non-Hispanic 8 (3.1) 15(2.7) 5 (2.4) 28 (2.7) 
Black, Non-His~anic 175 {66.8} 337 {67.4} 157(75.9} 709 (69.0} 
Education 
Some college or 109 (41 .'6) 167 (29.9) 59 (28.5) 335 (32.6) greater 0.0007 HS graduate or GED 81 (30.9) 180 (32.2) 57 (27.5) 318 (30.9) 
Some HS or less 72 {27.5} 212 {37.9} 91 {44.0} 375 {36.5} 
Insurance 
Uninsured/None 75 (28.6) 133 (23.8) 33(15.9) 241 (23.4) 
Private 46 (17.6) 57 (1 0.2) 19 (9.2) 
<0.0001 122(11.9) Medicare 32(12.2) 121 (21 .7) 62 (30.0) 215 (20.9) 
Medicaid 109(41.6) 248 {44.4) 93 (44.9) 450 (43.8} 
Place of Birth 
Outside of U.S. 53 (20.2) 110 (19.7) 35 (16.9) 0.62 198 (19.3) U.S. 209 (79.8} 449 (80.3) 172 {83.1) 830 {80.7} 
Language spoken the 
most 
Other 25 (9.5) 79 (14.1) 28 (13.5) 0.18 132 (12.8) English 237 {90.5} 480 {85.9} 179 (86.5} 896 {87.2} 
History of 
Incarceration 
Yes 17 (6.5) 45 (8.1) 6 (2.9) 0.04 68 (6.6) 
No 245 (93.5) 514 (92.0) 201 (97.1) 960 (93.4) 
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A e 
40-54 ' .. ~55 Total (n=559, · (n=207, p (n.=1028) 
· .. 54.4%} 20.4%} 
Careg_iver for Adults 
Yes 25 (9.5) 76 (13.6) 25(12.1) 0.25 126 (12.3) No 237 {90.5} 483 {86.4} 182 {87.9} 902 {87.7} 
Careg_iver for children 
Yes 87 (33.2) 101 (18.1) 19 (9.2) 
<0.0001 207 (20.1) No 175 {66.8} 458 {81 .9} 188 {90.8} 821 {79.9} 
EmeJoy_ment 
Employed 92 (35.1) 120 (21.5) 48 (23.2) 
<0.0001 260 (25.3) Unem~lo~ed 170 (64.9) 439 {78.5) 159 {76.8} 768 {74.7) 
Housing_ status 
Someone else's 58 (22.1) 116 (20.8) 39(18.8) 213 (20.7) home/apartment 
Other 28(10.7) 60 (10.7) 16 (7.7) 0.59 104 (1 0.1) 
Own 176 (67.2) 383 (68.5) 152 (73.4) 711 (69.2) home/a~artment 
Alcohol use 
High level of use 57 (21 .8) 119(21 .3) 38(18.4) 0.61 214 (20.8) Low level of use 205 {78.2} 440 {78.7} 169 {81 .6} 814 {79.2} 
Mental Health Distress 
High distress 121 (46.2) 272 (48.7) 84 (40.6) 0.14 477 (46.4) Low distress 141 {53.8} 287 {51 .3} 123 {59.4} 551 {53.6} 
Substance abuse 
Cocaine use 
Yes, in the past 90 19 (7.3) 88 (15.7) 25 (12.1) 132 (12.8) days 
Past history of use, 
<0.0001 but not in past 90 54 (20.6) 242 (43.3) 102 (49.3) 398 (38.7) 
days 
Never used 189(72.1) 229(41.0) 80 (38.7) 498 (48.4) 
Heroin use 
Yes, in the past 90 4 (1.5) 25 (4.5) 9 (4.4) 38 (3.7) days 
Past history of use, <0.0001 but not in past 90 25 (9.5) 105 (18.8) 70 (33.8) 200 (19.5) 
days 
Never used 223 (88.9) 429 (76.7) 128 (61.8) 790 (76.9) 
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Age 
<40 .. 
·40·54 . • . 2!:55 Total 
· (n=262, (n=559, (h=207,. . p. (n=1028) 
·· 25.5%} . 54.4%} 20,4%} . 
Other drug use 
Yes, in the past 90 18 (6.9) 30 (5.4) 7 (3.4) 55 (5.4) days 
Past history of use, 0.14 but not in past 90 54 (20.6) 123 (22.0) 33(15.9) 210 (20.4) 
days 
Never used 190 {72.5} 406 {72.6} 167 {80.7} 763 {74.2} 
Attitudes about 
coming_ to care 
Negative 8 (3.1) 21 (3.8) 18 (8.7) 0.006 47 (4.6) Positive 254 {96.9) 538 (95.2} 189 {91 .3} 981 (95.4) 
Life chaos 
High levels of life 27 (10.3) 84 (15.0) 26 (12.6) 137 (13.3) 
chaos 0.17 Low levels of life 235 (89.7) 475 (85.0) 181 (87.4) 891 (86.7) 
chaos 
Barriers to care 
Worried about paying 
for HIV medical care 
Yes 53 (20.2) 116 (20.8) 25 (12.1) 0.02 194 (18.9) No 209 (79.8) 443 (79.3) 182 (87.9) 834 (81 .1) 
Problems scheduling 
appointments due to 
lack of access to a 
phone 
Yes 17 (6.5) 55 (9.8) 14 (6.8) 0.18 86 (8.4) No 245 (93.5) 504 (90.2) 193 (93.2) 942 (91 .6) 
Problems getting 
someone to answer 
calls to schedule an 
appointment 
Yes 16 (6.1) 43 (7.7) 11 (5.3) 0.44 70 (6.8) 
No 246 (93.9) 516 (92.3) 196 (94.7) 958 (93.2) 
Problems finding 
providers who speak 
the same language 
Yes 32(12.2) 66 (11 .8) 15(7.3) 0.15 113(11.0) No 230 (87.8) 493 (88.2) 192 (92.8) 915 (89.0) 
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<40 40-54 . Total 
· .(n=262, <n=559, . p (n=1028) 
· . ' 25.5%) •.. 54.4%1 ' .... 
Problems getting 
appointment at 
convenient time 
Yes 6 (2.3) 20 (3.6) 5 (2.4) 0.51 31 (3.0) No 256 (97.7) 539 (96.4) 202 (97.6) 997 (97.0) 
Problems with 
transportation to 
appointment 
Yes 58 (22.1) 92 (16.5) 24(11 .6) 0.009 174 (16.9) 
No 204 {77.9} 467 {83.5) 183 {88.4) 854 (83.1) 
Risk categ_ory 
MSM 106 (40.5) 134 (24.0) 22 (10.6) 262 (25.5) 
MSM +IOU 6 (2.3) 11 (2.0) 7 (3.4) 24 (2.3) 
IOU 20 (7.6) 104 (18.6) 80 (38.7) <0.0001 204 (19.8) 
Unknown/Other 15(5.7) 19 (3.4) 17 (8.2) 51 (5.0) 
Heterosexual 115 {43.9} 291 {52.1} 81 {39.1} 487 {47.4} 
Currently Taking 
ART 
No 51 (19.5) 80 (14.3) 23(11 .1) 0.04 154 (15.0) Yes 211 {80.5} 479 {85.7} 184 {88.9} 874 {85.0} 
C04 (cells/mL)-
(within ±120 day_s2 
0-200 49(18.7) 92 (16.5) 32 (15.5) 173 (16.8) 
201-350 57 (21 .8) 113 (20.2) 43 (20.8) 0.83 213 (20.7) 
>350 156 {59.5} 354 {63.3} 132 {63.8} 642 {62.5} 
VL (copieslml)-
(within ±120 day_sl 
Detectable 121 (46.2) 166 (29.7) 52 (25.1) 339 (33.0) ( ~200) 
<0.0001 Undetectable 141 (53.8) 393 (70.3) 155 (74.9) 689 (67.0) {<200} 
Years living with 
HIV (range 0-
30) 
Mean± SD 7.7 ± 5.8 13.9 ± 8.3 13.0 ± 7.2 <0.0001 1028 
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Table G.2 Bivariate analysis of characteristics of study sample stratified by 
age <40 vs. ~40 
Age 
<40 ~40 . Total 
. (11=262, 25,5%} . {n=766, 74.5%) p (n=1028) 
Characteristics 
Social Support 
Low social support 103 (39.3) 328 (42.8) 0.99 431 (41.9) 
Hi9h social sueeort 159 (60.7} 438 ~57.2} 597 ~58 . 1) 
Stigma 
High stigma levels 92 (35.1) 251 (32.8) 0.49 343 (33.4) 
Low stigma levels 170 (64.9} 515 (67.2} 685 (66.6} 
Gender 
Female 110 (42.0) 287 (37.5) 0.19 397 (38.6) 
Male 152 (58.0} 479 (62.5) 631 (61.4) 
Race!Ethnicity 
White, Non-Hispanic 36 (13.7) 81 (1 0.6) 117 (11.4) 
Hispanic 43 (16.4) 131 (17.1) 0.54 174 (16.9) 
Other, Non-Hispanic 8 (3.1) 20 (2.6) 28 (2.7) 
Black, Non-Hiseanic 175 (66.8} 534 (69.7} 709 (69.0) 
Education 
Some college or 109(41.6) 226 (29.5) 335 (32.6) greater 
HS graduate or GED 81 (30.9) 237 (30.9) 0.0003 318 (30.9) 
Some HS or less 72 (27.5} 303 (39.6} 375 (36.5} 
Insurance 
Uninsured/None 75 (28.6) 166 (21.7) 241 (23.4) 
Private 46 (17.6) 76 (9.9) 
<0.0001 122(11.9) 
Medicare 32 (12.2) 183 (23.9) 215 (20.9) 
Medicaid 109(41.6) 341 (44.5} 450 (43.8} 
Place of Birth 
Outside of U.S. 53 (20.2) 145 (18.9) 0.65 198 (19.3) U.S. 209 {79.8} 621 {81 .1} 830 {80.7} 
Language spoken the 
most 
Other 25 (9.5) 107 (14.0) 0.06 132 (12.8) 
English 237 (90.5) 659 (86.0) 896 (87.2) 
History of Incarceration 
Yes 17 (6.5) 51 (6. 7) 
0.11 
68 (6.6) 
No 245 (93.5) 715 (93.3) 960 (93.4) 
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Total p {n=1028} 
Caregiver for Adults 
Yes 25 (9.5) 101 (13.2) 
0.12 
126 (12.3) 
No 237 (90.5) 665 (86.8) 902 (87.7) 
Caregiver for children 
Yes 87 (33.2) 120 (15.7) 
<0.0001 
207 (20.1) 
No 175 (66.8) 646 (84.3) 821 (79.9) 
Employment 
Employed 92 (35.1) 168 (21.9) 
<0.0001 
260 (25.3) 
Unemployed 170 (65.0) 598 (78.1) 768 (74.7) 
Housing status 
Someone else's 58 (22.1) 155 (20.2) 213 (20.7) home/apartment 
Other 28 (10.7) 76 (9.9) 0.72 104 (1 0.1) 
Own home/apartment 176 (67.2) 535 (69.8) 711 (69.2) 
Alcohol use 
High level of use 57 (21 .8) 157 (20.5) 
0.66 
214 (20.8) 
Low level of use 205 (78.2) 609 (79.5) 814 (79.2) 
Mental Health Distress 
High distress 121 (46.2) 356 (46.5) 0.93 477 (46.4) 
Low distress 141 (53.8) 410 (53.5) 551 (53.6) 
Substance abuse 
Cocaine use 
Yes, in the past 90 19(7.3) 113 (14.6) 132 (12.8) days 
Past history of use, 
<0.0001 but not in past 90 54 (20.6) 344 (44.9) 398 (38.7) 
days 
Never used 189 (72.1) 309 (40.4) 498 (48.4) 
Heroin use 
Yes, in the past 90 4 (1 .5) 34 (4.4) <0.0001 38 (3.7) days 
Past history of use, 
but not in past 90 25 (9.5) 175 (22.9) 200 (19.5) 
days 
Never used 233 (88.9) 557 (72.7) 790 (76.9) 
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Age 
···•·····••· ··· ··· 54o ····•· ·. ~40 p Total ;tn::;2&2, 2s:s%) 
··•·· {n=766, 74.5%) ·.· .· {n=1028} 
Other drug use 
Yes, in the past 90 18 (6.9) 37 (4.8) 55 (5.4) 
days 
Past history of use, 
0.44 but not in past 90 54 (20.6) 156 (20.4) 210 (20.4) 
days 
Never used 190 (72.5) 573 (74.8) 763 (74.2) 
Attitudes about coming 
to care 
Negative 8 (3.1) 39 (5.1) 
0.17 
47 (4.6) 
Positive 254 (96.9) 727 (94.9) 981 (95.4) 
Life chaos 
High levels of life 27 (10.3) 110(14.4) 137 (13.3) 
chaos 
Low levels of life 0.10 
chaos 235 (89.7) 656 (85.6) 891 (86.7) 
Barriers to care 
Worried about paying 
for HIV medical care 
Yes 53 (20.2) 141 (18.4) 
0.52 194 (18.9) 
No 209 (79.8) 625 (81.6) 834 (81 .1) 
Problems scheduling 
appointments due to 
lack of access to a 
phone 
Yes 17 (6.5) 69 (9.0) 
0.20 
86 (8.4) 
No 245 (93.5) 697 (91.0) 942 (91 .6) 
Problems getting 
someone to answer 
eall~ t6 ~~hadUI9 an 
appointment 
Yes 16 (6.1) 54 (7.1) 
0.60 70 (6.8) No 246 (93.9) 712 (92.9) 958 (93.2) 
Problems finding 
providers who speak 
the same language 
Yes 32 (12.2) 81 (10.6) 0.46 113(11 .0) 
No 230 (87.8) 685 (89.4) 915 (89.0) 
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Age 
. . <:40 . .. .. ..... , ;::40 . ·. , . Total 
''(h=262; 25;5%1 .• {n=7G6, 74;5%) p (n=1028} 
Problems getting 
appointment at 
convenient time 
Yes 6 (2.3) 25 (3.3) 0.42 31 (3.0) No 256 (97.7) 741 (96.7) 997 (97.0) 
Problems with 
transportation to 
appointment 
Yes 58 (22.1) 116(15.1) 0.009 174 (16.9) 
No 204 {77.9} 650 {84.9} 854 {83.1} 
Risk category 
MSM 106 (40.5) 156 (20.4) 262 (25.5) 
MSM +IOU 6 (2.3) 18 (2.4) 24 (2.3) 
IOU 20 (7.6) 184 (24.0) <0.0001 204 (19.8) 
Unknown/Other 15(5.7) 36 (4.7) 51 (5.0) 
Heterosexual 115 {43.9) 372 {48.6) 487 {47.4) 
Currently Taking ART 
No 51 (19.5) 103 (13.5) 0.02 154(15.0) 
Yes 211 {89.5) 663 {86.6) 874 {85.0) 
CD4 (cellslmL)-
(within ±120 da~s2 
0-200 49 (18.7) 124 (16.2) 173 (16.8) 
201-350 57 (21. 8) 156 (20.4) 0.50 213 (20.7) 
>350 156 {59.5} 486 {63.5} 642 {62.5) 
VL (copieslml)-
(within ±120 da~s2 
Detectable ( 2:200) 121 (46.2) 218 (28.5) 
<0.0001 339 (33.0) 
Undetectable (<200) 141 {53.8} 548 {71 .5} 689 {67.0} 
Years living with HIV 
(range 0-30) 
Mean± SO 7.7± 5.8 13.2± 7.5 <0.0001 1028 
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Table G.3 Bivariate analysis of characteristics of study sample stratified by 
age <50 vs. ~50 
Age 
· .. . · <50 
• 
0 ··.··.~50 Total 
{rt~621, 60:4%} .. {n=407, 39.6%} .. p .{n=1028) 
Characteristics 
Social Support 
Low social support 253 (40.7) 178 (43.7) 0.34 431 (41.9) 
High social su~~ort 368 {59.3} .229 {56.3} 597 {58.1} 
Stigma 
High stigma levels 207 (33.3) 136 (33.4) 0.98 343 (33.4) 
Low stigma levels 414 (66.7} 271 {66.6) 685 {66.6} 
Gender 
Female 258 (41 .6) 139 (34.2) 0.02 397 (38.6) 
Male 363 {58.5} 268 {65.9} 631 {61.4} 
Race!Ethnicity__ 
White, Non-Hispanic 88 (14.2) 29 (7.1) 117(11.4) 
Hispanic 107 (17.2) 67 (16.5) 0.003 174 (16.9) 
Other, Non-Hispanic 19 (3.1) 9 (2.2) 28 (2.7) 
Black, Non-Hiseanic 407 {65.5) 302 {74.2} 709 (69.0} 
Education 
Some college or greater 214 (34.5) 121 (29.7) 335 (32.6) 
HS graduate or GED 200 (32.2) 118 (29.0) 0.03 318 (30.9) 
Some HS or less 207 {33.3} 168 {41 .3} 375 {36.5} 
Insurance 
Uninsured/None 151 (24.3) 90 (22.1) 241 (23.4) 
Private 89 (14.3) 33 (8.1) 0.004 122 (11 .9) 
Medicare 115(18.5) 100 (25.6) 215 (20.9) 
Medicaid 266 {42.8} 184 {24.6} 450 {43.8} 
Place of Birth 
Outside of U.S. 53 (20.2) 145 (18.9) 0.65 198 (19.3) 
U.S. 209 {79.8} 621 {81.1} 830 (80.7} 
Language spoken the 
most 
Other 68 (11 .0) 64 (15.7) 0.03 132 (12.8) 
English 553 (89.0} 343 (84.3} 896 (87.2} 
History of Incarceration 
Yes 51 (8.2) 17 (4.2) 0.01 68 (6.6) 
No 570 (91.8) 390 (95.8) 960 (93.4) 
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Age 
<50 ~50 Total 
fn=621, 60.4%} . (n=407,39.6%} . P· {n=1028} 
Caregiver for Adults 
Yes 81 (13.0) 45 (11 .1) 126 (12.3) 
0.34 
No 540 (87.0) 362 (88.9) 902 (87.7) 
Caregiver for children 
Yes 168 (27.1) 39 (9.6) 207 (20.1) 
<0.0001 
No 453 (72.9) 368 (90.4) 821 (79.9) 
Employment 
Employed 166 (26.7) 94 (23.1) 
0.19 
260 (25.3) 
Unemployed 455 (73.3) 313 (76.9) 768 (74.7) 
Housing status 
Someone else's 130 (20.9) 83 (20.4) 213 (20.7) home/apartment 
Other 67(10.8) 37 (9.1) 0.63 104 (1 0.1) 
Own home/apartment 424 (68.3) 287 (70.5) 711 (69.2) 
Alcohol use 
High level of use 142 (22.9) 72 (17.7) 0.05 214 (20.8) 
Low level of use 479(77.1) 335 (82.3) 814 (79.2) 
Mental Health Distress 
High distress 301 (48.5) 176 (43.2) 
0.10 
477 (46.4) 
Low distress 320 (51 .5) 231 (56.8) 551 (53.6) 
Substance abuse 
Cocaine use 
Yes, in the past 90 days 84 (13.5) 48 (11 .8) 132 (12.8) 
Past history of use, but 205 (33.0) 193 (47.4) <0.0001 398 (38.7) 
not in past 90 days 
Never used 332 (53.5) 166 (40.8) 498 (48.4) 
Heroin use 
Yes, in the past 90 days 20 (3.2) 18 (4.4) 38 (3.7) 
Past history of use, but 85(13.7) 115 (28.3) <0.0001 200 (19.5) 
not in past 90 days 
Never used 516 (83.1) 274 (67.3) 790 (76.9) 
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Other drug use 
Yes, in the past 90 days 43 (6.9) 12 (3.0) 55 (5.4) 
Past history of use, but 132 (21 .3) 78 (19.2) 0.01 210 (20.4) 
not in past 90 days 
Never used 446 (71 .8) 317 (77.9) 763 (74.2) 
Attitudes about coming to 
care 
Negative 22 (3.5) 25 (6.1) 
0.05 
47 (4.6) 
Positive 599 (96.5) 382 (93.9) 981 (95.4) 
Life chaos 
High levels of life chaos 76 (12.2) 61 (15.0) 
0.20 
137 (13.3) 
Low levels of life chaos 545 (87.8) 346 (85.0) 891 (86.7) 
Barriers to care 
Worried about paying for 
HIV medical care 
Yes 130 (20.9) 64(15.7) 0.04 194 (18.9) 
No 491 (79.1) 343 (84.3) 834 (81 .1) 
Problems scheduling 
appointments due to lack 
of access to a phone 
Yes 54 (8.7) 32 (7.9) 0.64 86 (8.4) 
No 567 (91 .3) 375 (92.1) 942 (91 .6) 
Problems getting 
someone to answer calls 
to schedule an 
appointment 
Yes 47 (7.6) 23 (5.7) 0.23 70 (6.8) 
No 574 (92.4) 384 (94.4) 958 (93.2) 
Problems finding providers who speak the 
same language 
Yes 77(12.4) 36 (8.9) 0.07 113 (11 .0) 
No 544 (87.6) 371 (91 .2) 915 (89.0) 
Problems getting 
appointment at 
convenient time 
Yes 17 (2.7) 14 (3.4) 0.51 31 (3.0) 
No 604 (97.3) 393 (96.6) 997 (97.0) 
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A e 
•····•····•··•·••··· •····••· <50• ....•. ·.·. · ... ~50 .. Total . . . . . . . . . . .. , ... . p 
' ~ < {o::621, 60.4%} · ( m=407, 39.6o/o} (n=1028} 
Problems with 
transportation to 
appointment 
Yes 119 (19.2) 55 (13.5) 174 (16.9) 
0.02 
No 502 (80.8) 352 (86.5) 854 (83.1) 
Risk category 
MSM 200 (32.3) 62 (15.2) 262 (25.5) 
MSM +IOU 14 (2.3) 10 (2.5) 24 (2.3) 
IOU 80 (12.9) 124 (30.5) <0.0001 204 (19.8) 
Unknown/Other 26 (4.2) 25 (6.1) 51 (5.0) 
Heterosexual 301 (48.5) 186 (45.7) 487 (47.4) 
Currently Taking ART 
No 103 (16.6) 51 (12.5) 154 (15.0) 0.07 
Yes 518 (83.4) 356 (87.5) 874 (85.0) 
CD4 (cellslmL)-
(within ±120 days) 
0-200 106 (17.1) 67 (16.5) 173 (16.8) 
201-350 130 (20.9) 83 (20.4) 0.93 213 (20.7) 
>350 385 (62.0) 257 (63.1) 642 (62.5) 
VL (copies/ml)-
(within ± 120 days) 
Detectable (<::200) 228 (36.7) 111 (27.3) 0.002 339 (33.0) 
Undetectable (<200) 393 (63.3) 296 (72.7) 689 (67.0) 
Years living with HIV 
(range 0-30) 
Mean± SO 10.7 ± 6 .9 13.5 ± 7 .9 <0.0001 1028 
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Table G.4 Bivariate analysis of characteristics of study sample by 
continuous age 
Mean .J\ge ±.so p Total 
· ·. (range 19- 74} (n=1028) 
Characteristics 
Social Support 
Low social support 46.2 ± 9.3 0.34 431 (41 .9) 
High social su~~ort 45.6 ± 10.4 597 {58 . 1~ 
Stigma 
High stigma levels 45.5±10.1 0.39 343 (33.4) 
Low stigma levels 46.1 ± 10.2 685 {66.6} 
Gender 
Female 45.5 ± 9.9 0.31 397 (38.6) 
Male 46.1 ± 10.3 631 {61.4~ 
Race/Ethnicity_ 
White, Non-Hispanic 43.3 ± 8.9 117 (11.4) 
Hispanic 46.1 ± 10.0 0.04 174 (16.9) 
Other, Non-Hispanic 45.5 ± 10.8 28 (2.7) 
Black, Non-His~anic 46.3 ± 10.4 709 (69.0~ 
Education 
Some college or greater 44.6 ± 10.4 335 (32.6) 
HS graduate or GED 45.6 ± 10.0 0.002 318 (30.9) 
Some HS or less 47.3 ± 10.0 375 {36.5} 
Insurance 
Uninsured/None 43.8 ± 10.7 241 (23.4) 
Private 42.7 ± 10.7 
<0.0001 122(11 .9) 
Medicare 48.9 ± 9.3 215 (20.9) 
Medicaid 46.4 ±9.7 450 {43.8} 
Place of Birth 
Outside of U.S. 46.0 ± 10.0 0.83 198(19.3) 
U.S. 45.8 ± 10.2 830 {80.7~ 
Language spoken the 
most 
Other 47.9 ± 9.6 0.02 132 (12.8) 
English 45.6 ± 10.2 896 {87.2} 
History of Incarceration 
Yes 44.1 ± 8.5 0.08 68 (6.6) 
No 46.0 ± 10.3 960 (93.4) 
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· l\llean Age ±SO p Total 
· (range 19- 74) .·" . (n=1028) 
Caregiver for Adults 
Yes 46.5 ± 9.4 126 (12.3) 
0.49 
No 45.8 ± 10.3 902 (87.7) 
Caregiver for children 
Yes 42.0 ± 9.1 207 (20.1) 
<0.0001 
No 46.8 ± 10.2 821 (79.9) 
Employment 
Employed 43.5 ± 9.8 260 (25.3) 
0.19 
Unemployed 43.5 ± 10.9 768 (74.7) 
Housing status 
Someone else's 44.9 ± 10.5 213 (20.7) home/apartment 
Other 46.2 ± 9.0 0.29 104 (1 0.1) 
Own home/apartment 46.1±10.3 711 (69.2) 
Alcohol use 
High level of use 44.7 ± 9.3 214 (20.8) 
0.05 
Low level of use 46.2 ± 10.4 814 (79.2) 
Mental Health Distress 
High distress 45.3 ± 9.9 0.11 477 (46.4) 
Low distress 46.4 ± 10.4 551 (53.6) 
Substance abuse 
Cocaine use 
Yes, in the past 90 days 46.7 ± 8.1 132 (12.8) 
Past history of use, but 48.5 ± 8.6 <0.0001 398 (38.7) 
not in past 90 days 
Never used 43.6 ±11.2 498 (48.4) 
Heroin use 
Yes, in the past 90 days 48.1 ± 8.4 38 (3.7) 
Past history of use, but 49.9 ± 8.4 <0.0001 200 (19.5) 
not in past 90 days 
Never used 44.8 ±10.4 790 (76.9) 
173 
.. 
·Total 
.··. Mean ~ge ±so . p (n=1028) 
· · (ra~ge 19:.. 741 
Other drug use 
Yes, in the past 90 days 42.9 ± 9.6 55 (5.4) 
Past history of use, but 45.3 ± 9.2 0.04 210 (20.4) 
not in past 90 days 
Never used 46.2 ±10.4 763 (74.2) 
Attitudes about coming to 
care 
Negative 49.5 ± 9.9 47 (4.6) 
0.01 
Positive 45.7 ± 10.2 981 (95.4) 
Life chaos 
High levels of life chaos 46.7±9.7 
0.28 137 (13.3) Low levels of life chaos 45.7 ±10.2 891 (86.7) 
Barriers to care 
Worried about paying for 
HIV medical care 
Yes 44.3 ± 10.2 0.02 194 (18.9) No 46.2 ± 10.1 834 (81 .1) 
Problems scheduling 
appointments due to lack 
of access to a phone 
Yes 45.9 ± 10.2 
0.87 86 (8.4) No 45.7 ± 9.7 942 (91 .6) 
Problems getting 
someone to answer calls 
to schedule an 
appointment 
Yes 45.3 ± 8.9 
0.61 70 (6.8) 
No 45.9 ± 10.3 958 (93.2) 
Problems finding providers 
who speak the same language 
Yes 44.3 ± 9.6 
0.08 113(11 .0) No 46.1 ± 10.2 915 (89.0) 
Problems getting 
appointment at 
convenient time 
Yes 46.6 ± 9.6 
0.68 31 (3.0) No 45.9 ± 10.2 997 (97.0) 
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Mea.n Age ± S.D Total p (n=1028) 
··. {range19-74} . 
Problems with 
transportation to 
appointment 
Yes 43.8 ±10.5 0.003 
174 (16.9) 
No 46.3 ± 10.1 854 (83.1) 
Risk category 
MSM 41 .2±10.5 262 (25.5) 
MSM +IOU 46.2 ± 10.3 24 (2.3) 
IOU 50.8 ± 9.2 <0.0001 204 (19.8) 
Unknown/Other 47.9 ±12.7 51 (5.0) 
Heterosexual 46.1 ± 9.3 487 (47.4) 
Currently Taking ART 
No 43.3 ± 10.8 154 (15.0) 
0.002 
Yes 46.3 ± 10.0 874 (85.0) 
CD4 (cellslmL)-
(within ±120 days) 
0-200 45.4 ± 10.0 173 (16.8) 
201-350 45.7 ± 10.3 0.73 213 (20.7) 
>350 46.0 ± 10.2 642 (62.5) 
VL ( copies/ml) -
(within ±120 days) 
Detectable (2:200) 43.5 ± 10.4 339 (33.0) 
<0.0001 Undetectable ( <200) 47.0 ± 9.9 689 (67.0) 
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Figure G.1 Distribution of age 
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APPENDIX H. Correlation analysis among significant variables 
Correlations were computed for variables that were significant in the 
bivariate results (found in Table 2.1). The correlation results (Table F.1) suggest 
that the main variables of interest social support, stigma, and age were 
marginally significant with other variables. Mental health was significantly 
correlated with 12 variables included in the multivariable analysis. Of note, 
mental health distress had an inverse relationship with social support (-0.27, 
p<0.0001) and a positive relationship with stigma (0.22, p<0.001). This suggests 
that inclusion of mental health distress could lead to unreliable and unstable 
estimates because of the association with more than half of the variables 
included in the analysis. 
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Table H.1 Correlation analysis of variables for inclusion in multivariable analysis 
I 
2 
3 
5 
I 
2 kept visits 
> 90 days 
apart in past 
12 months 
Age ·0.07 1.00 I I 
Pearson Correlation Coeffici~nts, N = 1928 
Prob > under HO: Rho=O 
I ··· I ····· + I I ··········· + . 
·.· ·~;,t .q::::i181 '}:\:~ ~91 ::· ¥:~,,.~ ·'~'! 
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1··· ·· ········ 1······ ···· l + -
1 
Social 
support . ·· ······ · I I -· -+ ····· I···· · · l I I I· I 
.... + I ... +- ..  +· . I • I ·· ·· ········· I 
Stigma 1·-· ····· 1·····-· - I ·-
1.001 + . +· + I I . I · · t t · I t ·· ···· I I I I 
I Race 
Gender I -~-~i l ~:6~1 ri:cicil ·· ·· 6:~1 ·6:~~ ~ 1.0CI I ·· I · ·· · + I + · I·· I · I 
Education I ... 0.061 ·· _-0.121 ··· q:Q71 -0.131·· ~0.071·· -0:121 1.0Cj 
0.04 <.0001 0.03 <.0001 0.02 <.0001 
I I · I ·· I t ····· ·· I· I I · I 
,..,... :: :: :~1 ::r -~:1 ;~ ~~~ 100, I I · I · ··+ - I I · · · ·· I · ..... I ·. 
Housing I· _0.071····· -0.041 ······ :.0·.~-~~ - ... Q.07 0.031· ;{l.10[ -0.071 · . Q.1~J 1.0C 
status 0.03 0.16 o.oo 0.03 0.30 o.ool 0.03 0.00 I 
... .. I · I 
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Cocaine use 1 ·0:071 :Q.2QI 0.021 -0.051 O:Q91 0.081··· .... 0.101 · . -0.061· -0.12 
1.00 
·· I ·· I ··· I ····· ·· + I 1············ 1 · ·· · I 
11 0.03 <.0001 0.50 0.13 0.00 0.01 0.00 0.05 <.0001 
·0.19 
<.0001 
1.00 I········ I 
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0.00 0.03 
'"'' I ············· . . ,,.,.,,, , .... , , , ..... . ........... ,,. . ..... 
Other 0.99 0.21 <.0001 0.01 0.02 0.72 0.00 <.0001 <.0001 12 drug use 
Worried 0.13 
·· ···· -0.07 -0.12 0.12 -0.03 -0.17 0.09 0.01 0.11 0.10 0.01 -0.06 I···· 1.00 about <.0001 <.0001 
I .. ,,, .. 
. .... . 0.74 ' ' ' . .... .. ········ ....... ... ..... ,. ... ,,,, . ...... ... . . . .. 0.04 0.00 0.34 <.0001 0.00 0.72 0.00 0.00 0.08 13 paying 
forHIV 
care 
0.07 0.01 -0.06 0.14 0.01 -0.04 -0.02 0.08 0.13 0.15 -0.06 -0.01 0.27 1.00 
''"''' 
. .. 
'' ' .. ,, • •Y-•• •V ................ ... . ... ....... , ... 
Barrier 0.03 0.79 0.04 <.0001 0.78 0.23 0.62 0.01 <.0001 <.0001 0.04 0.81 <.0001 
due to 
14 lack of 
phone 
access 
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'''' 
. ..... , .. .. , .. .. , , , 
Difficulty 0.02 0.11 0.00 0.00 0.46 0.02 0.96 0.02 0.00 0.16 0.86 0.04 <.0001 <.0001 
with 
15 appoint 
mont 
-" time 
-....1 
<0 
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ation 
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0.23 0.40 
........ ,., ..... 
0.49 0.04 0.13 0.00 0.08 0.95 
, ..... 
'"' 
... 
'' I 
Years <.0001 <.0001 <.0001 0.00 <.0001 0.30 0.66 0.24 
17 living 
with HIV 
0.11 -0.03 -0.27 0.22 -0.01 -0.11 -0.03 0.04 0.15 0.11 -0.19 -0.13 0.16 0.18 0.16 0.24 -0.05 1.00 
Mental 0.00 0.29 <.0001 <.0001 0.65 0.00 0.39 0.16 <.0001 0.00 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 0.13 I ···· 
..... . I .. ........ 
18 health 
distress 
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APPENDIX 1: Recruitment Flier 
EXCEPTIONAL CARt. Wint0t;1" EXU:PTION Boston University School of Public Health 
*ARE YOU AN AFRICAN-AMERICAN OR BLACK WOMAN AGE 50 OR OLDER?* 
);> We are interested in talking to African-American or Black women age 50 or older 
who have HIV to participate in a research interview at Boston Medical Center. 
);> We want to understand your experiences related to social support, stigma, and 
retention in HIV medical care. 
);> Participation involves one confidential interview in English of no more than 1-
hour. 
>- You will receive a $25 gift card for your time. 
>- If you are interested please have the front desk page Michal Naisteter or 
contact Maya McDoom at 617.414.1362 mmcdoom@bu.edu 
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APPENDIX J: Qualitative Interview Guide 
Thank you so much for taking the time to talk with me about your HIV/AIDS 
experience. I would like to find out more information about your lifetime 
experiences with this disease and to understand your perceptions about health 
care. 
I would like to begin the conversation by finding out a little more about you. 
1. Can you tell me about yourself, what you do? Who you live with?: 
a. Age (If they don't want to be specific I can ask are you older 
than age 50?) 
b. How would you describe your race or ethnicity? 
c. Do you work? What do you do? 
d. What is your highest level of education? 
Now, I would like to understand your perspective on HIVAIDS 
2. Tell me about the time you found out you were diagnosed with HIV/AIDS 
a. What was it like for you? What did you think/feel when you first 
heard the diagnosis? 
b. What did you know about HIV before you were diagnosed? 
How did those ideas and knowledge affect how you felt? 
c. What were some of your major concerns about the disease? 
d. How long have you been living with the disease? 
a. How has your experience with treatment changed over 
time? 
3. Have you ever felt discriminated against because of HIV? 
Can you tell me what happened? 
How did you feel? 
Did anyone help you with this situation? 
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Next, I would like to understand your health care experience related to 
HIV/AIDS 
4. When you initially found out about your HIV/AIDS status how often did you 
come to the doctor? 
-probe for attitude and beliefs about care, medication adherence 
-probe about discussions with providers 
5. Now think about your current health care experience 
b. What has changed from your initial health care 
experience? 
c. How often do you take your medications? 
d. Can you describe what you typically discuss with your 
health care provider? 
e. How do you see regular medical care and treatment 
fitting into your life? 
f. Can you tell me about some things that help you to stay 
in care? 
g. Can you tell me about some things that might interfere 
with you staying in care? 
6. Health Status with HIV/AIDS 
a. How would you describe your current health? 
b. In what ways do you think your HIV contributes to how healthy 
you feel? 
[Sociodiagram activity] 
7. Thinking about your life with HIV, I'd like you now think about the 
people that impact your life and people whom you interact with most 
frequently 
a. List all of the people using their initials (list all of the applicable 
- can include anyone including friends, family, spouses, dating 
partners, medical professionals, community support groups, 
clergy members, neighbors, etc.) 
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b. Can you also list your relationship with that person (friend, 
acquaintance, family, doctor, clergy, etc) 
c. Is there anyone on this list who is important to you that does 
not appear in your list? 
d. Next, I would like for you to draw your relations with each of 
these individuals. You should draw a circle in the middle as 
you; the persons that you are closest with should be nearest to 
you. People who are not as close to you should be further 
away from your circle. (Use initials only) 
e. Can you tell me how frequently you interact with or talk to each 
person? (never, once a month, 2x a month, 1x a week, 2-3x a 
week, daily, other) 
8. Now, I'd like to know more about your experience with those people 
you have listed 
a. Tell me who in your list of people talk to or know each other? 
b. Who did you specifically tell you had HIV? Can you explain why 
you talked with these persons? 
c. What was it like for you to tell_ you had HIV/AIDS? What 
were you thinking when you told them? 
d. Can you describe their perspective about HIV/AIDS? 
e. What kinds of things have they said to you about your disease 
since finding out? 
f. Has having HIV/AIDS changed your relationship with any of 
these individuals? 
Probe for management, support, relationship , etc 
g. How have any the individuals that we talked about earlier 
helped you with your HIV/AIDS care? 
h. Are there other individuals who you are close to that do not 
know about your HIV/AIDS? 
- Probe for what has prevented disclosure 
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9. What do you think your future will be like living with HIV/AIDS? 
Thank you so much for your thoughtful responses to my questions. I really 
appreciate your willingness to participate in my research project. Do you have 
any further questions or additional details for me about this project? Thanks 
again! 
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